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Summary 
 
 
Mammalian behavior and physiology are coordinated by an intrinsic molecular 
clock into rhythms that are synchronized with the 24 h solar day. 
The circadian rhythms are an adaptation to the evolutionarily conserved 
environment, because they allow to coordinate temporally external environmental 
cycles (eg. light/ dark) with internal biological and physiological processes (eg. 
sleep/ wake). Forced misalignment of behavioral and circadian cycles in human 
subjects, have been associated with increased prevalence of obesity, diabetes and 
cardiovascular disease, in addition to certain cancers and inflammatory disorders. 
 
Since dysfunction of circadian rhythms has strong effects on human health, there 
are many clinical studies dedicated to this aspect. However study the properties of 
the circadian cycle directly on man and his tissue is difficult and expensive due to 
technical and ethical reasons. On the other hand, the study on animal model 
provides information about the entire organism and does not permit a dissection 
of mechanisms and accurate evaluation at specific tissue level. Moreover, animal 
model could not fairly represent the human physiology. Alternatively, in vitro 
model, based on cell culture could be suitable to study circadian clock, however, 
conventional cell culture technology is poorly mimicking the oscillatory nature of 
in vivo signaling systems. A technology able of cyclically delivering periodic 
biochemical stimulations is required to characterize oscillatory behavior of 
circadian cell signaling. 
 
The aim of the thesis is developing an in vitro model that resembles the cyclic 
dynamic fluctuations that can be correlated to the pertinent biological networks 
for dissecting the effects the metabolism on circadian clock; 
 First&of&all&conventional methodologies were tested measuring a cyclic dynamic 
oscillation of circadian rhythms on cell culture derived from peripheral tissues 
in conventional Petri dish. 
This approach allowed to rational understand the correlation between 
metabolite and hormone fluctuations and the circadian oscillators on cell 
culture, and to design ad hoc experiments that are unfeasible with conventional 
biological methods. 
Different experimental setups were developed and fabricated, according to the 
complexity level of study, the type of the readout and the requirement of multiple 
independent biological experiments. All these microfluidic platforms were 
validated for long-term culture, fundamental requirement for circadian rhythm 
study. Quantitative analysis of circadian oscillators was performed through 
quantitative molecular biology analysis or bioluminescence assay, which provides 
evaluation of the circadian clock dynamics. 
 
The results shows that the microfluidic technology could be suitable for hosting 
synchronized cell culture while allowing high-resolution temporal stimulations. 
The potential of this micro-scale approach will allow dynamic study on 
circadian behavior of peripheral tissues, opening a new perspective in circadian 
field. 
 
Sommario 
 
 
Comportamento mammiferi e fisiologia sono coordinate da un orologio 
molecolare intrinseca di ritmi che sono sincronizzati con giorno solare (24 h). 
I ritmi circadiani sono un adattamento all'ambiente evolutivamente conservato, 
in quanto consentono di coordinare cicli ambientali temporalmente esterni (ad 
es. luce / buio) con i processi biologici e fisiologici interni (ad es. il sonno / 
veglia). Il disallineamento forzato dei cicli circadiani comportamentali e in 
soggetti umani, sono stati associati a una maggiore prevalenza di obesità, 
diabete e malattie cardiovascolari, oltre ad alcuni tipi di cancro e patologie 
infiammatorie. 
 
Poiché la disfunzione dei ritmi circadiani ha forti effetti sulla salute umana, ci 
sono molti studi clinici dedicati a questo aspetto. Tuttavia studiare le proprietà 
del ciclo circadiano direttamente sull'uomo e su suoi tessuti è difficile e costoso 
a causa di motivi tecnici ed etici. D'altra parte, lo studio sul modello animale 
fornisce informazioni sull'intero organismo e non consente una dissezione di 
meccanismi e valutazione accurata a livello tessuto specifico. Inoltre, il modello 
animale non potrebbe rappresentare fedelmente la fisiologia umana. In 
alternativa, modelli in vitro, basati su colture cellulari potrebbe essere adatto 
per studiare l'orologio circadiano, tuttavia, la tecnologia di coltura cellulare 
convenzionale riesce ad imitare la natura oscillatoria dei sistemi di 
segnalamento in vivo con scarsi risultati. Una tecnologia in grado di fornire 
ciclicamente stimoli biochimici periodici è necessaria per caratterizzare il 
comportamento oscillatorio di segnalazione cellulare circadiano. 
 
Lo scopo della tesi è di sviluppare un modello in vitro in grado di mimare 
fluttuazioni dinamiche e cicliche che possono essere correlate a reti biologiche 
pertinenti per sezionare gli effetti che il metabolismo ha sull'orologio 
circadiano; 
 
Prima di tutto, sono state testate metodologie convenzionali, misurando 
un'oscillazione dinamica ciclica dei ritmi circadiani in coltura cellulare derivate 
da tessuti periferici in tradizionali Petri dish. 
 
Questo approccio ha permesso di capire razionalmente la correlazione che 
esiste tra fluttazioni metaboliche ad ormonali e gli oscillatori circadiani sulle 
colture cellulari, e di progettare esperimenti ad-hoc che sono irrealizzabile con 
metodi biologici convenzionali. 
Differenti configurazioni sperimentali sono stati sviluppati e realizzati, a 
seconda del livello di complessità di studio, del tipo di readout e della 
molteplicità di esperimenti indipendenti realizzabili. Tutte queste piattaforme 
microfluidica sono stati convalidati per la cultura a lungo termine, requisito 
fondamentale per lo studio del ritmo circadiano. L'analisi quantitativa degli 
oscillatori circadiani è stata effettuata attraverso l'analisi quantitativa di biologia 
molecolare o test bioluminescenza, che fornisce la valutazione delle dinamiche 
dell'orologio circadiano. 
 
I risultati mostrano che la tecnologia microfluidica potrebbe essere adatto ad 
ospitare colture cellulari sincronizzate, consentendo stimolazioni temporali ad 
alta risoluzione. Le potenzialità di questo approccio micro-scala consentirà 
studio dinamico sul comportamento circadiano dei tessuti periferici e l'apertura 
di una nuova prospettiva nel campo circadiano. 
!
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CHAPTER 1 
 
Introduction: The circadian clock 
 
This chapter will discuss the issue and importance of circadian clock in the human 
physiology and the research activity in this field. Moreover, it will highlight the 
limitations of the current approaches thus introducing the technology perspective 
that guided the thesis and the technological needs to make a step forward in the 
investigation of the biological processes behind the circadian clock. 
 
 
1.1 The circadian clock 
 
Mammalian behavior and physiology are coordinated by an intrinsic molecular 
clock into rhythms that are synchronized with the 24 h solar day (from Latin circa 
diem,  meaning  “about  a  day”)  (Partch C.L. et al., 2014). 
The circadian rhythms are an adaptation to the evolutionarily conserved 
environment, because they allow to coordinate temporally external environmental 
cycles (eg. light/ dark) with internal biological and physiological processes (eg. 
sleep/ wake). The coordination of the internal time with the external time allows 
to prepare the organism to daily-based environmental changes. Among different 
physiological processes the circadian clock ensures the maintenance of energy 
homeostasis. (Bell-Pedersen D. et al, 2005; Mohawk et al, 2012). 
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For instance it maintains synchrony with the environmental cycles of light and 
nutrients. It has been known for many years that numerous aspects of metabolism 
exhibit daily rhythmicity, including many types of circulating and intracellular 
metabolites, feeding-related hormones, and ingestive behaviors (Green C. B. et al, 
2008). 
For keeping this coordination, that determines the rhythmicity of biological 
activities and behavior, is fundamental the internal oscillator that controls the 
circadian rhythms of gene expression. The oscillator consists of a network of 
genes called clock genes, which are characterized by having an oscillating gene 
expression profile that is repeated with a period of approximately 24 hours. The 
clock genes create a self-regulating circuit  with a negative feedback loop able to 
support its own expression 
The oscillator is located inside every cell in the body, where it receives signals 
that carry information on external environmental rhythms. These synchronizing 
signals, called also cues of entrainment1, can change the period, the phase and 
amplitude of the expression of clock genes. The oscillator regulates the expression 
of genes in the cell and arranges temporally physiology so that opposite reactions 
(eg. glycolysis / gluconeogenesis) does not occur at the same time (Albrecht U., 
2012; Mohawk J.A. et al, 2012). 
 
 
1.1.1 Cellular and molecular architecture of circadian system 
 
The cell-autonomous molecular clock in mammals is generated by two 
interlocking transcription/translation feedback loops (TTFL) that function 
together to produce robust 24 h rhythms of gene expression. The core TTFL is 
driven by four integral clock proteins: two activators, CLOCK and BMAL1, and 
two repressors, PER and CRY (Figure1.1). 
CLOCK and BMAL1 are subunits of the heterodimeric basic helix-loop-helix-
PAS (PER-ARNT-SIM) transcription factor CLOCK:BMAL1, which activates 
transcription of the repressor Per and Cry genes, as well as other clock-controlled                                                         
1 Synchronization of an internal circadina oscillator to an environmental stimulus that occurs at 
regular internals (usually with a24 h periodicity). 
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output genes. PER and CRY proteins heterodimerize in the cytoplasm and 
translocate to the nucleus to interact with CLOCK:BMAL1, inhibiting further 
transcriptional activation. 
As PER and CRY proteins are degraded through ubiquitin (Ub)-dependent 
pathways, repression on CLOCK:BMAL1 is relieved and the cycle begins again 
with  a24 h periodicity. 
 
 
Figure 1.1: Simplified version of the molecular core clock mechanism. The core loop is formed by 
Clock:Bmal1 and Per and Cry 1. The Clock:Bmal1 heterodimer stimulates the transcription of Per 
and Cry. Subsequently, Per's and Cry's heterodimerize, translocate to the nucleus, and inhibit 
Clock:Bmal1 activity. As a consequence, Clock:Bmal1 transcriptional activity drops, which 
reduces the transcription of Per and Cry genes, thereby activating Clock:Bmal1 again. Additional 
loops formed by RevErbs and RORs enhance the robustness of the core loop (Source  Kalsbeek A. 
et al, 2014). 
 
 
A second TTFL is generated through transcriptional activation by the retinoid- 
related orphan receptors (RORa) and repression by REV-ERBD. TTFL drives 
rhythmic changes in Bmal1 transcription and introduces a delay in Cry1 mRNA 
expression that offsets it from genes regulated strictly by CLOCK:BMAL1. 
Although rhythmic changes in BMAL1 abundance are not required to drive the 
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core TTFL loop, the ROR/REV TTFL-induced delay in Cry1 expression is crucial 
for proper circadian timing. The presence of cooperative, interlocking feedback 
loops provides robustness against noise and environmental perturbations to help 
maintain accurate circadian timing, and also helps to generate phase delays in 
circadian transcriptional output that optimally time gene expression for local 
physiology (Partch C.L. et al, 2014). 
A more detailed representation of the TTFL is reported in Figure 1.2. 
 
 
Figure 1.2: Detailed autoregulatory transcriptional feedback loop of the circadian clock in 
mammals. (Source Mohawk J.A. et al, 2012). 
 
 
1.1.2 The circadian clock in the body: a hierarchical timing system  
 
The ability of living systems to sustain approximately 24-hour rhythms in the 
absence of environmental cues shows that most daily oscillations are not 
responses to the diurnal cycle, but rather are generated by an internal clock 
(Herzog E.D., 2007). 
The mammalian circadian system is composed of a central clock in the 
suprachiasmatic nucleus (SCN) and a network of peripheral oscillators located in 
all of the major organ systems (Figure 1.3). 
Introduction: The circadian clock Chapter 1  
5  
MASTER'CLOCK'
PERIPHERAL''
CLOCKS'
 
Figure 1.3: Schematic organization of circadian clock: the SCN derives  “time  of  day”  information  
from environmental light signal providing timing cues to peripheral tissues via the autonomic 
nervous system and hormones (modified from Froy O., 2012). 
 
 
The   ‘master’   internal   clock   in   mammals   is   located   in   the   hypothalamic  
suprachiasmatic nucleus (SCN), that is composed of bilateral nuclei containing 
approximately 10.000 neurons each, capable of independently generating self-
sustained circadian rhythms (Takahashi J. S. et al, 2008). The SCN functions as a 
network in which the population of SCN cells are coupled together and oscillate 
in a coherent manner (Herzog E.D., 2007). 
This oscillator is synchronized to daily light-dark cycles by direct photic inputs 
(Figure 1.4) received from the retina through the retinohypothalamic tract (RHT), 
being the light the most dominant Zeitgeber2; the retina, together with the RHT, 
represent the sole light input pathway in mammals and, through retinal 
photoreceptors, allow the entrainment of the circadian system by light (Lowrey 
P.L. et al, 2004). 
                                                         
2 German  word  meaning  “time  giver”.  A synchronizing agent capable of resetting a pacemaker or synchronizing a self-sustaining oscillation. The zeitgeber "gives" the local time, not the ability to keep time, which the organism already possesses.  
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Figure 1.4: Suprachiasmatic nucleus (SCN), and other neurological structures, that are involved in 
human circadian rhythm control (Source http://thebrain.mcgill.ca). 
 
 
The dynamics of the spatial and temporal coordination of rhythms in the SCN 
have been studied recently with the advent of single-cell circadian reporter 
technology, which has revealed unexpected complexity in the temporal 
architecture of the nucleus (Evans J.A.et al, 2011; Foley L.E. et al, 2011; 
Yamaguchi S. et al, 2003). 
Thanks to the high sensibility of this technology it is possibile to isolate the 
circadian rhythms at single unit level, allowing to investigate the single cell 
behavior that may be different from that of the entire population. 
At the single-cell level, SCN neurons exhibit a wide range in cell autonomous 
circadian periods that vary from 22 to 30 hours (Ko C.H. et al, 2010; Liu A.C. et 
al, 1997; Welsh D.K. et al, 1995). Intercellular coupling among SCN neurons acts 
to mutually couple the entire population to a much narrower range that 
corresponds to the circadian period of the locomotor activity rhythm which is 
extremely precise (Herzog E.D. et al, 2004). The heterogeneity in intrinsic period 
of the SCN cells confers at least two important functions: phase lability and phase 
plasticity. 
Intrinsically shorter period cells have earlier phases and intrinsically longer period 
cells have later phases within the SCN, this is a reflection of phase lability 
(Yamaguchi S. et al, 2003). 
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Under different photoperiods (e.g., long vs. short photoperiod light cycles), the 
waveform of the SCN population rhythm is modulated such that in short 
photoperiods, the SCN waveform is narrow and high amplitude; whereas, in long 
photoperiods, the SCN waveform broad and low amplitude, this is a reflection of 
phase plasticity (Inagaki N. et al 2007; VanderLeest H.T. et al 2007). 
The SCN, as master clock, is able to set the phase of cell-autonomous, self-
sustained cellular oscillators in peripheral tissues through both neuronal and 
humoral signaling pathways, which control diverse physiological functions 
(Figure 1.5) (Asher G. et al, 2011). 
Examples of SCN-directed circadian rhythms include feeding, the sleep-wake 
cycle, glucose metabolism, insulin secretion, and even learning and memory 
(Eckel-Mahan K. et al, 2013). 
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Figure 1.5: The SCN coordinates appropriate metabolic responses within peripheral tissues with 
the light-dark cycle.  
 
 
Although the SCN drives behavioral rhythms and coordinates, the many 
peripheral clocks so that they maintain proper phase relationships with each other, 
it is now known that peripheral clocks can themselves also be entrained by 
various stimul, such as food, and temperature (Green C.B. et al, 2008). 
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Therefore, the organization of the circadian system, shown in Figure 1.6, requires 
a combination of: 
1) autonomic innervation of peripheral tissues: 
the SCN controls peripheral oscillators through both sympathetic and 
parasympathetic pathways (Mohakw J.A. et al, 2012). For example, sympathetic 
innervation from the SCN to the paraventricular nucleus of hypotalamus (PVN) to 
the liver results in daily rhythms of plasma glucose, presumably by directly 
influencing the rhythm of hepatic gluconeogenesis (Cailotto C. et al, 2005; 
Kalsbeek A. et al, 2004); 
2) endocrine signaling: 
it was demonstrated that the glucorticoid hormones have a role of entrainment 
signals for peripheral oscillators, in particolar the rhythmic release of the 
glucocorticoids could shift the phase of peripheral tissues in vivo (Balsalobre A. 
et al, 2000); 
3) temperature: 
in most organisms, temperature is a powerful entraining agent for circadian 
rhythms; however, in mammals external temperature cycles are very weak 
entraining agents and this has been attributed to the fact that homeotherms 
regulate their body temperature and can defend their body temperature against 
environmental fluctuations; 
4) local signals: 
in addition to controlling hormone secretion and body temperature directly, the 
SCN coordinates rhythms in behavioral processes, such as locomotor activity and 
feeding, which can influence endocrine function and body temperature. These 
behaviors, feeding in particular, can regulate peripheral clocks at the local level, 
modulating local signaling pathways and metabolic processes (Mohakw J. A. et 
al, 2012). 
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Figure 1.6: Resetting signals for central and peripheral clocks. The SCN dictates rhythms in 
peripheral tissues and physiological activities, such as locomotor activity, sleep-wake cycle, blood 
pressure, and heart rate. Light, food, and feeding regimens affect either the central clock in the 
SCN or the peripheral clocks. 
 
 
1.1.3 Peripheral oscillators and properties 
 
For many years, neurons of the suprachiasmatic nucleus (SCN) in the 
hypothalamus were thought to contain the unique mammalian clock controlling 
circadian rhythmicity of peripheral tissues via neural and humoral signals. 
Surprisingly, the cloning and characterization of mammalian clock genes have 
revealed that they are expressed in a circadian manner throughout the body. It is 
generally accepted now that peripheral cells contain a circadian clock which is 
similar to the one present in SCN neurons (Figure 1.7). 
CIRCADIAN'RHYTHMS'DRIVEN'BY'PERIPHERAL'CLOCKS'
 
Figure 1.7: Schematic representation of self-sustained circadian rhythms in peripheral tissues.  
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Indeed, analysis of clock gene expressions in mammals revealed that most of their 
corresponding mRNA products accumulated in a circadian manner not only in the 
SCN but also in a variety of peripheral tissues including liver, muscle, kidney and 
lung (Balsalobre A. et al. 1998; Zylka M.J. et al, 1998).  
Surprisingly, it was demonstrated that even mammalian fibroblasts cultured in 
vitro for about 30 years were still capable of circadian gene expression when 
treated with a serum shock (Balsalobre A. et al., 1998). 
A following study showed that the glucocorticoid hormone analog dexamethasone 
induces circadian gene expression in cultured rat-1 fibroblasts and transiently 
changes the phase of circadian gene expression in liver, kidney, and heart 
(Balsalobre A. et al., 2000). 
By exploring glucocorticoid signaling, which does not affect the central circadian 
pacemaker in the SCN, it has determined that peripheral oscillators can be phase 
delayed or phase advanced during the entire 24-hour day; in particolar, the SCN 
clocks can be defined as pacemakers which are able to independently generate and 
maintain their circadian oscillations whereas peripheral clocks are oscillators 
which require external signals (serum/glucorticoid shock, temperature cycle (Buhr 
E.D. et al, 2010)) to sustain and/or to synchronise their circadian rhythms. 
With the discovery of peripheral oscillators (Balsalobre A. et al 1998; Yamazaki 
S. et al 2000; Yoo S.H. et al 2004) and the apparent ubiquity of clock mechanisms 
(Yagita K. et al 2001), a critical question concerns the similarity and differences 
in the SCN pacemaker as compared to peripheral oscillators. 
This result has led to a critical question concerning the similarity and differences 
in the SCN pacemaker as compared to peripheral oscillators. 
In particolar it was demonstrated that a wide range of peripheral tissues shows to 
have the capacity to generate circadian oscillator (Plautz J.D. et al, 1997); 
however, in all such cases, there appears to be a dichotomy between the SCN and 
peripheral oscillators. The SCN can express persistent, self-sustained oscillations 
(>30 cycles in isolation), whereas peripheral rhythms damp out after two to seven 
cycles (Yamazaki S. et al, 2000). This finding has led to a widely accepted 
hierarchical model of the mammalian circadian system in which the SCN acts as a 
pacemaker, independently able to both generate and sustain its own circadian 
oscillations, and necessary to drive circadian oscillations in peripheral cells of 
neural and non-neural origin (Schibler U. et al, 2003). Consistent with this model 
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is the observation that peak expression of core circadian genes in peripheral 
tissues is phase-delayed by 3–9 hours relative to their maximal expression in the 
SCN, suggesting that the SCN phase leads and drives the peripheral circadian 
rhythms (Zylka M.J. et al, 1998). 
Afterward, Yoo S.H. et al. have observed a long-term persistent and robust 
circadian oscillations, for more than 20 days, in explanted tissues (liver and lung), 
as well as those found in the SCN. This finding, also confirmed in a following 
study on peripheral tissues explanted from SNC-lesioned mice, suggesting that 
peripheral circadian rhythms contain the molecular component required for SCN-
indipendent, persistent circadian oscillation (Yoo S.H. et al, 2004). 
To define further the role of the SCN in relation to peripheral clocks, they were 
developed methods to study the circadian properties of peripheral tissues at the 
level of single cells, using the mPer2Luc reporter animals. Closely spaced cells in 
the same culture did not have similar phases, implying a lack of functional 
coupling among cells; individual fibroblasts result to be independent, non-
damping circadian oscillators, however, lack of oscillator coupling in dissociated 
cell cultures leads to a loss of synchrony among individual cells and damping of 
the ensemble rhythm at the population level.  
These results suggest to consider the SCN as a phase coordinator, preventing 
internal desynchronization among persistently rhythmic peripheral clocks with 
tissue-specific periods, rather than as a pacemaker driving peripheral oscillations 
(Nagoshi E. et al, 2004; Welsh D.K. et al, 2004; Leise T.L et al, 2012). 
 
 
 
 
 
 
 
 
 
 
1.2 Circadian rhythms and metabolism: reciprocal control 
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Interesting findings show that regulation of metabolism by the circadian clock and 
its components is reciprocal (Figure 1.8), suggesting that metabolism and 
circadian clocks are tightly interlocked: clocks drive metabolic processes, and 
various metabolic parameters affect clocks, producing complex feedback 
relationships (Green C.B. et al., 2008). 
In the next paragraphs it will be described in more detail the intimate connection 
between these two systems, whose function is influenced reciprocally. 
 
Circadian(
system( Metabolism(
 
Figure 1.8: Schematic representation of the reciprocal interplay between circadian rhythms and 
metabolism. 
 
 
1.2.1 Circadian regulation of the energy metabolism 
 
The most important function of the circadian system is to maintain energy 
homeostasis by anticipating changes in the external environment and preparing 
the internal molecular environment to respond to these changes; this requires a 
close cooperation between signaling systems and gene regulation. 
There are three main ways through which the circadian clock influences the 
expression of metabolic genes in peripheral organs: 
a) direct regulation at the level of the promoters of metabolic genes; 
b) rhythmic expression of transcription factors that regulate metabolic genes; 
c) modulation of sensors metabolic state. 
 
Direct regulation at the level of the promoters of metabolic genes 
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Many promoters of genes that control metabolism are recognized directly by the 
transcriptional machinery of the clock. Two prominent examples of direct 
regulation will have on key genes of cholesterol synthesis and glucose. 
In rats, the enzyme that catalyzes the reaction HMGCR limiting of cholesterol 
synthesis has circadian activity with a maximum peak during the night, the active 
phase of the rats. The gene transcription of Hmgcr is rhythmic and is determined 
by the binding of rhythmic BMAL1 and REV-ERBα  to  his  promoter. 
The transcriptional activators BMAL1 / CLOCK regulate so circadian genes of 
gluconeogenesis. In mice BMAL1 and CLOCK bind E-box sequences in the 
promoters of genes Fbp1, PCK1, G6PC, Pcx with a peak during the day, when 
mice are inactive and do not feed (Koike N. et al, 2012). 
 
Rhythmic expression of transcription factors that regulate metabolic genes 
The clock controlled genes are expressed with different phases. This is because 
not all genes are transcribed directly from BMAL1 / CLOCK: the transcription of 
some CCGs is mediated by other transcription factors. 
For example, in mouse liver dimer BMAL1 / CLOCK binds E-box sequences in 
the promoters of transcription factors such PARbZIP DBP, TEF and HLF and 
drive their rhythmic transcription with a peak during the day, that is, during the 
inactive phase of the rat. These factors recognize the D-box sequences of many 
genes involved in detoxification and drive the circadian transcription (Yang X. et 
al, 2006). 
 
Modulation of sensors metabolic state 
The sensors of the metabolic state act as an interface between the cellular 
environment and gene expression. The clock propagates the circadian information 
to the metabolic pathways interacting with the sensors of the metabolic state and 
modulating their effect on gene expression. 
They are of two categories: (i) nuclear receptors and (ii) enzymes involved in 
cellular signaling, sensitive to the levels of NAD+ and AMP. 
(i) Nuclear receptors are able to sense the metabolic state binding endocrine 
substances and metabolic signals related to diet. The ligand activates the receptor, 
which translocates to the nucleus and acts as a transcription factor. PER2 and 
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CRY interact with nuclear receptors and modify the activity, thus that indirectly 
modulate the expression of their target genes, many of which are involved in 
metabolism. 
The glucocorticoid receptor (GR) is a nuclear receptor activated by steroid 
hormones such as cortisol and the synthetic hormone dexamethasone. When 
activated, it translocates to the nucleus and can act either as an activator that as a 
transcriptional repressor. CRY1 and CRY2 interact with GR active and promote 
its repressive action. Since CRY1/2 are expressed rhythmically, also their 
interaction with the GR is circadian (Lamia K.A. et al, 2011). 
PER2 interacts with several nuclear resceptors in a tissue-specific. 
In the liver, PER2 interacts with the nuclear receptor HNF4α   and   together   bind  
the  gene  promoter  Hnf1α.  HNF1α  and  HNF4α  are  transcription   factors   involved  
in glucose homeostasis (Schmutz I. et al, 2010). 
In  white   adipose   tissue,   circadian   PER2   interacts  with   nuclear   receptor   PPARγ  
and inhibits its transcriptional activity preventing the binding to promoters of 
genes involved in lipid metabolism. The deletion of Per2 alters both the phase and 
amplitude   of   the   transcription   of   target   genes   of  PPARγ   in  white   adipose   tissue  
and KO mice have an altered lipid metabolism (Grimaldi B. et al., 2010). 
(ii) enzymes involved in cellular signaling  that use as cofactors NAD+ and AMP, 
act as molecular sensors metabolic state, in fact the ratios NAD(P)+/ NAD(P)H 
and AMP/ATP reflect the state energy and reductive power oof the cell. Thus the 
activity of these enzymes depends on the presence of NAD+ and AMP, and when, 
since actived, trigger a signal cascade that ends with the regulation of metabolic 
pathways and gene expression. 
The circadian clock can act on this two-levels system: regulating the activity of 
the sensors, or by modulating the levels of NAD+ present. 
A sensor metabolic state regulated circadian clock is AMPK, a heterotrimeric 
kinase activated by AMP. In the early stages of fasting, the cellular levels of AMP 
rise and trigger different signaling directed to raise the energy levels of the cell. In 
this context also AMPK is activated and acts promoting catabolic processes and 
inhibiting anabolic processes, such as the synthesis of lipids, carbohydrates and 
proteins. The activity of AMPK is circadian, as well as the expression of its 
subunits  β2  that  promotes  nuclear   localization  of  the  enzyme,  with  a  peak  during  
the day in mice. The day coincides with the inactive phase of the rat, then with his 
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fasting period. Therefore, in line with the anticipatory function of the circadian 
clock, the activity of AMPK is maximum in correspondence with the period in 
which the rat is fasted and also AMP levels are higher, favoring thus the 
expression of catabolic pathways during the rest phase. (Lamia K.A. et al., 2009). 
The levels of NAD+ depend on the nutritional status of the organism, but they are 
also indirectly regulated by the circadian clock. Indeed, the enzyme NAMPT, 
responsible of the NAD+ pathway, is regulated directly by BMAL1/CLOCK. The 
circadian oscillation of NAD+ has effect on many enzymes sensitive to the 
concentration of this cofactor. Of particular importance are the deacetylase 
sirtuins that modify histones and transcription factors; they are indirectly involved 
in the regulation of mitochondrial function, in lipid metabolism and glucose and 
oxidative stress. Among these it should be mentioned SIRT1, that has circadian 
activity in mice and plays a key role in the regulation of PER2, BMAL1 and 
CLOCK, implementing thus an important feedback between energy metabolism 
and the circadian system (Nakahata Y. et al, 2008). 
 
 
1.2.2 Metabolic feedback on circadian clock 
 
Not only the circadian clock regulates energy metabolism, but also the metabolic 
signals send feedback to the circadian system peripheral, modulating the phase, 
amplitude, period. The existence of this feedback is made evident by experiments 
in which mice with intact SCN are fed during their resting phase. In this case, it is 
noted that the phase of gene expression is altered in peripheral organs but not in 
the SCN. In mouse liver, two days of treatment is sufficient to translate the 
circadian phase of the expression of 10 hours (Stokkan K.A. et al, 2001). 
Moreover, recent studies have shown that a high-fat diet in mice leads to changes 
in the period of the locomotor activity rhythm and alterations in the expression 
and cycling of canonical circadian clock genes, nuclear receptors that regulate 
clock transcription factors, and clock-controlled genes involved in fuel utilization 
in the hypothalamus, liver, and adipose tissue (Kohsaka A. et al, 2007). 
Some of the molecular mediators involved in the feedback are those sensors 
involved in the metabolic state already seen in the previous section: the nuclear 
receptors and enzymes sensitive to levels of NAD+ and AMP. They have a dual 
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role: to propagate the circadian information to the metabolic pathways and 
transduce information metabolic clock. 
The kinase AMPK, regulates the repressive axis of the circadian clock at both 
CRY1 both of PER2 level (Figure 1.9). AMPK phosphorylates CRY1 and 
promotes its recognition by the ubiquitin-proteasome system and then the 
degradation (Lamia K.A. et al, 2009). AMPK acts indirectly on PER2, activating 
the   kinase  CKIε,   responsible   of   phosphorylation that makes PER2 recognizable 
for degradation. Consistent with these observations, the over-activation of AMPK 
metformin-mediated, a drug for type II diabetes, shortens the period of the 
circadian cycle (Um J.H. et al, 2007). 
SIRT1 is a deacetylase activated by NAD+. SIRT1 deacetylates PER2, promoting 
its degradation, and BMAL1, counteracting the activity of CLOCK. Experiments 
on fibroblasts and rat liver have shown that SIRT1 is required to obtain a high 
oscillation amplitude of the circadian genes. Indeed knockdown of SIRT1 causes 
a reduction of the oscillation of the mRNAs of Per2 and Bmal1, probably because 
the absence of SIRT1 determines an increase of PER2 acetylation and even its 
accumulation. Higher levels of PER2 imply greater repression of the expression 
of Bmal1 and consequently a reduced activation of the Per2 expression. Since 
SIRT1 is sensitive to the levels of NAD+, its activity varies with the metabolic 
state of the cell and varies accordingly its modulation amplitude circadian 
oscillation (Asher G. et al, 2008). 
Another class of enzymes sensitive to the levels of NAD+ are the poly-ADP-
ribose polymerases (PARPs), which synthesize ADP polymers using NAD+. One 
of these enzymes, PARP1, the dimer interacts with BMAL1/CLOCK and poly-
ADP-ribosila CLOCK, changing its affinity for DNA. PARP1 has circadian 
activity with a peak during the day, the inactive phase of the rat. If the mouse is 
fed only during the day, the activity of PARP1 is translated of 12 hours, while in 
the knockout PARP1 mice more time is needed to shift the circadian expression in 
peripheral organs than is seen in WT . These observations suggest that PARP1 
transmits nutritional signals to the circadian clock causing a synchronization of 
the peripheral clocks caused by nutrition (Asher G. et al, 2010). 
The metabolism of glucose, lipids, proteins and nucleotides, influence cellular 
levels of UDP-GlcNAc, the substrate of the enzyme O-GclNac-transferase (OGT). 
This enzyme is responsible for the post-translational modification of many 
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proteins, including those of the circadian clock. In mice, the overexpression of 
OGT promotes the transcription of Per2 mediated by BMAL1/CLOCK. Indeed 
OGT adds an O-GclNac in BMAL1 on a site of ubiquitination, increasing 
stability. The inhibition of the synthesis of UDP-GlcNAc, leads to a lengthening 
of the circadian period and a reduction in the amplitude of oscillation of Bmal1 
(Li M. et al, 2013). 
Some transcription factors act as mediators between the metabolic signals and the 
regulation of the clock gene transcription of the clock. 
The   nuclear   receptor   PPARα   is   induced   during   fasting   and   regulates   the  
expression   of   Bmal1   binding   directly   his   promoter.   In  mice,   the  KO  of  PPARα  
causes a reduction in amplitude of the oscillation of Bmal1 mRNA (Canaple L. et 
al,   2006).   PGC1α   is   a   transcriptional   coactivator,   induced   by   fasting,   that,  
activating  RORα,  activates  the  transcription  of  Bmal1.  In  this  way  it  contributes  to  
integrate energy metabolism with the circadian rhythm. (Liu A.C. et al., 2007) 
The FOXO transcription factors are activated by signaling pathway triggered by 
insulin. Insulin acts on hepatocytes as synchronizer of circadian rhythm 
(Yamajuku D. et al, 2012). In mouse liver FOXO3 activates transcription of 
Clock; In the knockdown of FOXO3 rhythmicity of the liver is strongly reduced, 
but the phenotype is recovered by the overexpression of Clock (Chaves I. et al., 
2014). 
The glucose induces the expression of several transcription factors, one of these is 
TIEG1 (or KLF10); TIEG1 acts as a transcriptional repressor of Bmal1 directly 
by binding to its promoter. In rat fibroblasts, both the treatment with glucose and 
the over-expression of Tieg1 induce repression of Bmal1, and the knockdown of 
Tieg1 presents a circadian period shorter (Hirota T. et al, 2010). 
Here we show that a high-fat diet in mice leads to changes in the period of the 
locomotor activity rhythm and alterations in the expression and cycling of 
canonical circadian clock genes, nuclear receptors that regulate clock transcription 
factors, and clock-controlled genes involved in fuel utilization in the 
hypothalamus, liver, and adipose tissue. These results indicate that consumption 
of a high-calorie diet alters the function of the mammalian circadian clock 
(Kohsaka A. et al, 2007). 
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Figure 2. Interplay between regulators of circadian clock and metabolism
CLOCK and BMAL1 regulate circadian gene expression by binding to E-box elements
within the promoters of clock controlled genes (CCGs). Some of the CCGs are regulators of
metabolic pathways (e.g. Pepck, Glut2, Hmgcr), while some can influence metabolite levels
(e.g. Nampt, Alas1). Nutrient sensors AMPK and SIRT1 are regulated in a circadian manner,
and they can modulate circadian rhythms and metabolism by post-translational
modifications of key regulators.
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Figure 1.9: Interpalay between regula ors of circadina clock and metabolism (Source Sahar S. et 
al, 2012). 
 
 
1.3 Circadian disruption and metabolic pathology 
 
Although it has been known for several decades that many metabolic processes, 
such as glucose an  cholesterol metabolism, or renal function are regulated by the 
circadian clock, it is only in the past few years that the severe metabolic 
consequences of circadian disruption have emerged (Figure 1.8) (Eckel-Mahan K. 
et al, 2009). 
Metabolic syndrome and obesity have been observed in mice harboring mutations 
in the clock genes, which encode for transcription factors that affect both the 
persistence and period of circadian rhythms (Turek F.W. et al, 2005). The ablation 
of the pancreatic clock is sufficient to render the islet refractory to glucose and 
insulin secretagogues, resulting in hyperglycemia, obesity and certain features of 
metabolic syndrome including steatosis, adipose hypertrophy, and hyperlipidemia 
(Marcheva B. et al., 2010). 
Moreover, activities not considered by the circadian system as night shifts, 
repeated trips with changes of time zone and sleep deprivation, forcing 
metabolism to respond to unexpected stimuli. The presence of feedback from the 
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metabolic signals to oscillators, result in a change in the rhythm of peripheral 
clocks. Therefore the pacemaker is desynchronized respect to the other oscillators 
and the regulation of homeostasis is not optimal. 
Indeed, epidemiological studies have identified a correlation between metabolic 
syndrome and shift work; obesity, high triglycerides, and low concentrations of 
high density lipoprotein (HDL) cholesterol seem to cluster together more often in 
shift workers than in day workers, which might indicate an association between 
shift work and the metabolic syndrome (Karlsson B. et al, 2001; De Bacquer D. et 
al, 2009). 
It   has   been   suggested   that   increased   activity   during  what  was   ‘rest’   time   in   the  
pre-modern world, together with sleep disruption, have been associated with 
increased prevalence of obesity, diabetes and cardiovascular disease, in addition 
to certain cancers and inflammatory disorders (Bass J. et al, 2010). 
Forced misalignment of behavioral and circadian cycles in human subjects, 
caused by being active and eating at biological night time, was recently shown to 
cause a decrease in leptin and an increase in glucose and insulin levels (Scheer 
F.A. et al, 2009). Moreover, food intake during rest phase (Arble D.M. et al, 
2009) and exposure to light at night (Fonken L.K. et al, 2010) have been shown to 
cause weight gain in mice. With particular regard to feeding, intriguing behavioral 
studies   in   humans   suggest   that   nocturnal   feeding   patterns   (“night-eating 
syndrome”)  may  represent  an  risk  for  metabolic  disease  (Allison  K.C.  et  al,  2007). 
At the clinical and epidemiologic level, several lines of evidence suggest that 
circadian disruption is associated with cardiovascular and metabolic 
complications across large segments of the human population (Laposky A.D. et 
al., 2008).  
These observations raise the possibility that chronic misalignment between the 
cycles of rest and activity, and those of fasting and feeding, may contribute to the 
initiation and progression of obesity and metabolic syndrome. 
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Figure 1 The suprachiasmatic nucleus (SCN) is the central circadian
pacemaker. The SCN is located in the hypothalamus and is regulated by
light signals from the eye. The SCN then affects a wide variety of
physiological and behavioral outcomes.
(i.e., heterodimerize) to stimulate the transcription of target circadian
genes including period (Per) and cryptochrome (Cry) (i.e., Per1 to Per3
and Cry1 and Cry2) as well as a host of other clock-controlled genes.
When PER and CRY proteins accumulate in the cytosol, they
heterodimerize and translocate to the nucleus where they act as
transcriptional repressors to terminate Clock-Bmal1–mediated
transcription, thus ending the molecular circadian cycle (van der Horst et
al. 1999) (see figure 3). The cycle is further regulated by additional
proteins, including the enzyme sirtuin 1 (SIRT1), a histone deacetylase
that modifies circadian proteins or DNA by removing acetyl groups to
alter gene expression. SIRT1 is sensitive to levels of the coenzyme
nicotinomide adenine dinucleotide (NAD+), making NAD availability a
potential regulator of the molecular circadian clock (Grimaldi et al. 2009).
The details of this oscillating cycle are found elsewhere (Reppert and
Weaver 2002).
Figure 2 Central and peripheral circadian rhythms. (A) Under normal conditions, the central circadian clock in
the suprachiasmatic nucleus which is entrained by light, then regulates peripheral circadian clocks. (B)
Wrong-time eating can cause misalignment between the central circadian clock (entrained by light) and the
peripheral circadian clocks entrained by food (illustrated here are intestine and liver). (C) When the central
circadian clock is disrupted (e.g., due to lesion) peripheral circadian clocks will continue to cycle but will
gradually become more misaligned with each other.
 
Figure 3 The molecular circadian clock. Transcription of the clock-controlled genes, including Per and Cry is
initiated by the heterodimerization and binding of BMAL1 and CLOCK (the positive limb of the molecular
 
Figure 1.10: Central and peripheral circadian rhythms. (A) Under healthy, (B) wrong-time eating 
and (C) desynchrony conditions (Source Voigt R.M. et al, ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4 Motivation and aim of the thesis 
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The study of circadian rhythms is a complex problem at high social impact, that is 
studied by different experimental models and techniques complementary to 
understand their characteristics and properties. 
Since dysfunction of circadian rhythms has strong effects on human health, there 
are many clinical studies dedicated to this aspect. However study the properties of 
the circadian cycle directly on man and his tissue is difficult and expensive due to 
technical and ethical reasons. 
 In particular how the environmental condition or human behavior affects the 
clock is of fundamental importance for maintain healthy life-style. 
A major impediment in the study of human circadian rhythms is the difficulty and 
expense of assessing circadian rhythms in people. Because circadian clocks must 
be studied in temporal isolation, human circadian studies have demanded strict 
requirements of isolating subjects from environmental cues under constant 
conditions for a prolonged period of time. Unlike a mouse, it is difficult to 
convince a person to spend weeks living in temporal isolation. Thus, only a few 
investigators have had the resources and facilities necessary for such experiments 
(Takahashi J.S. et al, 2008). Therefore, surrogate measurements for assessing 
human circadian rhythms are essential. These have taken two forms. The first 
approach  has  been  to  assess  ‘diurnal  preference’  or  ‘chronotype’  of  subjects  using  
questionnaires, hormonal markers and actigraphy to measure phase of entrainment 
of circadian rhythms while living in the real world (Roenneberg, T. et al, 2003; 
Ancoli-Israel S., 2003). A second approach has been to develop cell-based and 
molecular methods to assess circadian rhythms in humans by biopsy or blood 
sample (Brown S.A. et al, 2005). 
However the study on humans require huge effort to develop methods that are 
effective and robust in defining inter-individual phenotypic differences, but also 
that would be sufficiently cost-effective to screen large number of subjects 
(Takahashi J.S. et al, 2008). 
For these reasons, the model organism for the in vivo study of role of circadian 
rhythms is the mouse. This is widely used to investigate what the relationship 
between the signals coming from the suprachiasmatic nucleus circadian and 
metabolism and viceversa. 
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This approach is based on the analysis of circadian and psychological behavioral 
and responses of mice carrying a functional knockout of a particular circadian 
gene of interest in different conditions of light:  dark (L  :  D) cycles (Pereira D.S. et 
al, 2014), or healthy mice exposed to external cues, such as high fat diet (Kohsaka 
A. et al, 2007). 
However, the study on mouse provides informations about the entire organism 
without dissecting the single contribution of the different organs (SCN, liver, 
lung, skeletal muscle) in relation to the circadian rhythms. 
To investigate the organization of peripheral circadian clocks, cultures of 
peripheral organs explanted and cell lines are maintained in long-term culture, that 
allow to know some signaling pathway of interest using classical methods in cell 
biology, such as qPCR and western blot (Lee C. et al, 2001). 
With the introduction of the transgenic animals and cell lines with a DNA 
construct in which the promoter of a circadian gene is fused to the luciferease 
reporter gene, the study of the peripheral clocks is totally changed. 
Using this non invasive assay, it is able to measure real-time expression of 
circadian and circadian output genes, as well as the protein dynamic of the 
circadian genes. Serial measurement of rhythms from individual tissue samples 
greatly reduces the intersample variability seen using conventional sampling 
methods and, importantly, reduces the number of tissue samples required. In 
animal experiments, this has the potential to drastically reduce the number of 
experimental animals (Yamazaki S. et al, 2005). 
Although the in vitro approach allows to investigate the properties of the single 
oscillators, shows even some limitations: in a classical culture in a petri dish it is 
possible to study the biology in static conditions, but it is not simple mimicking 
the in vivo physiology, where the concentrations of proteins, metabolites and 
hormones change during the day. 
 
The aim of the thesis is developing a in vitro model that resembles the cyclic 
dynamic fluctuations of metabolites and hormones (i.e. glucose, insulin), and even 
circadian related pathological alteration, at which the peripheral tissues are 
exposed in vivo. 
A valid tool to achieve this complex model is the microfluidic technology for its 
capacity of delivering periodic extracellular chemical stimuli that mimics the 
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pulsatile nature of in vivo signaling systems in order to better characterize cell 
signaling dynamics. 
This approach was already used in some recent works for studying the circadian 
gene oscillations on algae and mold, demonstrating that it is a great strategy for 
investigating molecular responses under various conditions of culture with a good 
control of the micronviromental, permitting long duration measurements with 
high spatial and temporal resolution (Teng S.W. et al, 2013; Lee K.K. et al, 2013; 
Danino T. et al, 2010). 
Therefore, the first specific aim of this thesis is the development a cell model able 
to apply systematic stimuli that can be correlate to the pertinent biological 
networks for dissecting the effects the metabolism on circadian clock; the second 
one is to couple the model thus made with a methods of quantitative and imaging 
analysis for detecting the circadian genes expression. 
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CHAPTER 2 
 
Microfluidic technology for cell biology 
 
This chapter will review the microfluidic technology for cell culture, highlighting 
the state of art and the perspectives; moreover they will be introduced the basis 
requirements for cell culture and improvements and advantages when microfluidic 
approach is used in biology. 
 
 
 
2.1 State of art of microfluidic technology in cell culture and 
perspectives 
 
Microfluidics has the potential to significantly change the way modern biology is 
performed. This technology uses elastomeric materials, tipically 
(polydimethylsiloxane) (PDMS), are relatively easy to fabricate, and are 
compatible with most biological assays (El-Ali J. et al, 2006). Moreover, it has the 
unique ability to integrate biosensor technology with microscopy-based read-outs. 
In combination with automated imaging systems possessing high-throughput 
capabilities and new data processing and storage strategies, microfluidics provides 
new tools for highly parallel, multiplexed assays with a higher information quality 
(van Midwoud P.M., et al, 2010). 
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Microfluidic devices offer the ability to work with smaller reagent volumes, 
shorter reaction times, and the possibility of parallel operation. They also hold the 
promise of integrating an entire laboratory onto a single chip (i.e., lab-on- a-chip). 
In addition to the traditional advantages conferred by miniaturization, the greatest 
potential lies in the physics of the microscale. By understanding and leveraging 
microscale phenomena, microfluidics can be used to perform techniques and 
experiments not possible on the macroscale, allowing new functionality and 
experimental paradigms to emerge (Beebe D.J. et al, 2002). 
Microfluidic cell culture platforms combine the advantages of miniaturization and 
real-time microscopic observation with the ability to pattern cell culture substrates 
controlling parameters of the cell microenvironment at relevant length and time 
scales (Rhee S.W. et al., 2005).They can also vary the composition of culture 
medium over space using gradient generators (Chung B. G. et al, 2005; Kim S. et 
al, 2010; Lee P. J et al, 2006, Zambon A. et al, 2014), creating cell culture 
conditions that are more physiological than those found in other in vitro systems, 
in terms of nutrients exchange rates and tunable mechanical stimulation (Leclerc 
E. et al, 2006; Zhou J. et al 2012). 
Microfluidic cell systems are applied to many different situations, from 2D and 
3D cell culture systems (Kuo C.T. et al, 2012). These systems differ on how cells 
are seeded: as monolayer on a substrate surface (2D systems), or on 3D scaffolds 
(3D systems). 3D cell-culture models have recently garnered great attention 
because they often promote levels of cell differentiation and tissue organization 
not possible in conventional 2D culture, because more closely resemble cell 
behaviour in vivo (Pampaloni F. et al, 2007). Several studies, for example, have 
shown that there are different mechanisms of drug resistance in three-dimensional 
cultured cancer cells compared to two-dimensional cultured cells (Chen A.A. et al 
2010; Tung Y.C. et al, 2011). 
 A number of 3D microfluidic perfusion culture systems have been developed 
recently for application in complex biological processes such as in vitro organ 
development (Huh D. et al, 2011). For tissue types that are highly perfused in 
vivo, such as the liver and kidney, microfluidic perfusion culture may more 
accurately mimic the in vivo microenvironment, where cells are in close 
proximity with the microvascular network (Domansky Z. et al, 2010). 
Considerable progress has been made in the design and use of novel microfluidic 
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devices for culturing cells and for subsequent treatment and analysis (Young 
E.W.K et al, 2010; Pasirayi G et al, 2011). Automated cell culture screening 
systems based on a microfluidic chip are recently built including valves, mixers 
and pumps, capable of controlling fluid (Gómez-Sjöberg R. et al, 2007). 
Microfluidic systems are in development that not only model biological 
environments but also physically mimic biological tissues and organs; such 
‘organs  on  a  chip’  could  have  an  important  role  in  expediting  early  stages  of  drug  
discovery and help reduce reliance on animal testing (Neuzil P. et al, 2012). 
Co-culture or multitissue-based microfluidic devices integrate two or more cell 
types in two-dimensional or three-dimensional cell cultures to simulate various 
human organs on a single chip (Baker M., 2011; van Midwoud P. M. et al, 2010; 
van Midwoud P. M. et al, 2011). These systems aim to mimic the tissue–tissue 
interfaces in the body or at least some of the physiologically relevant processes 
that are part of the so-called ADME (absorption, distribution, metabolism and 
elimi- nation) processes in the body (Esch M. B. et al, 2010). This approach 
delivers results of drug efficacy and toxicity on an organ level, may provide 
valuable information for early-phase decisions in future drug development. 
Moreover, patient-derived cells could even lay the groundwork for personalized 
medicine, providing the ability to optimize drug concentrations and compositions 
for different patient groups or even individual patients (Neuzil P. et al, 2012). 
 
2.2 Principles of the cell culture microfluidic technology 
 
The techniques to maintain and grow cells in vitro are considerably changed over 
time from their introduction (Carrel A., 1912) and new methods have been 
developed for culturing, expanding, differentiating and de-differentiating cells. 
The basic tools and requirements for cell culture have not changed significantly 
since then, but substantial improvements have been obtained with the introduction 
of technology in biology (Mehling M. et al, 2014). 
The field of microfluidic is significantly impacting cell biology research and 
application and emerging as powerful tool for tissue engineering (Figure 2.1) 
(Khademhosseini A. et al., 2006). 
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Figure 2.1: Overview of advantages and challenges of both macroscopic and microfluidic cell 
culture (Source Halldorsson S. et al., 2015). 
 
 
Microfluidic cell culture allows controlling fluid flow in the micro- and nano-liter 
scale in precisely defined geometries and facilitates simultaneous manipulation 
and study cells effectively on both a single- and multi-cellular level with high-
resolution and localized application of experimental environment with biomimetic 
physiological conditions (Breslauer D.N., et al, 2006), demonstrating to be a valid 
tool to satisfy the principal requirements for a cell culture (Table 2.1). 
 
 
Table 2.1: Requirements for cell culture and microfluidic strategy for developing an in vitro 
model for biological applications. 
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In particular the intrinsic property of gases permeability and biocompatibility of 
PDMS, with which microfluidic devices are manufactured, allows to support cells culture and keep it at temperature of 37 °C and CO2 partial pressure of 5%, 
placing the platform in a standard incubator, as it happens for the traditional 
cultures in dish. 
Although static culture systems are simple to operate and economical to 
manufacture, in terms of long-term cell culture, they may not be appropriate due 
to the risk of contamination caused by repeated manual intervention. Most 
importantly, the culture environment in such a system may fluctuate due to the 
intermittent medium replacement processes.  
Microfluidics provides high degree of control over cell culture conditions with 
high spatial and temporal resolution in various aspects (Figure 2.2). The ability of 
exactly timing fluid flow using liquid-handling systems, external (syringe pumps) 
or in-chip integrated (pneumatic valves), allows precise chemical and physical 
control of the microenvironment; the nutrients delivery to the cells with flow rates 
of microliters and nanoliters range, by continuous or transient media exchange, 
represents a significant improvement in precision compared to the traditional 
hand-held pipette (Wu M.H., 2009).  
This advantage allows to mimic a cell's natural microenvironment, for example by 
continuous perfusion culture or by fast or low medium exchanges; two works in 
our lab showed the possibility to control the glucose and oxygen concentrations 
with high temporal and spatial accurance (Zambon A. et al, 2014; Martewicz S. et 
al, 2012). 
Microfluidic cell culture devices bring the cell population down to a few hundred 
cells, or even a single cell, making it possible to capture perturbations to 
individual cells, increasing the spatial and temporal resolution for a given 
experimental setup.  
The fact to have a high surface-to-volume ratio allows to provide fast and cyclic 
stimuli, a controlled supply of nutrients and removal of metabolites and 
accumulation factors, and dynamic analysis of output in response to a specific 
input (Young E.W.K. et al, 2010). 
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Moreover this technology offers the possibility to deliver not only chemical but 
also mechanical signals, providing an extra degree of control over cultured cells 
(Morgan J.T., et al, 2012). 
PDMS based microfluidics provides excellent live cell imaging conditions as 
PDMS offers transparency and stable optical features, and the optical aberrations 
and auto-fluorescence induced by small volumes of cell culture medium in such 
devices are generally negligible. 
In combination with microscopes, biosensor integrated or other analytical and 
quantitative methods commonly used in cell biology and diagnostics, such as 
high-throughput qPCR, microfluidic cell culture devices therefore allow powerful 
characterization of a multitude of cellular responses on a single cell as well as 
population level (Mehling M. et al, 2014). 
The small dimensions of spatially separated microfluidic compartments allow 
assembly of a multitude of individually controllable cell culture chambers on a 
single device. This facilitates high parallelization of experiments, high throughput 
of samples and reactions and thus improvement of reproducibility, as well as a 
reduction in reagent costs. 
High potential for parallelization allows the recording of millions of data points of 
given biological processes during a single experiment: experimental replicates can 
be performed to achieve statistically significant results in a reasonable amount of 
time, that is impossible with the standard biological approach (Vyawahare S., 
2010). 
 
 
Figure 2.2: (A) Schematic rapresentation of microfluidic platform; (B) examples of stimulation 
protocols; (C) schematic rapresentation of the cellular micronviromental. 
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2.3 Conclusions 
 
Microfluidic technology is emerged as a powerful tools for addressing some of 
the challenges in cell biology. In biological research many advantages are possible 
with the introduction of microfluidic technology. In particular the capacity to 
implement cyclic stimulation with an accurate control of microenvironment is one 
of the crucial aspects that can be achieved. 
Orchestration of cellular operations requires precise conversion of chemical 
signals from the environment into intracellular messages that cells must interpret 
with their internal signaling pathways. Some cues from the environment and 
chemical messengers are regularly frequency-encoded, as happens for all those 
metabolic signals that regulate our circadian clocks.  
Despite the wealth of models (in vivo, in vitro and mathematical) available for 
studying, predicting and interpreting the mechanisms mediating the conversion of 
extracellular signals into cell responses, there is a lack of experimental setups that 
enable manipulation and further elucidation of this process.  
The approach of cell culture microfluidic technology allows to deliver periodic 
extracellular chemical stimuli that mimics the pulsatile nature of in vivo signaling 
systems in order to better characterize cell signaling dynamics real-time, even 
circadian clock dependent. 
In the next chapter they will be described the microfluidic devices designed 
during this PhD thesis, the strategic choises and prerequisites for developing a 
strong model of in vitro cell culture. 
Microfluidic technology for cell biology Chapter 2  
 40 
References 
 
Baker, M. Tissue models: a living system on a chip. Nature, 2001, 471, 661–665. 
 
Beebe D.J., Mensing G.A. and Walker G. M., Phisics and applications of 
microfluidics in biology, Annual Revie Biomed.Eng., 2002, 4, 261-286. 
 
Breslauer D.N., Lee P.J. and Lee L.P., Microfluidics-based systems biology, Mol 
Biosyst., 2006, 2, 97-112. 
 
Carrel A., Pure cultures of cells, Journ. Exp. Med., 1912, 16, 165-168. 
 
Chen A. A., Underhill G. H. and Bhatia S. N. Multiplexed, high-­‐throughput 
analysis of 3D microtissue suspensions, Integr. Biol., 2010, 2, 517–527. 
 
Chung, B. G., Flanagan L.A., Rhee S.W., Schwartz P.H., Lee A.P., Monuki E.S. 
and Jeon N.J., Human neural stem cell growth and differentiation in a gradient-
generating microfluidic device, Lab on a Chip, 2005, 5, 401-406. 
 
Domanski Z., Ciesielski M., Baran B., Network flow model for microfiltration, 
Civil and Environmental Engineering Reports, 2010, 5, 53-62. 
 
El-Ali J., PK Sorger P.K., KF Jensen K.F., Cell on chips, Nature, 2006, 442, 403-
411. 
 
Esch M.B., King T.L. and Shuler M.L., The role of body-­‐on-­‐a-­‐chip devices in 
drug and toxicity studies. Annu. Rev. Biomed. Eng., 2011, 13, 55–72. 
 
Gómez-Sjöberg R., Leyrat A.A., Pirone D.M., Chen C.S. and Quake S.R., 
Versatile, fully automated, microfluidic cell culture system, Analytical Chemistry, 
2007, 79, 8557-8563. 
 
Microfluidic technology for cell biology Chapter 2  
 41 
Halldorsson S., Lucumi E., Gomez-Sjoberg R., and Fleming R.M.T., Advantages 
and challenges of microfluidic cell culture in polydimethylsiloxane devices, 
Biosensors and Bioelectronics, 2015, 63, 218–231. 
 
Huh D., Hamilton G.A., Ingber D.E, From 3D cell culture to organs-on-chips, 
Trends in Cell Biology, 2011, 21, 745-754. 
 
Khademhosseini A., Langer R. and Borenstein J. and Vacanti J.S., Microscale 
technologies for tissue engineering and biology, PNAS, 2006, 8, 2480- 2487. 
 
Kim S., Kim H.J. and Jeon N.L., Biological applications of microfluidic gradient 
devices, Integr Biol (Camb), 2010, 2, 584-603. 
 
Kim L., Vahey M.D., Lee H.Y. and  Voldman J., Microfluidic arrays for 
logarithmically perfused embryonic stem cell culture, Lab on a Chip, 2006, 6, 
394-406. 
 
Kuo C.T., Chiang C.L., Huang R.Y.J., Lee H. and Wo A.W., Configurable 2D 
and 3D spheroid tissue cultures on bioengineered surfaces with acquisition of 
epithelial–mesenchymal transition characteristics, NPG Asia Materials, 2012, 4, 
e27. 
 
Leclerc E., David B., Griscom L., Lepioufle B., Fujii T., Layrolle P. and 
Legallaisa C., Study of osteoblastic cells in a microfluidic environment, 
Biomaterial, 2006, 27, 586–595. 
 
Lee P. J., Hung P.J., Rao V.M. and Lee L.P. Nanoliter scale microbioreactor array 
for quantitative cell biology, Biotechnology and Bioengineering, 2006, 94, 5–14 
 
Martewicz S., Michielin F., Serena E., Zambon A., Mongillo M., Elvassore N., 
Reversible alteration of calcium dynamics in cardiomyocytes during acute 
hypoxia transient in a microfluidic platform, Integrative Biology , 2012, 4, 153-
164. 
Microfluidic technology for cell biology Chapter 2  
 42 
 
Mehling M. and Tay Savas, Microfluidic cell culturem, Current Opinion in 
Biotechnology, 2014, 25, 95-102. 
 
Morgan J.T.., Wood J.A., Shah N.M., Hughbanks M.L., Russell P., Barakat A.I. 
and Murphy C.J., Integration of basal topographic cues and apical shear stress in 
vascular endothelial cells, Biomaterials, 2012, 33, 4126-4135. 
 
Pampaloni F., Reynaud E.G. and Stelzer E.H.K. , The third dimension bridges the 
gap between cell culture and live tissue, Nat. Rev. Mol. Cell Biol., 2007, 8, 839-
845. 
 
Pasirayi G., Auger V., Scott S.M., Rahman K.S.M.P., Islam M., O'Hare L. and Ali 
Z., Microfluidic bioreactors for cell culturing: A review, Micro and Nanosystems, 
2011, 3,137-160. 
 
Rhee S.W., Taylor A.M., Tu C.H., Cribbs D.H., Cotman C.W. and Jeon N.L., 
Patterned cell culture inside microfluidic devices, Lab on Chip, 2005, 5, 102-107. 
 
Tung Y.C., Hsiao A.Y., Allen S.G., Torisawa Y.S., Ho M. and Takayama S., 
High-­‐throughput 3D spheroid culture and drug testing using a 384 hanging drop 
array. Analyst, 2011, 136, 473–478. 
 
van Midwoud P.M., Merema, M.T. Verpoorte E. and Groothuis G.M.M., A 
microfluidic approach for in vitro assessment of interorgan interactions in drug 
metabolism using intestinal and liver slices. Lab Chip, 2010, 10, 2778–2786.  
 
van Midwoud P.M., Verpoorte E. and Groothuis G.M.M., Microfluidic devices 
for in vitro studies on liver drug metabolism and toxicity, Integr. Biol., 2011, 3, 
509–521. 
 
Vyawahare S., Griffiths A.D., Merten C.A., Miniaturization and parallelization of 
biological and chemical assays in microfluidic devices, Chem Biol., 2010, 17, 
1052-1065. 
Microfluidic technology for cell biology Chapter 2  
 43 
 
Wu M.H., Simple poly(dimethylsiloxane) surface modification to control cell 
adhesion, Surface and Interface Analysis, 2009, 41, 1-16. 
 
Young E.W.K. and Beebe D.J., Fundamentals of microfluidic cell culture in 
controlled microenvironments, Chem. Soc Rev., 2010, 39, 1036-1048. 
 
Zambon A., Zoso A., Luni C., Frommer W.B., Elvassore N., Determination of 
glucose flux in live myoblasts by microfluidic nanosensing and mathematical 
modeling, Integr Biol, 2014, 6, 277-88. 
 
Zhou J. and Niklason L.E, Microfluidic artificial   “vessels”   for   dynamic  
mechanical stimulation of mesenchymal stem cells, Integr Biol (Camb), 2012, 4, 
1487-97. 
 
! 44!
!
Development of microfluidic tecnology for circadian study ona chip  Chapter 3 
 45 
 
 
 
 
 
CHAPTER 3 
 
Development of microfluidic technology for 
circadian study on a chip 
 
This chapter relates to design a development of microfluidic cell culture 
technology for circadian rhythms in vitro study. After an analysis of requirements 
and constrains necessary for the circadian study, the rationale for the design of 
microfluidic platform will be described. The microfluidic prototypes developed in 
this thesis, will be validated from biological point of view. 
Feasibility of long-term cell culture within microfluidic platform will be provided. 
 
 
3.1 Rationale of microfluidic platform design for the circadian study  
 
Major components of energy homeostasis, feeding, glucose and lipid metabolism, 
are subjected to circadian regulation that synchronizes energy intake and 
expenditure with changes in the external environment.  
For example it would be interesting mimicking the daily oscillation of hormones 
and metabolites during the prandial and postprandial cycle, for understanding the 
crosstalk between circadian clock and glucose metabolism. 
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Microfluidic technology looks to be a valid experimental strategy to achieve this 
complex model, for its capacity of delivering periodic extracellular chemical 
stimuli that mimics the metabolic and hormonal oscillations; moreover it allows to 
investigate the circadian molecular behavior by coupling analysis of circadian 
gene expression by quantitative techniques (qPCR) and optical microscopy 
(luminescence acquisition through luciferase gene-reporter assay), highlighting 
the mechanisms that ensure the synchrony between peripheral clocks and 
entrainment signals and the even those that lead to desynchrony. 
 
 
Figure 3.1. Schematic representation of principal units and operation necessary for developing 
circadian study on a chip. 
 
 
3.2 Design of the microfluidic device: project strategies 
 
The aim of this paragraph is to describe experimental requirements and 
consequently design solutions to effective develop a microfluidic technology for 
in vitro circadian study. 
The design constrains related to specific circadian could be clustered in different 
classes: 
1. experimental set-up (cell culture system, medium delivery and stimulation 
approach, portability); 
2. experimental measurement of circadian target (type of read-out, 
integration with analysis equipments); 
3. target of study (population or single cell behavior). 
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Figure 3.2 shows the different approaches of microfluidic technology in biological 
field.  
Increase the automation degree, if on the one hand, ensures high sample 
throughput and flexibility on the other increases the complexity of the systems; 
opposite considerations can be made if the ease to use is examined. 
It is obvious that low complexity-based devices are suitable during the 
preliminary and initial phases of study, for optimization of cell culture conditions, 
coating, seeding density and numbers of daily medium exchanges, in order to 
develop a robust in vitro cell culture model. Once these parameters are optimized, 
more complex platforms can be implemented in terms of miniaturization degree, 
integration with liquid handling systems and software, and parallelization for 
increasing the highthroughput of the biological experimentation. 
The requirement to perform fast and cyclic perturbations, that mimic the in vivo 
physiological conditions, needs an accurate control of metabolites and, in general, 
entrainment factors, delivery with high temporal resolution; the advantage of 
being able to integrate the microfluidic device with liquid handling systems, off- 
and on-chip integrated, makes possible the implementation of different 
stimulation protocols in the same chip and a dynamically study the cell response. 
 
 
Figure 3.2: Schematic representation of different approaches of microfluidic technology in 
biology.  
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During this work three different experimental set-up, depending on the level of 
complexity, were used for specific phase of the thesis: 
i) Platform A (one-channel chip) for fast biological validation; 
ii) Platform B (multiple channel chip off-line liquid handling) for biological 
validation of cyclic perturbations; 
iii) Platform C (large scale integration chip on line liquid handing) for multiple 
parallel independent biological experiments exposes to cyclic perturbations. 
 
Platform A (one-channel chip) 
The first prototype developed for the study of circadian clock on a chip (Figure 
3.3) consists of ten indipendent parallel channels (18 x 1.5 x 0.2 mm) with well-
shaped reservoirs for fresh medium upstream and tubing connection downstream.  
In this case the procedures of coating, cell seeding, medium change and sample 
collection are made by hand held pipette. 
This approach does not allow performing study of the system dynamics, but it is 
suitable to optimize all conditions necessary for a more complex analysis. It has 
been used for testing if the microfluidic technology is a valid tool for in vitro 
circadian rhythms study. It was used to optimize the mRNA extraction from the 
microfluidic cell culture for performing analysis of gene expression. The surface 
area of culture chamber, of 27 mm2, is sufficient to perform downstream 
quantification of genetic material by qPCR technique, obtaining informations 
about the expression of circadian genes of interest at different time points. 
 
 
Figure 3.3: Schematic representation of Platform A. The exploded view show the single parts that 
composed the chip: a bottom glass slide serves as a sealing surface for cell culture adhesion and 
proliferation, the microfluidic channels serve to make better the cellular microenvironment and the 
upstream wells serve as a fresh medium reservoir. 
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Although, this approach was very easy to use, was shown to be very limited in 
term of readout; it is not able to generate data in efficient manner, especially in 
cases of elevate number of time points, given that the mRNA extraction involves 
a manual action by operator. 
This issue reduces considerably the parallelization and the high throughput tipical 
of the microfluidic approach. 
 
Platform B (multiple channel chip off-line liquid handling) 
This device was developed in order to increase the efficiency in term of readout 
and at the same time to perform dynamic studies of circadian behavior by 
integration a liquid handling system off-chip. 
Figure 3.4 shows the different component of this experimental set-up. This 
experimental setup is integrated within a luminescence microscopy thanks to the 
collaboration with the J.S. Takahashi lab (University of Texas - Dallas), one of 
the top laboratories that works in circadian field. 
 
 
Figure 3.4: Schematic representation of the different part of Platform A. The chip connected to the 
syringe pump is placed on the stae of microscope for real-time bioluminescence imaging. 
 
The chip consists of two parallel culture chambers (5.0 x 2.5 x 1.0 mm), whose 
surface is imposed by dimension of observation field of a 10x objective (5 x 5 
mm), in order to monitor the circadian behavior in both chambers at the same 
time; every culture chamber exhibits two independent inlets, connected to the 
pump by teflon tubes, in order to perfuse the cells with different composition 
media. 
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The serpentine was design as gas-equilibration unit: the permeable PDMS will 
allow fast gas transport leading to equillibration of media in term of carbon 
dioxide concentration and oxygen concentration in the medium. This particolar 
function is not required when a buffer with costant pH was used. 
This approach is a fair balance between the two approaches, single-channel and 
highly integrated chip. All procedures for cell culture integration (coating, cell 
seeding) are manually made, on the other hand after the connection to the pump, 
every procedure, such as medium delivery, is automatically managed. 
The remote control of the liquid handling system syringe pump allows to 
implement any medium delivery and stimulation protocol with accurate temporal 
resolution. 
Furthermore, the integration with a luciferase reporter assay ensures on-chip 
analysis of circadian gene expression by time-lapse microscopy. The microfluidic 
chip together to liquid-handling system was placed on the stage of an inverted 
microscope integrated with a CCD camera, allowing the real-time detection of the 
photons emission from the luciferase-reporter cell lines, whose intensity depends 
on level of gene expression of interest. Luminescence reporters have been used 
successfully in studies of circadian rhythms, allowing real-time measurements of 
circadian variations in gene expression (Yamazaki S., et al, 2005). 
Using transgenic luciferase-reporter cell lines it is possible to monitor the genic 
expression the expression of a gene of interest in continuous. More details about 
luciferase reporter assay are reported in § 4.2. 
 
This approach opens new perspectives in the chronobiology research and in 
particular in the study of crosstalk between circadian and metabolic systems. 
The possibility to interact with the cellular microenvironment during the 
acquisition of circadian behavior by imaging permits to explore mechanisms still 
unknown. 
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Platform C (large scale integration chip on line liquid handing) 
The last protype that we design for circadian study was an improvement of 
Platform A in term of high throughput. 
A typical circadian experiment requires continuous monitoring of biological 
readouts over a period of time ranging between days and weeks. In order to 
provide a technology able to simultaneously investigate a number of different 
experimental conditions, we specifically design a multi-chamber microfluidic 
systems capable of performing indipendent experiments. 
The possibility of fabricating miniature devices with complex fluidic architectures 
together with the flexibility of parallelization and automation ensures to develop a 
high throughput microfluidic platform for studying the circadian clock in 
peripheral tissues by metabolic cycles. 
In particolar, we focus our design in a mLSI (microfluidic Large Scale 
Integration) that allows to investigate the effects of different physiological 
perturbations on the peripheral circadian clocks, over long-term culture, with high 
temporal resolution. 
Moreover this device has to satisfy the requirements of high throughput in terms 
of readout both in sampling collection downstream culture chamber and real-time 
imaging analysis. 
The device (Figure 3.5) developed and fabricated in PDMS by multilayer soft 
lithography techniques, consists of 32 individually addressable culture chambers 
(18 x 1.5 x 0.2 mm), with a volume of 5.4 ul each. In the chip there are also 16 
bypass channels that allow flow channels wash out and changing media 
concentration without perturbation of the cell culture environment.  
Individual liquid handling offers access to multiple and customized experimental 
conditions in terms of cell culture environments from chamber to chamber as well 
as a function of time. 
Every procedure (coating of cell surface, cell loading, delivery and change of 
reagents for cell manipulation experiments) occurs sequentially in the 32 
chambers, through a network of flow distribution, by 3 independent inlets, while 
the discard removal by 2 independent wastes. 
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Figure 3.5: Schematization of the microfluidic chip, platform C. In yellow the control line; in 
green the distribution line; in purple di cell culture chamber. 
 
Multilayer soft lithography have been used to fabricate the microfluidic chip 
(Gómez-Sjöberg R., et al, 2007; Unger M.A. et al, 2000) in order to obtain 3 
PDMS layers; each one is separately cast from a different mold (Figure 3.6). 
The three layers differ each other for its own specific functionality: 
• the control layer (CL) provides the pneumatic control of the valves 
network; 
• the flow layer (FL) allows the delivery of medium to the cell cultures; 
• the chamber layer (CHL) allocates the cellspermitting the cell culture. 
More details about the design and fabrication the microfluidic device are reported 
in Appendi A1. 
 
 
Figure 3.6. Schematization of the microfluidic chip, platform C. Detailed view of the three 
separated layers.  
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Before use microfluidic chip has been technically validated. First of all all the 
valves on the chip must close automatically together when the relative control line 
is pressurized. Secondly any delaminations have to be absent when an high 
pressure is applied (30 psi to the CL, 10 ps other layes) If the chip is robust 
enough for at least 24 hours it will become a valid candidate for a further 
experiment. Fluido dynamic has alse been tested in order to dertermine the correct 
residential time, volume, time delay for the sequence of operations necessary 
during the automatic liquid handling. The chip has been tested with food dyes. 
 
 
 
3.3 Cell culture integration within microfluidic platform 
 
The common elements of microfluidic devices developed in this thesis is the 
culture chamber and the procedures for providing robust long-term cell culture. 
Biological issues have to be considered in order to define the main constrain for 
platform design.  
The phase of cell integration is made manually by hand-held pipette or by 
automatized system in the large scale integration chip. This phase includes 
preliminary coating for enhancing adhesion of the cells to the glass. The tuning 
operation parameters are: 
(i) extracellular matrix chamber coating 
choosing the correct coating is critical in order to achieve an 
uniformcell seeding. In microfluidic devices, glass is often used as 
cell culture substrate because it can be permanently bonded to the 
PDMS chipby plasma activation. While glass is an attractive cell 
substrate material for PDMS microfluidic devices and microscope 
imaging, it can present many issues to cell adhesion. The cell 
substrate material allows cell attachment via adhesive proteins or 
peptides adsorbed from the cell culture media, or pre-immobilized 
cell attachment protein, such as gelatin and collagen (El-Ali J. et al, 
2006). 
(ii) density of cell seeding 
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this parameter had important effects on the process of cell 
expansion and cell-cell crosss talk in the microfluidic chamber; 
different cell densities lead to changes in cell-to-cell paracrine 
signaling that influences the proliferation of the culture; therefore 
the optimization of variable is crucial for the future of the 
experiment (Gómez-Sjöberg R. et al, 2007). 
After cell culture integration, the chip was placed in a standard incubator, for 
temperature and gases control, providing a water bath to limit medium 
evaporation. 
 
System automation makes the platform completely free to any manual operation 
and enables to perform dynamic perturbations of the cellular microenviromental. 
In this stage, tubings, filled with sterile culture medium or stimulation buffers, are 
connected to the inlets or outlets of each channel, depending on the pump works 
in aspiration or expiration mode. The managment of medium exchanges and every 
protocol of stimulation for inducing cell proliferation and perturbation of cellular 
microenvironment occurs by ad-hoc software implementation for the specific 
experimental aim. 
 
 
3.4 Biological Validation of microfluidic platforms 
 
Both microfluidic devices were tested and validated for long-term cell culture 
(2-15 days) 
The quality of proliferation is due to the system capability of cell integration and 
feeding turnover, that allowed to obtain an healthy confluent cell layer, as shown 
in Figure 3.7. Every protocol of culture medium change for nutrients delivery is 
reported in Appendix 1. 
We have biological validated the microfluidic device by culturing human 
fibroblasts, as reported in Figure 3.7, obtaining proliferating long-term cell 
culture up to 15 days. 
All microfluidic platforms were biologically validated by long term cell culture 
(Figure 3.7 and 3.8). 
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Figure 3.6: Phase image of human fibroblasts inside microfluidic culture chamber of Platform 
A, at different stage of confluence, respectively at 3 (A) and 10 days (B) from seeding.  
 
 
Figure 3.7: Human fibroblast culture integrated in microfluidic chamber of Platform B. On the a 
detail captureed with 20x objective. 
 
 
Figure 3.8: Human fibroblasts integrated in microfluidic chamber of Platform C.  
 
 
3.4 Conclusions 
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In this chapter, the development of the following three types of microfluidic 
device derives from the bio-tecnological state of art of our lab and the 
improvements performed step by step in order to obtained a robust in vitro model 
for study of circadian rhythms: i) platform A for fast biological validation; ii) 
platform B  for biological validation of cyclic perturbations; iii) platform C  for 
multiple parallel independent biological experiments exposes to cyclic 
perturbations. 
Moreover we design and development different liquid-handling system that 
could be classified into two different approaches: 
• Off-chip liquid control, by syringe pumps 
• On-chip liquid control, by pneumatic valves on-chip integrated. 
Both approaches ensure a precise chemical and physical control of the 
microenvironment with temporal resolution. 
Moreover, the microfluidic platforms used during this PhD thesis, have been 
developed in order to obtain devices as simple and easy-to-use as possible, while 
maintaining the following capability: 
• long-term cell culture integration; 
• accurate dynamic perturbation by chemical stimulus; 
• quantitative analysis of circadian targets: 
 sample collection downstream culture chamber; 
 real-time analysis by optical microscopy. 
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CHAPTER 4 
 
Metabolic perturbations of circadian clock 
using conventional approach 
 
In this chapter, we first described the conventional approach used for investigating 
the circadian behavior on in vitro cell culture in a Petri dish. These conventional 
methods were used for confirming the relevance of the entrainment signals, in 
particular both metabolic and hormonal signals, in the synchronization of a cell 
culture. Finally, the limitations of conventional methods as well the potential of 
microfluidic technological for the in vitro study of circadian clock of pheripheral 
tissus will be discuessed. 
 
4.1 Molecular analysis of the circadian behavior in cell culture 
 
Conventional approach for the analysis of circadian gene expression in cell 
populations is mainly based on two different analytical techniques: 
x Realtime RT-PCR or quantitative RT-PCR (qRT-PCR); 
x luminescence gene-reporter assay. 
In the next paragraph, concise description of the methods will be provided. 
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4.1.1 Realtime RT-PCR 
Real time RT-PCR (Reverse Transcription Polymerase Chain Reaction) or 
quantitative PCR (qPCR) is a molecular biology assay aimed at the precise 
quantification of the levels a target mRNA sequence relatively to a reference 
sequence. The reference sequence is usually chosen among   “house-keeping”  
genes, which expression is assumed to be constant among the same cell type. RT-
PCR is currently the most sensitive method of RNA detection available. 
The assay is based on a two step process:  
i) retrotrascription (RT) of the mRNA extract from a cell population to DNA 
molecules; 
ii) amplification by Polymerase Chain Reaction (PCR) of the cDNA with 
quantification  of  cDNA  amount  at  each  amplification  cycle  (in  “real-time”). 
 
The first step process it allows the conversion of the mRNA template extracted 
from the cell into a complementary DNA (cDNA) using a reverse transcriptase, 
which is an enzyme able to generate complementary DNA from an RNA 
molecules in a process termed reverse transcription. The cDNA could be 
sucessively used as a template for exponential amplification using PCR.  
 
The step of cDNA amplification are based on standard PCR: after a first step of 
Taq polymerase activation by 95°C heating, cycles of denaturation (95°C) in 
which every double stranded DNA molecul is broken apart, primer annealing (the 
termperature of this step is primer specific) in which the primer sequences specific 
for the target gene anneal to the complementary sequences and elongation (60°C), 
allows the polymerase to synthetize the complementary strand of DNA beginning 
with the primer sequence. At every cycle fluorescence emission from the sample 
is acquired after the annealing step. 
 
POLYMERASE*CHAIN*REACTION* TaqMan*ASSAY* QUANTIFICATION*CURVE*
Ct*
 
Figure 4.1: schematic description of the TaqMan assay used in this thesis 
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The cDNA quantification is performed mainly by fluorescence probes activated 
when interacting with the DNA double strand. At each amplification cycle, the 
amount of double stranded amplicons grows exponentially doubling at every 
cycle, and the fluorescence intensity of the sample grows proportionally until the 
plateau of the reaction is reached.  
In this thesis, among different quantification methods we use the TaqMan assay. 
It is based on a pair of fluorophore-quencher covalently bound to a short sequence 
of DNA, so the fluoorescence of the probe is effectively quenched by the 
proximity of the two molecule. The DNA short sequence is designed specifically 
to bind to a strand of the target cDNA between the recognized primer sequence. 
During the amplification step, the Taq polymerase will digest the probe while 
synthetising the new DNA strand, separating the fluorophore from the quencher, 
allowing the fluorescence to be emitted. The fluorescence intensity will increase 
linearly with the amount of new DNA strands synthetized. The specificity of this 
assay is due to the direct dependence of the probe digestion on the amplification 
of the specific target cDNAsequence. 
The intensity of the fluorescence emitted during Real-Time PCR is correlated to 
the amount of DNA product formed. Figure 4.1 show a model of amplification 
plot used for the quantification. 
It is important to underline, that the TaqMan assay used in this thesis ensures high 
sensitivity and high specificity excluding the probability of aspecific mRNA 
sequance detection and other possible technical artefact. 
 
The quantification is based on the cycle number (Ct) in which the specific 
fluorescence produced by the genuine amplification of the target gene surpasses in 
intensity the non-specific background fluorescence. 
Because specific errors can be introduced (due to difference in the starting amount 
of RNA, quality of RNA or difference in efficiency of cDNA synthesis and PCR 
amplification), a cellular RNA is simultaneously amplified with the target gene, 
wich serves as an internal reference against which other RNA values can be 
normalized. 
The most common gene used for the normlization, termed housekeeping genes, 
are ß-actin, a cytoscheletal protein and glyceraldehyde 3-phosphate 
Metabolic perturbations of circadian clock using conventional approach Chapter 4   
 62 
dehydrogenase (GAPDH), a glycolitic enzyme. In this thesis the housekeeping 
gene used is GAPDH. 
The amount of the target gene in the sample, normalized to an endogenous 
heousekeeping gene and relative to the normalized calibrator, is given by 2-∆∆Ct, 
where 
∆∆Ct=∆Ct (sample)-Ct(calibrator) 
and ∆Ct is the Ct of the target gene subtracted from the Ct of the housekeeping 
gene. 
 
In this work, it was used the ABIPrism 7000 Sequence-Detection-System 
(Applied Biosystems) and TaqMan probes (Applied Byosystem) for performing 
Real-Time PCR. 
In conclusion, qRT-PCR allows accurate and quantitative analysis of multiple 
genes in the same time. On the other hand, it require to prepare large number of 
samples (at least two for each time point) given that the mRNA extraction from 
the cell culture entails cell destruction. For these reasons, the study of dynamic 
response of gene expression to biochemical perturbations by Real Time PCR is 
associated to a huge experimental effort.  
 
4.1.2 Luminescence genetic-reporter assay 
 
Genetic reporter systems have contributed greatly to the study of gene expression 
and regulation and they are most frequently used as indicators of transcriptional 
activity in cells. Typically, a reporter gene is joined to a promoter sequence of the 
gene of interest. The cells are assayed for the presence of the reporter by directly 
measuring the reporter protein itself or the enzymatic activity of the reporter 
protein. In an ideal case, the meaurable quantitative activity of the reporter protein 
is strivtly correlated to the level of expresion of the gene of interest.  
 
Thus, in contrast to qPCR, the luminescence genetic-reporters assay allows 
temporally-resolved quantification of a gene expression. For this reasons, this 
approach hasbeen used successfully in studies of circadian rhythms allowing real-
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time measurements of circadian variations in gene expression. This continuous 
noninvasive measurement of reported gene from cell and tissue cultures could 
result in drastic reduction in the number of parallel experiments required with 
qPCR (Yamazaki S., et al, 2005). 
On the other hand, becasuse the complexity of genetic manipulation and the 
limied possibility of simultaneously measuring more than one reporter protein, 
only single gene expression can be evaluated (respect to multiple gene expression 
obtained from qPCR). 
Using luciferase as reporter protein in transgenic luciferase-reporter cell lines, 
derived by genetic engineering technology (luciferase knockin mice or stable 
plasmid transfection), it is possible to monitor the genic expression of a gene of 
interest in continuous manner by acquiring the luminescence signal from cell 
culture. 
 
Luciferase reporter gene 
A gene consists of multiple functional parts, including the coding region that 
specifies the protein to be made and regulatory elements that control the 
transcription of the coding region. 
The luciferase reported gene are obtained fusing the putative regulatory elements 
to a reporter gene and monitoring the amount of the reporter protein expressed. 
Because reporter expression is under the control of the fused genetic elements, 
reporter expression is directly correlated with the activity of the regulatory 
elements (Figure 4.2). 
Transfering the luciferase reporter construct in a cell culture is relatively simple, 
because occurs by normal transfection procedures.  
Details about the a virus production are reported in Appendix A3. 
Two agents are essential for the bioluminescent reaction to occur:  
x luciferase, the enzyme that catalyzes the reaction, 
x the luciferase substrate.  
Chemical energy from ATP is converted to light by an enzyme-catalyzed reaction 
whose reactants are luciferin, adenosine triphosphate (ATP), and oxygen (O2); the 
enzyme luciferase catalyzes the reaction. The final products of this reaction are 
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oxidized   luciferin   (“oxyluciferin”),   adenosine  monophosphate   (AMP),   inorganic  
pyrophosphate (PPi), carbon dioxide (CO2), and light (Figure 4.2). 
 
A" B"
 
Figure 4.2: (A) The schematic representation of the the luciferase reported gene; (B) The 
bioluminescence reaction. 
 
 
Photons emitted from bioluminescent reactions are typically measured using a 
photomultiplier tubes (PMTs) or luminescence imaging systems. In both cases, 
high sensitive detectors are necessary. 
 
During the thesis, we made a number of tentatives for adapting existing detector 
or imaging systems to the luminescence acquisition from luciferase-reporter cell 
lines. All these tentative has been carried out at the Venetian Institute of 
Molecular Medicine (Padova). Bioluminescence systems, such as conventional 
plate reader equipped with photomultiplier tubes, did not have the proper 
sensitivity to acquire robust luminescence signals from microfluidic cell culture. 
On the other hand, microscope imaging systems equipped with high performance 
cameras for high sensitive imaging and image analysis (Second generation CMOS 
camera with sCMOS sensor) showed strong limitations in the long-term 
acquisition necessary for circadian study. 
 
To properly carachterize the possibility of using microfludic cell culture in 
combination with luciferase-reporter cell lines for circadian study, we start a 
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collaboration with Prof. Joseph S. Takahashi (University of Texas Southwestern 
Medical Center, investigator at the Howard Hughes Medical Institute). 
Takahashi's research group discovered the genetic basis for the mammalian 
circadian clock in 1994 and identified the Clock gene in 1997 and developed for 
the first time circadian clock gene luciferase-reporter. 
Because   the   huge   experience   and   the   facilities   available   in   the  Takahashi’lab,   I 
spent six months as visitng scientist at University of Texas Southwestern under 
the supervision of Prof. Joseph S. Takahashi for properly testing the potential of 
microfludic approach in circadian study using luciferase-reporter cell lines. 
For the work of the thesis, two main equipments were used: an automatized Petri 
dish luminescence reader and a luminescence microscope. 
The LumiCycle (Actimetrics Inc., Evanston, IL) is a luminescence reader 
composed of 32channel carousel unit holding one 35mm diameter petri dishand it 
was used for the fast screening circadian experiments. In this device, light output 
is measured by photon-counting methods, integrating, or measuring the area under 
the  chemical  reaction’s  light  emission  curve  for  a  set  period  of  time.  This unit has 
no thermo-controller and needs to be placed in an incubator at 37°. One of the 
unique features of this unit is that it is designed for multiusers; loading new 
samples, taking out old samples, and/or pharmacological stimulations can be done 
without disrupting the recordings on other channels. 
Spatial resolution luminescence imaging, which is particular adapted to properly 
carachterized microfludic luminescence signals from microfludic cell culture, 
were performed using luminescence inverted microscope. Although luminescence 
from luciferase reporter is extremely weak, using high-sensitive cooled CCD 
cameras it was possible to detect both population and single-cell signal. In 
particular, series 600s camera made by Spectral Instruments, containing a black-
thinned CCD thermoelectrically cooled to -90 °C with a rated quantum efficiency 
of ~92% at 560 nm was used. The microscope was equipped with thermo 
controller and dark cabinet for avoiding any light contaminations. 
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4.2 Synchronization of circadian rhythms 
 
Single cell studies showed that closely spaced cells in the same culture did not 
have similar phases, implying a lack of functional coupling among cells (Welsh 
D.K. et al, 2004). 
Many different stimuli are capable of initiating rhythmicity in cultured cells. 
These include serum (Balsalobre A. et al, 1998), dexamethasone (Balsalobre A. 
et al, 2000), forskolin (Yagita K. et al, 2000), fibroblast growth factor (FGF), 
and epidermal growth factor (EGF) (Akashi M. et al, 2000; Balsalobre A., 
Marcacci L. et al, 2000) and glucose (Hirota T. et al 2002); Thus, they show to 
be phase coordinators (Figure 4.3), as SCN for the entire organism, preventing 
internal desynchronization among persistently rhythmic peripheral clocks 
(Nagoshi E. et al, 2004; Leise T.L et al, 2012). 
The damping of the oscilatory behavior of circadian gene expression is 
correlated to the uncoupling of single cell oscilators. Thus, we could be able to 
reinitiate rhythmicity in damped cultures by delivering specific entrainement 
signals or by simply changing the medium (Figure 4.3). In this latter case, this 
reinitiation could be due to removal of toxic substances in the old medium, 
replacement of depleted critical components, or simply to the shocks associated 
with the medium change (e.g., temperature, pH, and mechanical agitation). Any 
or all of these stimuli could act to restart oscillators that had stopped or to 
resynchronize multiple oscillators within the tissue (Yamazaki S. et al, 2000). 
These are important aspects to be considered in synchronization of circadian 
rhythms within microfluidic cell culture, which requires high frequency of 
medium delivery. 
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Figure 4.3: Schematic rapresentation of synchronization of circadian rhythms of a cell culture 
imposing a entrainment signal. Before the synchronization the self-sustained circadian rhythms 
of the single cells are not in phase each other, resulting in a low amplitude of the population 
rhythm (blue curve); after synchronization the cells are synchronized to the same frequence and 
the average signal (blue curve) displays oscillatory behavior. 
 
We used some of the synchronization treatments citated earlier 
(dexamethasone, serum shock, glucose and insulin). More details are reported 
in Appendix A2. 
 
As preliminary results we synchronized the circadian rhythm of a human 
fibroblasts cell culture in a Petri dish using dexamethasone (1nM) and serum 
shock (10% FBS contained in culture medium). Although both entrainment 
stimuli enable to induce a robust circadian cycle, in our hand, dexamethasone 
shock produces more robust 24 h rhythms of gene expression in the cell culture. 
Figure 4.4 shows the mRNA accumulation profiles of BMAL1 a PER2 analyzed 
by qPCR technique, during the 48 hours following the dexamethasone shock; 
12 time points were analyzed, for each time point n=3 independent 
measurements were performed and each measurement is based on n=2 technical 
replicates (qPCR was performed in double). 
The expression of BMAL1 and PER2 mRNA is rhythmic and in antiphase of 12 
hrs, according the mechanism of transcription/translation feedback loop that 
regulates the molecular circadian clock. 
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These results are consistent with the in vitro models reported in literature 
(Basalobre A. et al, 2000). 
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Figure 4.4: Temporal profiles of clock gene expression, BMAL1 and PER2, in human fibroblasts, 
after the synchronization (t=0) with dexamethasone. The mRNA level of clock genes was 
normalized to housekeeping gene (GADPH) expression. Values represent the mean ± SD (n = 3 
per time point). 
 
 
The qPCR analysis is very accurate and sensitive analysis with the advantage to 
be able to study the expression of any gene of interest; on the other hand, it 
implicates that the experiments should be stop to extract mRNA samples from the 
cell culture and it makes impossibile to have high temporal resolution of dinamics 
of circadian gene oscillation. 
 For these reasons, we used the luciferase reporter gene assay enables to monitor 
the rhythms of circadian genes in non invasive manner and to measure real-time 
its expression, allowing for evaluation of the persistence and dynamics of 
molecular rhythms. 
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Necessary condition for following this approach is to use a lucifersase reporter 
cell line. 
In this regard we operated in two different way using: 
x a primary Per2::Luc (Per2 Luciferase Reporter) cell line derived from 
trangenic mice, that show with a DNA construct in which the promoter of 
the Per2 gene is fused to the luciferase reporter gene were made for 
monitoring the circadian oscillation of the transcription; 
x stable transfection of cell lines using lentivirus-mediated gene delivery. 
The lentiviral vector system is superior to traditional methods such as 
transient transfection and germline transmission because of its efficiency 
and versatility: it permits efficient delivery and stable integration into the 
host genome of both dividing and non-dividing cells. Once a reporter cell 
line is established, the dynamics of clock function can be examined 
through bioluminescence recording. 
In particolar we produced a lentivirus for the Bmal1::luciferase 
(Bmal1::Luc) gene reporter,  that can be used for generate luciferase cell 
lines both in mouse and human cells. 
The procedures of the virus production and the generation of Bmal1::Luc 
reporter lines are described in Appendix A3. 
 
Figure 4.5 shows a stable oscillation of Per2::Luc cell line after a circadina 
entrainment by serum shock, with a period of [22.99 ± 0.06] h (n=3). 
The Per2::Luc cell culture is a clonal cell line (#128 clone of p53 mutant 
immortalized ear fibroblasts) derived from Per2::Luc knockin mice. 
The luminescente signals acquired by LumiCycle every 10 min. 
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Figure 4.5: Long-term luminometer recording of luminescence in 3.5 mm from two culture dishes 
contaiting Per2::Luc mouse line, after serum shock (10% FBS). 
 
 
The long-term acquisition of circadian gene expression allows to investigate many 
parameters of interest, such as period, amplitude and damping rate of the 
oscillation. 
This analysis, performed by LumiCycle data analysis program (Actimetrics, 
Evanston, IL; courtesy of D. Ferster), is obtained after to subtracted the baseline 
to the raw data. 
The baseline subtraction is made to avoid the frequent drastic changes in the 
baseline in the first few days in culture, that  are also sample-dependent. 
Period calculation is obtained from baseline-subtracted   data   by   the   ‘sin   fit’  
method. 
This function identifies the largest sinusoidal component in the data by calculating 
a power spectrum by the following equation (1) as a function of a range of closely 
spaced frequencies: 
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The power, P(f), is calculated by performing the summations at each frequency, f, 
over all N data points comprising the baseline-corrected data series, Y(t), at each 
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of the corresponding time points, ti. The period (1/fpeak) corresponding to the peak 
power is selected as the dominant period, after which the associated optimal phase 
is calculated. 
The amplitude and the damping rate are determinated fitting the data to a sine 
wave multiplied by an exponential decay factor. The damping rate (d) is the time 
constant of the following exponential fit: 
 
Y=A{[sin (2πf+Φ)][exp(-t/d)]}      (2) 
 
where d is the damping rate, Y is the luminescence (counts/min), A is the 
amplitude, f is   the   frequency  of  the   sine  wave,     Φ   is   the  phase  of   the  oscillation  
and t is time. The data are fit to a low-order polynomial to get a baseline, which is 
thensubtracted from the raw data. A Fourier transform is performed to find the 
dominant frequency and phase. The time points for the peaks and troughs of the 
dominant sine wave are taken from the baseline-subtracted data, and the time 
points are then fitted to an exponential decay, which gives the amplitude (A) and 
the time constant of the damping (d). Damping rate (d) is the number of days 
required for the amplitude of the rhythm todecrease to 1/e (~=36.79%) of the 
starting value. 
For instance, the values of amplitude and damping rate, relative to Figure 4.5 are 
of 2490 ± 180 counts/s and 2.2 ± 0.2 days, respectively.  
 
 
4.3 Metabolic and cyclic perturbations of circadian clock 
 
Motivation 
The main biological hypothesis of this thesis is that the daily physiological 
fluctuations of hormones and metabolites can affect the circadian behavior can 
be affected from metabolic fluctuations. 
Emerging evidences suggests that not only the circadin clock controls the 
metabolic homeostasis but also metabolic processes feed-back into the 
circadian clock can influence clock gene expression (Kovac J. et al, 2009). It 
was shown that rhythmic feeding is both necessary and sufficient to drive the 
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circadian expression of liver genes (Hara R. et al 2001; Kornmann B. et al 
2007) and that by restricting food intake to the rest phase (i.e., the light period 
for nocturnal animals) it is possible to set the peripheral clocks and the central 
SCN clock to two different time zones, 12-h apart. 
Blood glucose homeostasis can be seen as a paradigm of the circadian control 
of energy metabolism. Its concentrations in the blood are highly rhythmic 
because of changes in insulin sensitivity and insulin secretory capacity of 
endocrine pancreas. 
Indeed, whereas during the activity/feeding period blood glucose is mainly of 
dietary origin, during the resting/starvation period glucose is progressively 
recruited from endogenous glucose production in the liver to maintain blood 
glucose levels within a relatively narrow range. In this process liver glycogen 
content undergoes large daily fluctuations to sustain blood glucose levels, as 
glycogen synthesis and degradation are specifically recruited during the 
activity/feeding and resting/starvation periods, respectively (Peret J. et al 1973; 
Armstrong, S., 1980). 
 
Therefore, using conventional approach, we tested the possible effects of cyclic 
perturbations on circadian behavior, first, imposing different levels of glucose, 
and then modulating levels of glucose and insulin together. 
Figure 4.6 shows the schematic protocol of the 4 cyclic glucose and insulin 
perturbation; that can be summarized in two phase: 
x stimulation phase, by alternate cycles of high (20 mM) and low levels (2 
mM) of glucose every 12 h, for three days;  
x recording phase, in which the bioluminescence signal is acquired by 
lumicycle in two different constant concentration of glucose, high or 
low. No media changes are performed during recording phase.  
The perturbations by glucose fluctuations (before the recording) studied are 4: 
1. ciclyc of 12 h High glucose medium pulse - 12 h Low glucose medium 
pulse (HL 12h); 
2. ciclyc of 12 h Low glucose medium pulse - 12 h High glucose medium 
pulse (LH 12 h);  
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3. ciclyc of 12 h High glucose medium pulse - 12 h High glucose medium 
pulse (HH 12h); 
4. ciclyc of 12 h Low glucose medium pulse - 12 h Low glucose medium 
pulse (LL 12 h); 
moreover, circadian response to each of these stimulations was studied both 
in low (-L) and high (-H) glucose level, during the recording phase. 
 
During the stimulation phase we used chemical serum-based media, istead of 
animal serum (FBS- fetal bovine serum), whose nutrients concentration is 
random because is animal-dependent; this strategy allows to make sure of the 
medium composition, given that we want to manipulate its composition without 
background effects. 
The chemical serum used is B27 (gibco-lifetechnologies). 
The exact composition of the different media used for these experiments is 
reported in Appendix A2. 
Afterwards we stimulated the cell culture by cyclic perturbations, modulating 
glucose and insulin together; in particular we decided to use high glucose 
concentration medium (20 mM) with 50 nM of insulin and low glucose medium 
(2 mM) without insulin. 
The  experiment  aims  to  understand  if  ‘oscillating’  hystory  before  the recording, 
that mimics mebabolic and hormonal fluctuaction, can alterate the circadian 
clock. 
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Figure 4.6: Schematic representation of the experimental strategy with two different conditions 
of recording, in high and low glucose level, respectively. 
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Oscillatory glucose perturbation in constant insulin level 
 
As cellular model we used #128 Per2::Luc cell line. Brifely they were seeded 
in confluent layer the day before the stimulation protocol, in DMEM 10% FBS 
and with 25 mM of glucose. The bioluminescence signal was acquired by 
LymiCycle in continuous for 6 days. 
Because the conventional glucose concentration used in the experiment is high 
(25 mM), we decided to considered the condition HH 12h-H as control for all 
the cases. 
 
Figure 4.7 shows the circadian oscillation of Per2 gene in the 4 conditions of 
perturbation, in high glucose recording for 6 days; the signals presents a stable 
period for all the acquisition and a robust amplitude for almost all 6 days. 
There are not significant difference in term of period and amplitude among all 
conditions. 
Consequently the shift phase, calculated as the absolute value of time different 
peak-to peak between each condition compared to the control (HH 12h-H), 
results trascurable, given that it is around 0.5 h in average for all protocols. 
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Figure 4.7: Per2 luminescence rhythms after alternate cycles of two different glucose levels (20 
mM and 2 mM); 6 day luminescence recording was performed in high glucose condition (20 
mM). Period, amplitude and phase shift are reported in the 3 integrative panels. Each 
experiemental condition is based on n=3 independet biological replicates. 
 
 
The experiment was replicated in the same way for the first part of cyclic 
perturbation but using a low glucose medium during the recording phase. 
Figure 4.8 shows the Per2 luminescence acquired for 6 days; there is not 
relevant difference among the perturbations in period and amplitude, and also 
the phase shift, calculated compared to the control condition (HH 12h-L) 
remains below 1.5 h. 
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Figure 4.8: Per2 luminescence rhythms after alternate cycles of two different glucose levels (20 
mM and 2 mM); 6 day luminescence recording was performed in low glucose condition (2 
mM). Period, amplitude and phase shift are reported in the 3 integrative panels. Each 
experiemental condition is based on n=3 independet biological replicates. 
 
Oscillatory glucose and insulin perturbation 
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From previously experiments (Figure 4.7 and 4.8) it is clear that the different 
glucose pre-treatments have not strongly influenced the circadian behavior. 
Considering that the glucose changes in the blood in postprandial state are 
closely related to insulin level, we decided to modulate both glucose and 
insulin. Specifically, we used a chemical serum without insulin, that was added 
(50 nM) just in the medium with high glucose (20 mM). 
Because the insulin experiments require insulin-free media, we seeded the #128 
Per2::Luc cell line in media without insulin three day before starting the 
stimulation. 
The temporal expression patterns of Per2 acquired after the 4 cyclic glucose-
insulin perturbations (Figure 4.9), in high glucose-insulin recording, show to be 
sensitive to the different perturbations. In particular, while the quantitative 
analysis shows that the period was not affected by the cyclic metabolic and 
hormonal perturbations, the amplitude and the phase shift seem differentially 
perturbed in LH 12h-H conditions. 
The amplitude of the first peak of Per2 in LH 12h-H is relatively lower than the 
control amplitude (HH 12h-H), with p<0.05. 
The effect of perturbations is more evident in the phase shift graph; particular  
the LH 12h-H stimulation provides an increasing phase advance a in the range 
of [4.5 ± 0.2 : 5.8 ± 0.5] h between peak 1 and 4, compare to the control (HH 12 
h-H), with p<0.0001. 
The LL 12h-H also produce smaller positive phase shift in the range of [2.389 ± 
0.22 : 2.67 ± 0.32]h between peak 1 and 4, compared to the control (p<0.01). 
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Figure 4.9: Per2 luminescence rhythms resulting by alternate cycles of two different glucose 
and insulin levels (20 mM- 50nM and 2 mM- 0 nM glucose-insulin); 6 day luminescence 
recording was performed in high glucose condition (20 mM). Period, amplitude and phase shift 
are reported in the 3 integrative panels. Each experimental condition is based on n=3 independe 
biological replicates. 
 
The experiment was replicated in low glucose medium, without insulin, during 
the recording phase and the Per2::Luc bioluminescence signals are shown in 
Figure 4.10. As for the previous case (Figure 4.9), the glucose and insulin 
perturbations induce some alteration in the circadian behavior. 
In particular, the period of LH 12h-L is significantly longer (23.3 ± 0.3 h) 
compared to the control, HH 12 h-L, (25.0 ± 0.5 h), with p<0.01. 
Moreover the quantification of amplitude showes relevant difference between 
the HL 12h-L and HH 12h-L (p<0.05). 
The phase shift remains the parameter that feels more the effect of the cyclic 
perturbations imposed. 
In particular LH 12h-L exibits a phase advance in a range of [3.55.33 ± 0.40 : 
4.83 ± 0.58] h between peak 1 and 4, compared to the control. 
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Figure 4.10: Per2 luminescence rhythms resulting by alternate cycles of two different glucose 
and insulin levels (20 mM- 50 nM and 2 mM- 0 nM glucose-insulin); 6 day luminescence 
recording was performed in low glucose condition (2 mM). Period, amplitude and phase shift 
are reported in the 3 integrative panels. Each experimental condition is based on n=3 
independent biological replicates. 
In order to have a complete vision of the effect of each cycle perturbation on 
the circadian behavior, it was plotted the phase shift at the third cycle-peak, for 
all conditions. 
Statistic analysis shows that the LH 12h-H and LH 12h-L stimulations produce 
a very high phase shift on the Per2 expression, in condition of glucose and 
insulin fuctuation. 
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Cyclic+Perturba2on
 
Figure 4.17: Phase shift produced from all conditions at the third cycle peak. 
 
All together these results stronlgy suggest that the oscillatory glucose variations 
alone, it is not sufficient for elicting circadian resyncrhonization on cell culture 
derived from pheripheral tissues. The phase shift can only altered when glucose 
and insulin are oscilatory delivered together. However, the reason why only in 
the LH 12h condition we observed reproducible phase shift require more 
specific study. 
 
 
 
 
 
4.4 Conclusions 
 
In this chapter, first of all, we describe two different molecular methods, qPCR 
and luciferase reporter gene assay, selected for analysing the temporal 
oscilatory behavior of the circadian genes. We also discussed about the 
advantages of using qPCR for quantitative multiple circadian gene expressions 
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for a single time point or the efficacy of following the temporal dynamic of 
single circadian gene using luciferase reporter gene assay. 
Both metodology were tested mesuaring a cyclic dynamic oscillation of 
circadian rhythms on cell culture derived from pheripheral tissues in 
conventional Petri dish. 
In order to rational understand the correlation between metabolite and hormone 
fluctuations and the circadian oscilators on cell culture, we design a set of 
experiments in which we expose cell culture to 12 h cyclic perturbation. 
The results cleary show how oscillatory perturbation of glucose and insulin 
togheter could affect the circadian bheavior with particular influence on the 
phase shift. These date are quite important in the context of this thesis because 
they are actually confirming that the hypothesis of metabolic perturbation on 
circadian rhythms could be relevant in peripheral tissue. 
This data provide only some experimental evidence, but new more experiment 
and deeply study between cyclic perturbation a clock bheavior are needed. 
However what is also emerged from the measure reported in this chapter is the 
militation of the conventional technology in performning new experimetal 
investigations. 
For instance, it would be of paramount importance to perturb the system with 
specific daily metabolic fluctuactions and hormonal oscillations while 
simulatneously recording the circadian oscillatory behaviors.  
Moreover, the conventional cell culture technology, which is based on batch 
experiment management by manual medium chenge, allow only couple of 
cyclic perturbations within the 24 daily cycle. In contrast, the oscillatory 
behavior of metabolic and hormonal stimuli in the body are based on multiple 
oscillations during the day time, which are possible to reproduced without the 
integration of automatized approach within cell culture technology. 
In conclusion, from this chapter, it is clear that  the lacking of simultaneos 
perturbation recording systems and the low level of automatization in the 
conventional cell culture methods represent a strong limitation to further 
progress in circadian field. In particular, these main limitations strongly reduce 
the capacity of investigation, compromizing the rational understanding of the 
mechanistic correlation between metabolic perturbation and genetic oscillation 
in pheripheral tissues. 
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The microfludic tehcnology could overcome all these limitation and open a 
completely new perspective in circardian study. The proof of concept that the 
microfluidic technolgy could be sucesefully used in the circadian experiments 
are described in the next chapter. 
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CHAPTER 5 
 
Microfluidic technology for circadian study 
on a chip 
 
In this chapter, we will describe the results about the circadian clock of cell 
culture within microfluidic environment. We will discuss how different operative 
parameters typical of microfluidic cell culture such as, the frequency of medium 
delivery or metabolite perturbation, could affect circadian synchronization. We 
will also analyze circadian synchronization heterogeneity over all microfluidic 
culture chambers. Finally, this chapter will provide a clear evidence of the 
potential of using microfluidic technology in circadian study. 
 
5.1 Circadian gene expression on a chip by RT-PCR 
 
We first asked whether it is possible to synchronize the circadian gene expression 
of cell culture within a microfluidic environments. 
This microfluidic application is not straightforward. As reported in Chapter 3, the 
ratio between medium volume and cell volume is 20 times smaller in microfluidic 
cell culture chamber than in conventional Petri dish. This high reduction of 
extracellular volume is actually electing different biological and cellular 
phenomena; for instance, consumption of metabolite by cell culture will strongly 
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decrease the level of metabolite in the media, as well the cytokines releases from 
the cell will fast accumulated at higher concentration within microfluidic (Giulitti 
G. et al., 2013). 
Both fast metabolite deprivation and cell release products accumulation could 
strongly affect circadian clock. 
 
With this in mind, the synchronization protocol for the circadian entrainment was 
adapted from the protocol  used for in vitro cell culture in a Petri dish, described 
in § 4.2.   The synchronizing perturbation was applied to a confluent culture of 
human fibroblasts integrated into the microfluidic technology. The platform used 
for this experiment, widely described in § 3.2, is a multi-channel device that 
allows performing parallel cell culture conditions with a low degree of 
complexity. 
The dexamethasone shock (1 mM) was applied at t=0 and in the following 48 
hours the total mRNA, extracted from each channel, was isolated from cells for 
performing make qRT-PCR Analysis. Three mRNA samples were collected for 
each time point and qPCR was performed in duplicate. 
More details about the mRNA extraction from the microfluidic cell culture 
chamber and qPCR protocol of small sample are reported in Appendix A2. 
The mRNA accumulation profiles (Figure 5.1) show the gene expression of 
BMAL1 and PER2 achieved on a chip. 
Consistent with the results obtained in the conventional Petri dish (Figure 4.4), the 
dexamethasone shock produces robust 24 hrs rhythms of gene expression also in 
human fibroblasts integrated in microfluidic channels. 
The small volume (less than 10 uL) characterizing the microfluidic devices has 
not precluded the circadian synchronization of cell culture, demonstrating the 
microfluidic technology is feasible approach in biology, comparable to the 
traditional cell culture approach. 
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Figure 5.1: Temporal profiles of clock gene expressions, Bmal1 and Per2, in human fibroblasts, 
after the synchronization (t=0) with dexamethasone. The mRNA level of clock genes was 
normalized to housekeeping gene (GADPH) expression. Values represent the mean ± SD (n = 3 
per time point). 
 
 
5.2 Circadian gene expression by bioluminescence imaging 
 
Because the qRT-PCR analysis is time consuming and it requires multiple 
sampling to provide dynamic profile of gene expression, we integrated a cellular 
system with luciferase readout within the microfluidic platform. 
This approach allows on the one hand increasing the amount of data collected in 
high temporal resolution and on the other hand enabling to dynamically 
manipulate the cellular microenvironment by integration of liquid handling 
system; this latter aspect allows to perform biochemical system perturbation while 
detecting gene expression dynamic through imaging analysis. 
The experimental setup used in this part of the work (described in § 3.2), is made 
up of two parallel microfluidic chambers connected to a syringe pump, all 
integrated into an apparatus of bioluminescence detection based inverted 
microscope equipped with  super high sensitive CCD camera. 
The cells were seeded in the microfluidic chip, at the precise density of 200 
cell/mm2, 24 h before the bioluminescence acquisition running and kept in 
incubator (37 °C, 5% CO2 and 95% humidity). 
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Before to place the sample on the microscope stage for real-time imaging, the 
inlets of each chamber were connected to the syringe pump (Cavro Pump XLP 
6000- Tecan) by teflon tubes, filled with sterile medium in order to perfuse the 
cells during the days; the medium contained 1 mM of luciferin substrate. Every 
protocol and detail about cell integration and long-term culture on a chip are 
reported in Appendix A2. 
A heated lucite chamber custom-engineered to fit around the microscope stage, 
kept the cells at constant 36 °C; the absence of CO2 was buffered by 350 mg/L of 
sodium bicarbonate 10 mM of HEPES; the proper humidity was kept covering the 
bottom of the Petri dish, containing the microfluidic platform with 1mL of PBS 
1X. 
The microscope rested in antivibration table in a dark and windowless room. After 
focusing carefully with brief-field illumination, we eliminated stray light by 
covering the microscope with a back lucite box, darkening the acquisition room 
completely. 
Light from the sample was collected by 10x objective and transmitted directly to 
the cooled CCD camera mounted on the bottom port of the microscope. We used 
the Series 600s camera made by Spectral Instruments, containing a black-thinned 
CCD thermoelectrically cooled to -90 °C with a rated quantum efficiency of 
~92% at 560 nm. 
Adapting the microfluidic technology to this very sensitive equipment was not 
simple, we needed to perform several preliminary experiments (n=10) to optimize 
all those critical parameters, such as cell density, humidity control, CO2 buffer, 
flow rate and darkness around the sample, in order to acquire specific high quality 
luminescence signal. 
The figure 5.2 shows a time-lapse of the circadian behavior of a Per2::Luc mouse 
cell line (# 128 clone) derived from Per2::Luc knockin mice. 
The intensity variation of photons emission from the cells corresponds to the 
different levels expression of Per2. 
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Figure 5.2: Time-lapse of bioluminescence images, at F=1/6 h-1 (frequency of medium delivery 
within the microfluidic cell culture chamber), of immortalized fibroblasts cell line derived from 
Per2::Luc knockin mice, showing circadian rhythms of luminescence 10 x . 
 
 
5.2.1 Influence of the medium delivery frequency in the clock synchronization 
 
The possibility to implement different protocols of medium delivery, by remote 
control of the liquid handling system, allowed to investigate the effects of 
different occurrence frequencies of a entrainment signal on the circadian 
expression of the cells. 
It was used a serum shock (10% FBS), contained in the culture medium, as 
entrainment signal (Balsalobre A. et al, 1998). 
Two different protocols of circadian synchronization (Figure 5.3A) were imposed 
to two independent parallel chambers, tuning the frequency of medium delivery: 
x medium change every 24 h (F=1/24 h-1); 
x medium change every 1 h (F=1 h-1.) 
The medium flow rate of 3uL/min ensures the minimal stress to the cells, that 
conserve a healthy morphology for all experiment duration. 
The bioluminescence images of both cell culture chambers were acquired every 
30 min by CCD camera for 7.5 days. 
Figure 5.3B shows the daily profiles of the raw bioluminescence signals (without 
background subtraction) correlated to Per2 expression for the two different 
conditions of the circadian entrainment imposed. 
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The temporal oscillation of the Per2:luminescence signals were obtained as the 
average of the luminescent intensity on the entire culture chamber by imaging 
processing (Matlab Software- Appendix A3). 
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Figure 5.3: A) Schematic representation of the two different protocols of medium delivery 
imposed by microfluidic approach. B) Per2::luminescence signal monitored during the two 
different medium delivery (F=1/24 h-1 and F=1 h-1), for 7.5 days. 
 
The results of Figure 5.3 are in a way surprising. One could be expected that each 
medium change delivered to the microfluidic cell culture chamber it could results 
in cell culture resynchronization. This expectation is consistent with the 
experimental observation of conventional circadian experiments, in which the 
temporal variation of circadian gene expression is studied after an only one pulse 
of serum, provided to the culture by medium change.  
However, Figure 5.3 clearly shows that circadian clock is maintained regardless 
of the frequency of medium delivery. 
In order to deeply analyze differences between the two experimental conditions, 
the circadian parameters (period, amplitude damping and phase shift) were 
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evaluated by baseline correction on row data and fitting with polynomial curve by 
LumiCycle Software. The Figure 5.4 shows an example of circadian oscillation 
before and after fitting and the baseline subtraction. Major details of luminescence 
imaging and signal were described reported in § 4.2). 
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Figure 5.4: An example of bioluminescence processing. A) Raw data. (B) Data after baseline 
correction. 
 
 
Moreover, in order to better characterize the uniformity of circadian behavior 
overall the cell culture within microfluidic environments, the average of the 
luminescent signal was calculated on 9 different regions of interest, 32x32 pixel, 
for each chamber (insert of Figure 5.5). It is worth to underline that a possible 
upstream down stream differential biological behavior could be take place. 
For each ROI was calculated the average intensity frame by frame. The signals, 
thus obtained, before to be manipulated for the following circadian analysis, were 
baseline subtracted, as shown in Figure 5.5. 
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Figure 5.5: Per2::Luc bioluminescencepatterns of the two different medium delivery imposed 
(F=1/24 h-1, F=1/h-1); the signal was calculated as average intensity of bioluminescence integrated 
in the time of 9 ROI 32x32 pixel, as shown in the insert). 
 
 
A first qualitative observation shows evident differences in circadian behavior 
between the two entrainment conditions. 
A quantitative analysis is necessary to better understand the role of entrainment 
frequency on the period, amplitude and phase of circadian gene expression. 
The period can be obtained as the time difference peak-to-peak of the circadian 
gene oscillation or by interpolation function provided from the LumiCycle 
software. 
There is a significant difference (p< 0.001) in term of period between the two 
different protocols of circadian clock synchronization. 
In   particular   the   culture   ‘entrained’   once   per   day   has   a   circadian   rhythm  with   a  
period of 23.7 ± 0.1 h (n=9), whereas the other one shows a period of 22.5 ± 0.1 h 
(n=9); the low values of standard deviation evidences the robustness of intrinsic 
and self-sustained circadian rhythms that characterize the peripheral clocks. 
The comparison between the two period values leads to conclude that more 
frequent medium deliveries seem to cause decrease in the period. 
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Figure 5.6: : Comparison of period values between the two conditions of medium delivery. 
 
 
A quantification of peak amplitude was performed for both conditions (Figure 
5.7). 
It is interesting to see that there is a difference (p<0.01) only for the first peak, 
comparing the two condition of medium change; this result is consistent with the 
gradual lack of significant phase clustering because of desynchronization among 
individual cellular oscillators. 
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Figure 5.7: Temporal evolution of the peak amplitude for both conditions of medium delivery. 
 
 
The last circadian parameters analyzed was the shift phase (Figure 5.8). 
We already noted that the two Per2 temporal variation begin with small phase 
shift that continuously increase up to the end of the experiment. 
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It seem evident that the entrainment frequency of 1 h-1 produces a negative phase 
shift compared to the frequency of 1/24 h-1; in particular frequent medium 
changes (F= 1 h-1) provide a phase delay of circadian gene expression in the 
range [0.1 ± 0.3, 0.9 ± 0.4] h for the first three days, that becomes more 
significant from the 4th day to the end of experiment, varying in the range of [2.0 
± 0.6, 9.0 ± 0.6] h. 
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Figure 5.8: Phase shift, calculated as absolute value of different peak-to-peak time between the 
two medium conditions delivery. 
 
 
5.2.2 Spatial distribution of circadian rhythms 
 
The lack of significant phase clustering by the end of the experiment suggests an 
absence of functional coupling among individual cellular oscillators, which seem 
to drift freely out of phase over the course of the experiment without influencing 
one  another’s  rhythms. 
In order to investigate whether there is some correlation between the synchrony 
damping and the spatial positions, we mapped some region of the culture chamber 
in horizontal and vertical directions. 
Figure 5.8 shows luminescence intensity from different ROIs. 
Each horizontal line represents a pixel space of luminescence image, with elapsed 
time plotted left to right. 
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In particular it was mapped the horizontal circadian behavior, running in time a 
vertical ROI (8x8 pixel) at the center of chamber, viceverca for the vertical 
behavior. 
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Figure 5.99: Heat-map of Per2 bioluminescence; each line represents a single ROI, taken along the 
horizontal or vertical direction of chamber, with elapsed time plotted left to right. 
 
 
The color-maps show that the frequency of 1/24 h-1 ensured a homogenous 
distribution of the luminescence signal in both horizontal and vertical 
directions, proving a sorted circadian behavior. 
Conversely the frequency of 1 h-1 was able to keep a good organization until to 
the 2 days, after that the circadian gene expression became irregular in both the 
directions. 
Constant delivery of medium (frequency of 1 h-1) is actually resulting in high 
concentration of exogenous factors for the entire 24 h cycle (quasi-steady-state 
conditions). On the other hand, frequency of 1/24 h-1 ensures high concentration 
of exogenous factors only right after the medium change; concentration of 
exogenous factors will decrease by cellular consumption and uptake. 
Intuitively, these two different hypothetical experimental conditions only 
partially reproduce physiological glucose fluctuations observed in vivo.  
The first case (frequency of 1 h-1) maintains constant high level of glucose 
concentration without the typical oscillatory day/night behavior, on the other 
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hand, the second case (frequency of 1/24 h-1) has oscillatory behaviors but with 
unknown dynamic. 
With these considerations in mind, we designed new experiments in which we 
compare to different condition in which the cyclic glucose perturbation has a 12 
h phase shift. 
 
 
5.3 Cyclic glucose perturbation within microfluidic device 
 
As proof of concept we performed an experiment for studying the variation of 
circadian gene expression by metabolic cycles. 
This experiment has the same rationale of those described § 4.3, with the 
advantage being able to analyze the circadian behavior also during the 
stimulation phase. 
In particular we wanted to test the effect of alternate cycles of low (2mM) and 
high (20 mM) glucose concentration, delivered with a flow rate of 3 uL/min 
and at the frequency of 1 h-1, on circadian gene expression. 
The two different cycles of glucose perturbation imposed are: 
1. cyclic 12 h High glucose medium pulse – 12 h Low glucose medium 
(HL 12h); 
2. cyclic 12 h Low glucose medium pulse – 12 h High glucose medium 
(LH 12h). 
This experiment was monitored for almost 3 days and the Per2 luminescence is 
shown in Figure 5.10. 
The signals represent the average intensity of bioluminescence, time integrated, 
di 9 ROIs, (32x32) pixel, for each chamber, after baseline subtraction. 
# 128 Per2::Luc 
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Figure 5.10: A) Schematic representation of the two different protocols of medium delivery 
imposed by microfluidic approach. B) Per2::luminescence signal monitored during the two 
different medium delivery (HL12h, LH 12h), for 3 days. 
 
 
For a complete characterization of circadian behavior it was performed a 
quantification of period, amplitude and phase shift. 
The period, shown in Figure 5.11, does not exhibit significant difference 
between the two protocols of stimulation. The HL-12h  ‘entrained’  culture  has  a  
period of 24.0 ± 0.4 h (n=9) while LH-12h   ‘entrained’   culture   of   23.4 ± 0.6 
(n=9). 
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Figure 5.11: Comparison of period values between the two conditions of medium delivery. 
 
 
The quantification of peak amplitude was performed for both conditions (Figure 
5.12); the HL-12h seems being able to synchronize the cell culture more than the 
LH-12 h protocol (p< 0.01); this is gradually damped by the second day, obtained 
peak amplitude comparable between both conditions. 
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Figure  5.12: Temporal evolution of the peak amplitude for both conditions of medium delivery. 
 
 
The phase shift (Figure 5.13) between the two conditions was also valuated, 
showing that the LH-12h exhibits a positive phase shift of 2.5 ± 0.4 h (p<0.0001) 
in the first peak and of 1.2±0.6 h (p<0.05) in the second peak. 
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Figure 5.13: Phase shift, calculated as absolute value of different peak-to-peak time between the 
two medium conditions delivery. 
 
 
These results show that microfluidic cyclic glucose perturbations within 
microfluidic device result in oscillatory circadian clock gene expression without 
substantially difference between the two different conditions. 
This result suggests that the glucose only acting on the amplitude of the initial 
oscillation but, alone, it does not override the initial clock synchronization. 
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5.4 Conclusions 
 
In this chapter, first of all a clear experimental evidence that circadian 
synchronization is possible within a microfluidic environments was provided. 
It is worth to highlight that, so far our knowledge this is a first example of 
circadian clock detected in microfluidic for mammalian cell culture. 
Moreover, targeted experiments (one experiment is long 10 day) were produced 
to analyze the effect of medium delivery on circadian clock within the 
microfluidic environment. The effect of media supply was more evident in the 
phase shift, suggesting that using high frequency medium delivery the 
composition of entrainment factor within the media should be accurately 
controlled. Analysis about spatial homogeneity of circadian synchronization 
overall microfluidic culture chamber provide useful information on optimal 
condition to obtain uniform cell culture synchronization. 
Finally, we provide a proof of concept that we could also perform cyclic 
metabolite stimulations within the microfluidic environment while 
simultaneously recording circadian gene expression. This technological 
achievements open completely new perspective in circadian study. 
  
From scientific point of view, these latest microfluidic results are very 
encouraging. In particular, it seems straightforward that the use of cyclic 
glucose and insulin perturbations, as suggested from the results of chapter 4 
obtained using conventional methodology, will be next step. 
 
In this perspective, the number of experimental combinations required for 
properly studding simultaneous metabolic and hormonal perturbation is 
exponential growing; for instance the main variables to be considered are: 
frequency of medium delivery, glucose and insulin concentrations, period of 
stimulation, number of cyclic perturbation within 24h. 
 
With this in mind, it was considered unfeasible to continue on using the 
microfluidic platform B (multichannel platform with off line liquid handling) 
described on chapter 3. On the other hand, the microfluidic platform C 
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(multichannel platform with online liquid handling), specifically designed for 
parallel independent biological experiments, will be the perfect solution. We 
demonstrate the feasibility of the microfluidic platform C for long-term 
biological experiment and circadian study with this platform are now ongoing. 
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CHAPTER 6 
 
Conclusion and perspective 
 
 
 
The study of circadian rhythms is a complex problem, which has a high social 
impact. Dysfunction of circadian rhythms has strong effects on human health and 
many clinical studies show that circadian disruption may have great implication in 
metabolic syndrome or obesity. This is not surprising if we think that many 
metabolic processes, such as glucose and cholesterol metabolism, are directly 
regulated by the circadian clock; the most important function of the circadian 
system is to maintain energy homeostasis by anticipating changes in the external 
environment and preparing the internal molecular environment to respond to these 
changes. On the other hand, the metabolic signals send feedback to the circadian 
system, modulating the phase, amplitude and period of circadian oscillators of the 
peripheral tissues. Therefore, how the environmental conditions or human 
behavior affects the clock is of fundamental importance for maintain healthy life-
style. 
 
Whereas cell-autonomous molecular clock in mammals is known to be generated 
by two interlocking transcription/translation feedback loops (TTFL) that function 
together to produce robust 24 h rhythms of gene expression, the mechanism of 
clock synchronization and its correlation with behavioral conditions is still 
unknown.  
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The general aim of the thesis is developing an in vitro model that resembles the 
cyclic dynamic fluctuations of metabolites and hormones (i.e. glucose, insulin), 
and even circadian related pathological alteration, at which the peripheral 
tissues are exposed in vivo. 
The correlation between metabolite and hormone fluctuations and the circadian 
oscillators on cell culture derived from peripheral tissues, were specifically 
evaluated. The results clearly show how oscillatory perturbation of glucose and 
insulin together could affect some aspects of the circadian behavior. These 
results are quite important in the context of this thesis because they are actually 
confirming that the hypothesis of metabolic perturbation on circadian rhythms 
could be relevant in peripheral tissue. 
Moreover, the circadian experiments using conventional technology show that 
the lacking of simultaneous perturbation/recording systems and the low level of 
automation in the conventional cell culture methods represent a strong 
limitation to further progress in circadian field.  
As innovative technological tool, we identified the microfluidic technology for its 
capacity of delivering periodic extracellular chemical stimuli that could mimic the 
pulsatile nature of in vivo signaling systems.  
In this perspective, three types of microfluidic platforms suitable for robust in 
vitro model for study of circadian rhythms were developed: i) single independent 
channel for fast biological validation; ii) multiple channel chip with off-line liquid 
handling for biological validation of cyclic perturbations; iii) large scale 
integration chip with on line liquid handing for multiple parallel independent 
biological experiments exposes to cyclic perturbations. 
All microfluidic platforms have been developed in order to obtain devices as 
simple and easy-to-use as possible, while maintaining the following capability: 
long-term cell culture integration, accurate dynamic perturbation by chemical 
stimulus and quantitative analysis of circadian targets. These latter points were 
deeply investigated by developing to different molecular methods suitable for 
quantitative analyzing the temporal oscillatory behavior of the circadian genes 
circadian analysis, qPCR and luciferase reporter gene assay. 
 
First of all a clear experimental evidence that circadian synchronization is 
possible within a microfluidic environments was provided; it is worth to 
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highlight that, so far our knowledge this is a first example of circadian clock 
detected in microfluidic for mammalian cell culture. 
Targeted experiments (one experiment is long 10 day) were produced to 
analyze the effect of medium delivery on circadian clock within the 
microfluidic environment. The effect of media supply was more evident in the 
phase shift, suggesting that using high frequency medium delivery the 
composition of entrainment factor within the media should be accurately 
controlled. Analysis about spatial homogeneity of circadian synchronization 
overall microfluidic culture chamber provide useful information on optimal 
condition to obtain uniform cell culture synchronization. 
We also provide a proof of concept that we could also perform cyclic 
metabolite stimulations within the microfluidic environment while 
simultaneously recording circadian gene expression.  
 
Altogether, the results reported in this thesis have the potential to open a new 
perspective in circadian study. From technological point of view, the 
simultaneous cyclic perturbation of cell culture and gene expression recording 
will allow to perform high sensitive screening on potential entrainment factors.  
In particular, as demonstrated in this thesis work using conventional 
technology, the use of cyclic perturbations with glucose and insulin in the same 
time could synchronize peripheral cells.  
The number of experimental combinations required for properly studding 
simultaneous metabolic and hormonal perturbation is exponential growing; for 
instance the main variables to be considered are: frequency of medium delivery, 
glucose and insulin concentrations, period of stimulation, number of cyclic 
perturbation within 24h. 
With this in mind, it was considered unfeasible to continue on using simple 
microfluidic platform such as the multichannel platform with off line liquid 
handling. On the other hand, the microfluidic platform with multichannel 
platform with online liquid handling, specifically designed for parallel 
independent biological experiments, will be the perfect solution. We already 
demonstrate the feasibility of this microfluidic platform for long-term 
biological experiment and circadian study with this platform are now ongoing. 
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As mentioned above, the molecular correlation between entrainment factors and 
circadian clock of peripheral tissues is still largely unknown. The dissection of 
mechanisms and isolation of specific factors will be almost impossible using 
human individuals or even animal model.  
The microfluidic technology could offer a unique opportunity to explore the 
correlation between entrainment factors and human behavior. Alternatively to 
screening relevant entrainment factors with a series of multiple parallel 
experiments, it would be possible to use directly serum samples collected from 
human individual at different time of the day. This experimental strategy it would 
be feasible just because typical microfluidic experiments are based on the 
consumption of few microliter of medium per day.  
In order to provide the proof of concept of this idea, we collect plasma sample 
from 12:12 LD (12 h Light- 12 h Dark) entrained mice at ZT=3 h and at ZT= 15 
h, corresponding to starvation phase and to iperglicemia peak, respectively. 
This condition, as reported in figure 6.1, could be correlated to high glucose and 
high insulin at ZT=3 and low glucose and low insulin for ZT=15. 
 
 
Figure 6.1. Daily profile of food consumed by 12:12 LD (12 Light :12 Dark) entrained mice. 
 
 
Figure 6.2 shows Fibroblasts-Per2 luminescence resulting by synchronization 
with two different sera derived from plasma of 12:12 LD (12 h Light- 12 h Dark) 
entrained mice. Surprisingly, the post-prandial condition (corresponding to 
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iperglicemia peak) is a strong entrainment of circadian clock. In contrast, the 
plasma sample collected at starvation phase seems to have minimal influence on 
circadian clock. 
 
 
Figure 6.2. Fibroblasts-Per2 luminescence resulting by synchronization with two different sera 
derived from plasma of 12:12 LD (12 h Dark- 12 h Light) entrained mice. ZT=3 corresponds at 
starvation phase, whereas the ZT= 15h corresponds to iperglicemia peak. 
 
These preliminary results show that the plasma collected from animal models 
contains information about the behavior of the animal. The development of ad hoc 
microfluidic technology cold be effective used to identify specific entrainment 
factor. 
These microfluidic approaches offer a unique possibility that is not possible with 
conventional technology. 
Serum&ZT=3&h&
Serum&ZT=15&h&
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Appendix A1 
Microfabrication 
 
In this Appendix, the material and methods of the protocols used for the designing 
and fabrication of single or multi layer mold and chip. 
 
 
A1.1 Soft lithography 
Soft lithography is the most used technique to fabricate silicon-based devices that 
use replica molding of elastomeric materials to produce microfluidic devices 
The first step in multi layer soft lithography is mold making. 
 
Mold Making 
This  mold…….. 
 
At the end of these operations, molds contain the relief of the wanted microfluidic 
device. The thickness of the resist used during mold making determines the 
channel height on the further microfluidic device. It is obvious that this step is 
very crucial for the entire process and the minimum imperfection will be reflected 
on the following operations. 
For molding making can be used two different type of photoresist, negative and 
positive. 
In general a negative resist is a type of photoresist in which the fraction of the 
resist that is exposed to light becomes polymerized and more difficult to dissolve. 
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Therefore, the negative resist exposed to the light stays on the surface, and the 
developer solution removes only the unexposed fraction. 
A positive resist behave in just the opposite way: the fraction of the photoresist 
that is exposed to light becomes soluble to the photoresist developer. The exposed 
resist is then washed away by the developer solution, leaving windows of the bare 
underlying material. Only the fraction of the photoresist that is unexposed 
continues to remain insoluble to the developer (Figure A1.1). 
 
Figure A1.1: differences in exposure mask and hard bake for negative and positive photoresist. In 
the negative photoresist only the fraction exposed to the light (white in the mask) crosslink, the 
remain resist will be dissolved by the solvent. During hard bake the positive resist re-flow and the 
geometry from square becomes round. 
For manufacturing the microfluidic device in this thesis we used SU8, as negative 
resist, that involves thickness about 5 to 200 um, and SPR, as positive resist, that 
involves thickness about 5 to 45 um. The thickness of the resist on the substrate 
used is determined by the type of resist and the spin speed used during the coating 
process (further details on general thickness will be found on the specific 
photoresist datasheets). The lowest aspect ratio of structure is 1.10 (height: 
width): structures with lower aspect ratios are prone to collapse.  
The process to produce molds can be classified in subsequently steps: 
x Substrate cleaning and treating 
x Photoresist coating 
x Pre-expose bake 
x Exposure 
x Post-expose bake 
x Development 
x Hard bake 
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The steps are followed in total for the negative resist, instead for the positive there 
is a little change. 
One of the more frequent issues is imperfections due to not perfect cleaning, and 
adhesion problems due to wet surface. Before coating, the substrate must be clean 
with solvent and dried with clean air and heat. For the positive resist the substrate 
treatment with HDMS (hezadymetilsilazane) improve adhesion at the substrate.  
 
The photoresist coating is made with a spin coater, in which spin speed, 
acceleration and length determine the thickness.  
 
The pre-exposure bake (PEB) consists in 2-3 baking steps: for the negative resist 
at 65°C and 95°C followed to the expose. In this step the solvent starts to 
evaporate and the polymer improve mechanical properties before exposure. For 
the positive resist there are 2 bakes during the entire process and time and 
temperature can vary from 90°C to 105°C with the thickness. In general, lesser is 
the temperature longer is the bake time and stronger will be the polymer adhesion. 
Before the exposure the positive resist needs to be rehydrated, to reduce the 
strength induced by the solvent evaporation. It is achieved at room temperature in 
the dark. During light exposure there is geometry transfer by chemical reaction 
due to photoresist properties through an overlaying specific mask placed between 
the light and the photoresist. There is selective exposure on the mold by these 
transparency films printed with high resolution: the masks used for negative resist 
contain the inverse (the "negative") of the pattern to be transferred; the positive 
masks, therefore, contains an exact copy of the pattern which has to remain on the 
wafer.  
Exposure time depends with the resist thickness: increasing in thickness involve 
to increasing in exposure energy and therefore in exposure time. In general the 
energy required is lesser for the negative photoresist than for the positive one, in 
order to 10-20 times. Since the exposure time required for positive resist is very 
long, it could generate overheating and consequently it can damage the surface. A 
multiple cyclic exposure can be used to avoid overheating, alternating short 
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exposure time with delay time. They can be repeated until the total energy amount 
is transferred to the positive resist. 
For the negative photoresist an additional 2 step bake follows the exposure at 
65°C and 95°C; this improve the polymerization due to the light and increase 
mechanical properties to the structure before the development. 
Development is a very tricky step. Length and shake are two important parameters 
to control in the process and they depend from the resist thickness. Shake decrease 
the development time, reducing issues connect to over-development. Longer 
development time can damage the polymer and generate modified structure  
 The last step is hard baking, in which the polymer is baked at high temperature to 
complete the crosslink and increase resistant and hardness. For the positive this 
step is very important because it causes the reflow and therefore the obtaining of 
round channels. After reflow the polymer is very strong and hard and cannot be 
solved anymore by solvent. The reflowing must be done very slowly, due to not 
damage the channels. After reflow the channels blow up a little bit and it has to be 
considered during design. 
A1.2 Multi-layer chip fabrication 
PDMS is a popular material for microfluidic applications due to its chemical 
resistance, low cost and rapid fabrication. 
Using PDMS material in the last decay, an extension of soft lithography, called 
multilayer soft lithography, has been proposed [5, 6]. With this technique active 
microfluidic devices have been built, generating the new automation era for 
microfluidic chip and the development of mLSI, integrating microvalves and 
pumps. 
In general a basic multilayer microfluidic device is composed of two PDMS 
layers: the layer that contains channels for flowing liquid is called flow layer (FL), 
and the other one is called control layer (CL). 
 
Before to pour PMDS, the molds are treated with silanized reagent that makes the 
PDMS not stackable to the mold. PDMS is a silicon-based organic polymer; it’s  
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optically clear, and, in general, is considered to be inert, non-toxic and non-
flammable. PDMS consist of two components: the base and the cure agent. The 
manufacture recommendation is to use these two components in the weight ratio 
10:1 (“ON  RATIO”). For application regarding valves technology and multilayer 
PDMS chip, the ratio between the two PDMS layer (CL and FL) has been 
modified in order to make multilayer PDMS structures using thermal bonding. In 
multilayer soft lithography the bond of multiple PDMS layers is a necessary 
condition that has to be achieved during fabrication.  
Moreover the two layers have to be allocated in a precise position in which the 
control channels create the valve areas in the right point over the flow channels. 
To achieved this, in the design process some marks have been added at the edge 
of the chip and in the center of the pattern. These marks help the operator during 
the alignment process in the fabrication. Thermal bonding it has been preferred 
for mLSI (microfludic large scale integration) because it is more yielding during 
alignment:   it   isn’t   a   one   shot   process   (as   plasma  bonding)   and   the   operator   has  
more time to ensure the best alignment condition. This technique is  called  “OFF  
RATIO”  due to the modified ratio of the two layers from 10:1. One PDMS layer 
is made at high ratio (5:1) and the other one at low ratio (20:1); the two layers are 
partially cured before put in contact. A followed bake create an irreversible 
bonding at the interface due to rapid diffusion of the catalyst from the rich layer to 
the poor layer (about 10-40 µm).  
 
Figure A1.2: Multi layer PDMS chip is made by more than 1 PDMS layer in which the bond is 
ensure usually by plasma or by off ratio PDMS curing. In Thermal bonding, partially cured PDMS 
layer are aligned and placed in contact before put them together in oven to complete the curing 
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and ensure the bond. Therefore with plasma bonding the surfaces are treated with plasma and 
made in contact. Strong covalent bonds are guaranteed. 
The ability to create valves is achieved by interjection channels in two PDMS 
layers separates by a thin PDMS membrane. A valve is created by the thin 
membrane deflection that separates the two channels: when the control channel is 
pressurized a complete sealing is created. The thin membrane is formed by a thin 
PDMS layer spun over the mold: the PDMS height over the pattern determines the 
thickness of the membrane. The most important parameter that has to be evaluated 
at the end of the making process is the valve minimum closing pressure that is the 
minimum pressure applied to the  control  that  can  deflect  all  the  membrane’s  valve  
on the chip, creating a complete sealing in the valve region. This pressure must be 
guarantee during its use. The thickness of the membrane is the only constraint that 
could be adjust during chip making to improve the valve sealing during 
operations. Thicker is the membrane stronger is the valve, but higher will be the 
pressure that has to be applied to deflect the membrane, increasing the risk of 
breaking chip. Thinner membrane is preferred but the better choice is a 
compromise between robustness and workability: usually it is achieved with a 10-
20 µm membrane. Actually the most important parameters for the sealing are the 
valve cross section and the high of the flow channels. In general higher is the flow 
channel higher is the closing pressure, but this parameter has to be chosen during 
mask design and mold making. Also the shapes of the flow channels are 
important: round flow channels help the membrane deflection during sealing 
comparing with square flow channels. 
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Figure A1.3: A microfluidic valve is created when two channels are overlapped and separated by a 
thin membrane. When the control channel is pressurized the membrane deflects and there is 
sealing of the channel placed over.  
Two types of valves can be fabricated: if the control lines is under the flow 
channels it  has  been  made  a  “push  up”  valve, in which the membrane is deflected 
up into the flow channels. Therefore, if the control line is up the flow channels it 
has  been  made  a   “push  down” valve. There is a standard geometry for the flow 
channels and control channels for both valves type to ensure sealing. In general 
higher closing pressure is required for push down valves. The specific application 
has to be considering during the process design due choosing the right layers 
configuration.  It’s  not  possible  use  2  molds  that  were  produced  for  push  up  valves  
to make push down valves.  
In the OFF RATIO technique the thin layer is made in PDMS 20:1 ratio, 
therefore, the thick layer in PDMS 5:1 ratio.  
For making the devices used in this thesis we used PDMS  Sylgard 184 (Dow 
Corning), that ensures no toxicity to the mammalian cell culture. 
When microfluidic devices are ready, they are bonded to a resistant substrate that 
is usually a glass slide via plasma bonding. Devices sealed to glass are rated to 
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approximately a lower pressure before delamination than the devices sealed with a 
thin layer of PDMS over the glass slide. In this case delamination is not achieved 
up to 2 bars.  
Multi layer chip can be made also in the 10:1 ratio to reduce cure agent massive 
use. For mammalian cells it may avoid some toxicity problems due to high 
partially uncured PDMS when a different ratio from 10:1 is used. In this case 
thermal bonding cannot be used. Alternatively irreversible plasma bonding can be 
adapted easily for alignment of simple geometry where precision is not so 
important. 
The ratio used for making the three different layer of the Platform C described in 
tha Chapter 3 are: 
x 5:1 ratio (base:cure agent) for FL (Flow Layer)  
x 20:1 ratio for CL (Control Layer) 
x 10:1 ratio for chambers layer CHL (Chamber Layer). 
 
All the layers have been partially cured at 60 °C before peeling, cutting 
and punching: 45 minutes for FL, 60 minutes for CL and 70 minutes for 
CHL. After alignment, other 2 hours at 80 °C completed the curing. The 
chip has been finally bonded on large glass slip covered with a thin 20:1 
PDMS layer by plasma activation. 
 
 
A1.3 Mold Making Materials 
A1.3.1 Reagents and Substrates 
100 mm silicon wafer, orientation any, material type CZ silicon, dopant any, 
thickness min 400-600 um, resistivity 0-100 ohm cm, FrontSideFinished polished, 
BackSide Etched; (MCR Microsystems, Germany). 
Photoresist: SPR 220-7 (Dow Corning), SU8 2005 (Microchem), SU8 2010 
(Microchem), SU8 2025 (Microchem), SU8 50 (Microchem) 
Developer: MF319 developer (Dow Corning), SU8 developer (Microchem) 
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Solvent: Ethanol (Sigma), Isopropanol (Sigma), Methanol (Sigma), Acetone 
(Sigma) 
1,1,1,3,3,3 hexamethyl-disilazane (HDMS), reagent grade 97% (Sigma) 
A1.3.2 Equipments and Other 
Spin coater (Laurell WS-400b-6npp/lLITEHOR) 
programmable hot plate (Torreypines scientific) 
Rocking shaker (Reliable scientific inc) 
Karl suss alignment 
Karl suss UV intencity meter- model 1000 
Olympus TCH microscope ergolux (Olympus) 
White nitril gloves and clothes for clean room facilities (cover shoes, hairnet, 
bunny suit/frock, booties) 
Flat bottom and straight sides glass tank 125x75 (VWR) 
Wafer tweezers 
120 mm Petri dishes 
 
A1.4 Mold procedure 
A1.4.1 Flow Mold 
The flow mold is made by 3 photoresist layers. 
E.4.1.1 First layer, rounded channels 
1  Clean wafers 
Rinse wafers with acetone, then methanol, then distilled water (DI) (using squirt 
bottle), blow dry with pressure clean air. Dry on hotplate at T>100C for at least 15 
min 
2  Treat with HMDS 
Place the wafer in a closed chamber with an open container of HDMS for at least 
10 min 
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3  Spin photoresist 1st layers with SPR-220-7 
Place wafer onto spinner chuck and apply vacuum; pour 5 ml of SPR-220-7 on 
wafer. Use 7 steps spin program: 
 
Step number Time  
[sec] 
Speed  
[rpm] 
Acceleration 
[rpm/sec] 
1 10 0 0 
2 70 200 200 
3 15 200 400 
4 45 200 1000 
5 10 700 1000 
6 30 400 2000 
7 5 800 5000 
 
Let wafer sit on a flat level surface, covered with Petri dish for 10 min or less if 
de-wetting is observed on edges 
4  Soft bake photoresist 1st layer 
2-steps soft baking on 2 hotplates, covered with Petri dish leaving an air gap for 
solvent to escape while soft baking. Use 2 steps bake: 
 
Step number Temperature 
[°C] 
Time 
[min] 
1 65 5 
2 90 40 
 
Remove wafer from 90°C slowly, rising the wafer a millimeters every few 
seconds 
5 Resist rehydration 
let wafer sit in closet petri dish, wrapped in aluminum foil at room temperature for 
at least 3 hours (overnight is also good) 
6 Exposure 
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Prepare mask and place into Karl suss mask aligner. Choose exposure parameters 
and expose wafer: parameters: soft contact; Intensity:9mW/cm2; Time 14sec x 19, 
25 sec pause 
7  Develop MF-319 developer 
place wafer in MF-319 developer and continuously agitate the solution time for 
10-15 min. Rinse with DI water by filling agitation, and pouring out for 6 times. 
8  Measure profile 
Measure photoresist height in profilometer: expected photoresist thickness: 15-20 
um (depending on place on the wafer)  
9 Hard baking & reflow  
Reflow on hotplate, covering with petri dish. Hard bake recipe: leave at 65C for 
1hr, then from 65C to 190 using 10C/hr ramp. Set timer to 15hrs and use an auto 
off. 
10 Measure profile  
Measure photoresist height in profilometer: expected photoresist thickness: 27-32 
um (depending on place on the wafer)  
 
A1.4.1.2 Second layer, square channels 
1  Clean wafers 
Rinse wafers with acetone, then methanol, then distilled water (DI) (using squirt 
bottle), blow dry with pressure clean air. Dry on hotplate at T>100C  for at least 
15 min 
2  Spin photoresist SU8-50 
Place wafer onto spinner chuck and apply vacuum. Pour 5 ml of SU8-50 on wafer. 
Use 2 steps spin program 
 
Step number Time  
[sec] 
Speed  
[rpm] 
Acceleration 
[rpm/sec] 
1 10 500 100 
2 50 2000 260 
 
Let wafer sit on a flat, level surface, covered with petri dishes  for 10 min. 
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3  Soft bake photoresist  
3-steps soft baking on 2 hotplates: 
 
Step number Temperature 
[°C] 
Time 
[min] 
1 65 5 
2 95 15 
3 65 2 
 
Cover wafers with glass petri dish leaving an air gap for solvent to escape while 
soft baking. Remove wafer from 95C and from second 65C bake slowly, rising 
the wafer a millimeters every few seconds 
4  Exposure 
Prepare mask and place into karl suss mask aligner. Align mask to rounded 
channels on the wafer and chose exposure parameters. Recipe: soft contact; 
Intensity: 9mW/cm2; Time:22sec 
5 Post Exposure Bake 
3-steps soft baking on 2 hotplates 
 
Step number Temperature 
[°C] 
Time 
[min] 
1 65 2 
2 95 5 
3 65 2 
 
cover wafers with glass petri dish leaving an air gap for solvent to escape while 
soft baking. Remove wafer from 95C and from second 65C bake slowly, rising 
the wafer a millimeters every few seconds  
6 Develop SU8 developer 
place wafer in SU-8 developer and continuously agitation solution for 2 min-
2.5min. Rinse wafer with lots of isopropanol (using squirt bottle). Blow dry with 
clean pressurized air. 
7 Measure profile  
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measure photoresist height in profilometer: expected photoresist thickness: 47-51 
um (depending on place on the wafer) 
8 Hard bake  
Place the wafers on hotplate, covering with petri dish. Hard bake recipe: leave at 
65C for 2 min, then from 65C to 160 using 120C/hr ramp. Set timer to 2 hours 
and use an auto off. 
 
 
A1.4.2 Control Mold 
A1.4.2.1  
1  Clean wafers 
rinse wafers with acetone, then methanol, then distilled water (DI) (using squirt 
bottle), blow dry with pressure clean air. Dry on hotplate at T>100C  for at least 
15 min 
2  Spin photoresist SU8 2005 
place wafer onto spinner chuck and apply vacuum. Pour 5 ml of SU8 2005 on 
wafer. Use 1 steps spin program 
Step number Time  
[sec] 
Speed  
[rpm] 
Acceleration 
[rpm/sec] 
1 400 3000 400 
 
let wafer sit on a flat, level surface, covered with petri dish for 5 min. 
3  Soft bake photoresist  
3-steps soft baking on 2 hotplates: 
 
Step number Temperature 
[°C] 
Time 
[min] 
1 65 2 
2 95 5 
3 65 2 
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cover wafers with glass petri dish leaving an air gap for solvent to escape while 
soft baking. Remove wafer from 95C and from second 65C bake slowly, rising 
the wafer a millimeters every few seconds  
4  Exposure 
Expose the wafer without masks: all the polymer is exposed to the UV light. 
Recipe: soft contact; Intensity: 9mW/cm2; Time:18sec 
5 Post Exposure Bake 
3-steps soft baking on 2 hotplates 
Step number Temperature 
[°C] 
Time 
[min] 
1 65 2 
2 95 6 
3 65 2 
cover wafers with glass petri dish leaving an air gap for solvent to escape while 
soft baking. Remove wafer from 95C and from second 65C bake slowly, rising 
the wafer a millimeters every few seconds  
A1.4.2.2 Second layer, square channels 
1  Spin photoresist SU8-2025 
place wafer onto spinner chuck and apply vacuum. Pour 5 ml of SU8 2025 on 
wafer. Use 1 step spin program 
 
Step number Time  
[sec] 
Speed  
[rpm] 
Acceleration 
[rpm/sec] 
1 80 3000 130 
 
let wafer sit on a flat, level surface, covered with petri dish  for 10 min. 
2  Soft bake photoresist  
 3-steps soft baking on 2 hotplates: 
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Step number Temperature 
[°C] 
Time 
[min] 
1 65 2 
2 95 5 
3 65 2 
 
cover wafers with glass petri dish leaving an air gap for solvent to escape while 
soft baking. Remove wafer from 95C and from second 65C bake slowly, rising 
the wafer a millimeters every few seconds  
 
3  Exposure 
prepare mask and place into karl suss mask aligner. Choose exposure parameters 
and expose wafer. Recipe: soft contact; Intensity: 9mW/cm2; Time:18sec 
4 Post Exposure Bake 
3-steps soft baking on 2 hotplates 
 
Step number Temperature 
[°C] 
Time 
[min] 
1 65 2 
2 95 5 
3 65 2 
 
cover wafers with glass petri dish leaving an air gap for solvent to escape while 
soft baking. Remove wafer from 95C and from second 65C bake slowly, rising 
the wafer a millimeters every few seconds  
5 Develop SU8 developer 
place wafer in SU-8 developer and continuously agitation solution for 2.5 min-
3min. Rinse wafer with lots of isopropanol (using squirt bottle). Blow dry with 
clean pressurized air. 
6 Measure profile  
measure photoresist height in profilometer: expected photoresist thickness: 19-21 
um (depending on place on the wafer) 
7 Hard bake  
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Place the wafers on hotplate, covering with petri dish. Hard bake recipe: leave at 
65C for 2 min, then from 65C to 160 using 120C/hr ramp. Set timer to 2 hours 
and use an auto off. 
A1.4.2.3 Third layer, chamber layer 
1  Clean wafers 
rinse wafers with methanol (using squirt bottle), blow dry with pressure clean air. 
Dry on hotplate at T> 65°C for at least 15 min 
2  Spin photoresist SU8-2025 
place wafer onto spinner chuck and apply vacuum. Pour 5 ml of SU8 2025 on 
wafer. Use 2 steps spin program 
 
Step number Time  
[sec] 
Speed  
[rpm] 
Acceleration 
[rpm/sec] 
1 20 500 130 
2 50 1500 300 
 
let wafer sit on a flat, level surface, covered with petri dishes  for 10 min. 
3  Soft bake photoresist  
2-steps soft baking on 2 hotplates: 
 
Step number Temperature 
[°C] 
Time 
[min] 
1 65 5 
2 95 7 
 
cover wafers with glass petri dish leaving an air gap for solvent to escape while 
soft baking. Remove wafer from 95C and from second 65C bake slowly, rising 
the wafer a millimeters every few seconds  
4  Exposure 
prepare mask and place into karl suss mask aligner. Align mask to square 
channels on the wafer and chose exposure parameters. Recipe: soft contact; 
Intensity: 9mW/cm2; Time:18sec 
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5 Post Exposure Bake 
2-steps soft baking on 2 hotplates 
 
Step number Temperature 
[°C] 
Time 
[min] 
1 65 1 
2 95 6 
 
cover wafers with glass petri dish leaving an air gap for solvent to escape while 
soft baking. Remove wafer from 95C and from second 65C bake slowly, rising 
the wafer a millimeters every few seconds  
6 Develop SU8 developer 
place wafer in SU-8 developer and continuously agitation solution for 1 min. 
Rinse wafer with lots of isopropanol (using squirt bottle). Blow dry with clean 
pressurized air. 
7 Hard bake  
Place the wafers on hotplate, covering with petri dish. Hard bake recipe: leave at 
65C for 2 min, then from 65C to 160 using 120C/hr ramp. Set timer to 2 hours 
and use an auto off. 
8 Measure profile  
measure photoresist height in profilometer: expected photoresist thickness: 45-47 
um (depending on place on the wafer) 
 
A1.5 Chip Making Materials 
A1.5.1 Reagents and Substrates 
Chloromethylsilane (C 72854-500ml Sigma Aldrich) 
Sylgard 184 Dow corning kit (base and cure agent) 
Glass slide: Brain Research laboratories n 1 thickness 48x60 
VWR micro slides 25x75 (cat n 48300-025) 
VWR micro slides 50x75 cat 48300-050 
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A1.5.2 Equipments and others 
PDMS Mixer (Thinky AR-250) 
spic coater (Laurell WS-400b-6npp/lLITEHOR) 
Vacuum system (vacuum pump and crystallization tank)  
Stereomicroscope Nicon SMZ1500 
Convective Oven (VWR model NO 1350 FM) 
Punch machine (Schmidt technology press and camera) 
Plasma Machine  
Cutter 
White tape 
Wafer tweezers 
Al foil 
TX 1109 Non waven wipers Technicloth II 
TX 1010 Vectro Alpha 10, Vectro Sealed-border wipers 
Petri dishes 150x15 mm (VWR 25384-326 and 25384-302 100x15mm) 
A1.6 Chip procedure 
1 Coating 
Molds are placed under vapor of chlorotrimethylsylane for 10-20 minutes. Then , 
they are cleaned with pressurized dry air and placed in clean, covered petri dishes.  
2 PDMS preparation: Sylgard 20:1 
Prepare 20 g of PDMS 20:1 (base:cure agent): weight base and cure agent under 
hood;  mix for 2 minutes following degassing for 3 minutes. 
3 PDMS preparation: Sylgard 5:1 
Prepare 50 g of PDMS 5:1 (base:cure agent): weight base and cure agent under 
hood;  mix for 2 minutes following degassing for 3 minutes. 
4 Control Layer coating 
Place the mold onto spinner chuck and apply vacuum. Pour 10 ml of PDMS 20:1 
on the center of the mold. Use a 1 step program:  
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Step number Time  
[sec] 
Speed  
[rpm] 
Acceleration 
[rpm/sec] 
1 75 2200 133 
 
Let on a flat surface for 90 minutes inside a closed petri dish. 
5 Degassing  
Put the FL mold in a foil vessel and cover the mold with the uncured 5:1 PDMS. 
Degas until bobbles disappear.  
6 First curing 
Bake at 60°C for 45 minutes  the CL and for 35 minutes the FL. 
7 Flow layer chip casting  
Peel, cut and punch (20G) the FL chip and clean the surface with tape. 
8 Alignment 
Align the FL on the CL under stereomicroscope. Check all markers and valves 
intersection. No bubbles have to be present. 
9 Thermal Bonding 
Bake the 2 aligned layers together at 60°C for 15 minutes and then at 80°C for 90 
minutes. 
10 Two-layers chip casting 
Cut, peel and punch (20G) the two layers chip. Remove the eventual thin 
membrane on the chamber. Clean the surface with tape. 
 
CHL casting 
11 PDMS preparation: Sylgard 10:1 
Prepare 80 g of PDMS 10:1 (base:cure agent): weight base and cure agent under 
hood;  mix for 2 minutes following degassing for 3 minutes. 
12 Degassing 
Put the CHL mold in a foil vessel and cover the mold with the uncured 10:1 
PDMS. Degas until bobbles disappear.  
13 Curing and casting 
Bake at 60°C for 3 hours, then peel, cut and punch with a 4 mm puncher to make 
the hole for biopsies insertion.  
14 Plasma bonding 
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Clean the surface with tape. Treat the CHL  and the 2-layers chip with plasma for 
35 sec at 70W. Align under the microscope to center the chambers with the holes 
in the CHL. Put in the oven for at least 2 hours (better overnight). 
A1.8 Automation 
Automation is achieved by valve control with custom software. All the valves in 
the chip are driven by miniature pneumatic solenoid valves (24V, CKD 
Corporation) which are in turn controlled by electronic unit for the generation of 
digital signal (NI USB-6501, National Instruments) connected to the USB port of 
a computer. The electronic unit is plugged to a 24V transformer. There is also a 
system composed of rechargeable battery to guarantee charge during relocation, 
for example from the incubator to the microscope in another room (up to 15 
minutes declared). 
Each solenoid valve can switch more valves in the chip between atmospheric 
pressure (on-chip valve open) and 250 kPa (on-chip valve closed). Custom 
software developed using Labview® (National Instruments) operates the chip. 
This software permits fully automated and unattended operation of the system 
during an experiment. 
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Biological protocols 
A2.1 Cell Culture integration in the microfluidic device 
All fibroblasts culture used in this work (HFF, #128 Per2::Luc) were expanded in 
tissue culture 10 mm dishes with proliferation medium: Dulbecco Modified Eagle 
Medium (DMEM, Sigma-Aldrich), 10% Fetal Bovine Serum (FBS, Life 
Technologies), 1% Penicillin-Streptomycin mix (Life Technologies). Before 
reaching the confluence, cells were trypsinized with Trypsin-EDTA 0.25% (Life 
Technologies) and replated either in new dishes or into the microfluidic chip.  
Before cell seeding, microfluidic chip was sterilized by autoclave processing. After its 
sterilization, it is moved into a 35 mm Petri dish under sterile hood and injected with cold 
25 ug/mL fibronectin (Sigma Aldrich), 25 ug/mL in PBS 1X; the fibronectin coating is 
kept at room temperature for 1 hour and is removed by washing microfluidic chamber 
with culture medium. A cells suspension was then prepared in order to obtain a cell 
seeding density of 200 cell/mm2 and injected in the chip. The bottom of the dish was 
covered with 1 ml of PBS 1X, in order to maintain proper humidity. The cells were kept 
in incubator at 37°C, 5% CO2 for 3 to 5 hours, until they adhered to the bottom glass of 
the chip. After their adhesion, the lateral wells of the microfluidic chip were filled with 
proliferating medium and cells maintained in the incubator.  
Medium was then changed every 24 h, by adding new medium in the lateral wells 
and rapidly perfusing it inside the chambers with the help of a hand held pipette. 
This protocol allowed to have confluence cell culture after 4 to 5 days from 
seeding. 
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A2.2 Circadian synchronization of a cell culture 
 
Two different protocols of synchronization were used in this thesis, by 
dexamethasone and serum shock; the same procedures were applied in static an 
microfluidic condition. 
 
Synchronization by dexamethasone shock 
A shock of dexamethasone (10 nM) was applied to the confluent cell layer  for 
two hours, then washed twice with PBS 1X. The cells were kept in a FBS-free 
medium until the end of the experiment. 
 
Synchronization by serum shock 
This protocol involves just a medium change with 10% FBS medium after a wash 
with PBS 1X. The cells were kept in 10% FBS medium for all experiment 
duration. 
 
After imposing one of these protocols, the circadian gene expression was analysed 
by Real-Time PCR or luciferase reporter assay. 
 
 
 
A2.3 Extraction of mRNA sample 
 
Extraction from microfluidic channel 
A lysis buffer, RT-qPCR iScriptTM Sample Preparation Reagent (BIO-RAD), 
was used for extracting the mRNA sample from the microfluidic channels. 
Because this buffer was designed to degrade the cytoplasmic membrane while 
leaving intact nuclear membrane, just the cytoplasmic RNA was extracted, while 
the genomic DNA remains within the nuclei.  
Before the extraction, the cells must first be washed gently with cold PBS 1X 
twice. 10 uL of iScript was injected in microfluidic channel and left for 1 minute 
at room temperature.  
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All reagent was collected, without disturbing the cell pellet, in a 0.2 mL RNase-
free tube kept on ice. mRNA was stored at -80 ° C. 
 
Extraction from Petri dish 
The mRNA extraction from cell culture seeded in Petri dish involves two step: the 
isolation by Tryzol and the purification by chloroform. 
The mRNA contained in 3.5 mm dish was isolated in 1 mL of Tryzol for 5 min a 
room temperature. The samples were collected in 1.5 mL tube and kept at -80°C 
or immediately processed for the following purification. 
Chloroform (200 uL per 1 mL of Tryzol) was added and incubated for 15 minutes 
on ice. 
The sample was centrifuged at 12000g for 25 min at 4 ° C; after centrifugation, 
the mixture was separated into a phase that contains phenol and chloroform, an 
interphase, and a transparent aqueous phase on the top. 
The aqueous phase was collected, taking care not to remove the phases underlying 
in a RNase free tube previously put on ice. 
Ethanol (70 %, prepared with RNase free H2O and previously filtered with filters 
from 0:20 pM) was added and left at room temperature. 
After a centrifugation at 12000g for 25 min at 4 ° C, the mRNA pellet was formed 
and the surnatant was sucked. The mRNA was diluited in 100 uL of RNA free 
water and was quantified.  
 
A2.4 Retrotranscription  
 
The reverse transcription reaction is the synthesis of a cDNA molecule from an 
RNA mold, catalyzed by the enzyme reverse transcriptase. 
To perform the reverse transcription was used High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems), which contains all the reagents necessary 
to obtain single-stranded cDNA of high quality even starting from very small 
amounts of RNA mold, up to 0.02 g. The trigger for the enzyme is given by 
random primers. 
A single reaction mix (Table A2.1) was prepared, for being apportioned into 
individual RNase-free tubes to which are added 2 L of mRNA extracted. 
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RT mix (20 uL total) 
RNA free water  12 uL 
10x RT Buffer 2 ul 
10X Random Primers 8.4 uL 
25X dNTP Mix (100 mM) 0.8 uL 
Mtultiscrible Reverse Transcriptase 1uL 
RNA  2 uL 
Table A2.1: Retrotranscription reaction performed with High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems). The volume of 20 ul is the volume of the single reaction 
for sample. 
 
The RT-sample mixes were loaded in a thermocycler that imposes diverse 
temperature cycles (Table A2.2). The final product of the reaction is the cDNA, 
that could be kept at 20 °C or processed for the following Real-Time PCR. 
 
 Step 1 Step 2 Step 3 Step 5 
Temperature [°C] 25 37 85 4 
Time [min] 10:00 120:00 5:00  
Table A2.2: Temperature cycles imposed during the retrotranscription. 
 
 
A2.5 Real-Time qPCR 
 
The analysis of genes PER2 and BMAL1 was carried out by Real Time 
quantitative PCR following RNA extraction and reverse transcription to cDNA. 
To perform quantitative PCR was used the kit TaqMan® Gene Expression Assays 
(Applied Biosystems), which involves the use of fluorescent probes for the 
detection and quantification of an amplification product specific. The probes and 
primers for cDNA gene Per2, Bmal1 and GAPDH are designed and tested by the 
manufacturer, so they specificity and efficiency certified. The probes are equipped 
with a molecule MGB which further increases the specificity. 
The reaction mix for single sample of cDNA is reported in Table A2.3. 
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Reaction Mix for each probe (20 uL total) 
2X TaqMan Gene Expression Master Mix 10 uL 
TaqMan Gene Expression Assay  1 ul 
RNase & DNase-free water 7 uL 
cDNA 2 uL 
Table A2.3: Reaction mix performed with TaqMan® Gene Expression Assays (Applied 
Biosystems). The volume of 20 ul is the volume of the single reaction for sample. 
 
 
The temperature cycles imposed are reported in Table A2.4. 
 
40 Cycles 
 Step 1 Step 2 Step 3 Step 5 
Temperature [°C] 50 95 95 60 
Time [min] 2:00 10:00 0.15 1:00 
Table A2.2: Temperature cycles imposed during the Real-Time PCR. 
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Bioluminescence reporter assay 
A3.1 Development a luciferase reporter cell line 
 
Development of a stably transfected luciferase reporter gene assay requires two 
step: 
x production of the luciferase reporter plasmid by virus production 
x integration of genic material in the cell line by infection. 
 
A3.1.1Virus production: 
According to protocol cpmb, chapter 16.21, 16.22. 
 
The protocol below described the procedures, day by day, of the virus production 
used for stable transfection in order to obtain a Bmal1::Luc reporter cell line. 
This virus can be integrated in both human and mouse cell culture. 
 
Day 0 
x The day before the infection split 293T cells to 10 cm dishes so that they are 
semi-confluent the day of transfection; usually a confluent plate split 1:6 (up 
to 1:10) the day before transfection is about correct (aim at 30-50% 
confluence on the day of transfection). Big Petri Plates should contain 8ml 
DMEM/10%FCS/1%pennicillin-streptomycin-glutamine. Be careful when 
handling the dishes, 293T cells do not adhere very well: pipet slowly and 
against the walls of the dish. 
x Incubate 293T over night 
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Day 1 
x Make a solution per plate with:  
Backbone (coding) plasmide (BLUFpuro):  15 mg  
pSPAX2 (RNA pol. and packaging plasmid):   1  0 mg  
pMD2G (coat plasmid):       6 mg 
[CaCl2] 2.5M, filter-sterilized     100 ml  
DNAs freee H20:        500 ul 
 
The structure of the backbone plasmid is reported at the end of this Appendix. 
 
x Vortex 
x In 4-10ml (also 50 ml) polypropylene tube, place 0.5ml HeBS 2X per plate. 
x Take a sterile pipette, put it in the tube containing HeBS 2x, and make bubbles 
of the air and at the same time take the solution made before with a pipette and 
pour it drop by drop while letting slip the bubbles on the sterile pipette. Vortex 
immediately  during  5  seconds   (=>don’t   to  make  more   than   two  tubes  at   the  
same time). A fine white translucent precipitate should form.   
x Let rest 20 min at room temperature 
x Add dropwise 1 ml of the translucent solution per plate. Mix precipitate and 
medium by rocking plate back and forth, as for spreading cells 
Day 2 
x After 24 hours of incubation in standard incubator, change medium: 
x Rinse cells carefully with 5ml of PBS 1X 
x Replace medium with 10ml fresh medium containing 200ml of Hepes 1M  
Day 3 
x After 24 hours, harvest supernatant 
Day 4 
x After 24 hours harvest again medium, pool it with the one harvested on day 3 
and concentrate the virus 
x Plates of 293T can now be discarded 
x Spin supernatant at 500 rpm for 10 minutes to pellet debris 
x Filter the supernatant through filters with 0.2-0.4mm of diameter, to remove 
eventual 293T cells detached from the plate 
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Concentrate the virus using ultracentrifugation: 
x Ultracentrifuge   at   80000G   4’C,   90  minutes.   In   rotor   70Ti: 28000 rpm (it is 
80695 G) 
Dilute the virus: 
x Remove the supernatant to a new tube 
x Add 1/10 of initial volume (using the removed supernatant) to have 10x virus 
x Pipet up and down to suspend the virus 
x Aliquot the virus (1 ml aliquot) and store at -80⁰C. 
 
HeBS 2X:  
NaCl   0.283M,  
HEPES acid   0.023M 
Na2HPO4  1.5mM 
pH 7.05 
 
pH of HeBS is absolutely critical. 7.05 is ideal, less than 7.0 or more than 7.1 is 
useless. Use Fluka Buffer tablets pH 7.0 to calibrate pH meter. Calibrate three 
times. Store at -80⁰C. 
Check the pH of the solutions of HeBS.  
 
A3.1.1 Infection  
 
The day before infection, split confluent cells 1:4 in 35 mm dishes. The cell heve 
to be 40-50% confluent the day of infection. 
The day of thrasfetion, remove the medium and add drop by drop warmed viral 
surnatant. 
For increase the infection rate, add polybene 1 ug/mL final concentration, 
immortalizzated cells, protamine sulfate 8 ug/mL final concentration, for primary 
cells. 
Change to fresh surnatant after 12-24 h, replacing fresh culture media after 2 wash 
of PBS 1X. 
At the third day after the transfection, start the selection of the cells with selectin 
medium by adding 1 mg/mL of puromycin (Sigma Aldrich). 
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Split the cells in selection medium twice to be sure that all the cells are selected. 
Cultivate the cells in selecting medium for at least 2 weeks. 
A3.2 Long-term circadian rhythms recording 
 
LumiCycle and Imaging recording medium 
All media used during the recording phase are high-glutamine (2 mM, Sigma 
Aldrich) Dulbeccos Modified Eagles Medium (Sigma Aldrich), that contain 
different concentrations of glucose [25 mM: 2mM] according to the purpose of 
experiment. 
Because the equipment for luminescence detection (LumiCycle and microscope)  
are controlled in temperature but not in CO2, we add 350 mg/L of sodium 
bicarbonate (Sigma Aldrich) and Hepes 10 mM (Sigma Aldrich), for  buffering 
the CO2 concentration. 
B27 supplement (2%, Life Techologies) or fetal bovine serum (10%, Life 
Techologies) was used as serum. Because phenol red reduces light signal 
penetration, the culture media should not contain phenol red. The medium must 
be sterilized by filtering. Luciferin (final concentration 0.1 mM, beetle luciferin, 
potassium salt, Sigma Aldrich) should be added just before the luciferase activity 
assay. The medium should be warmed at 37° before being used.  
 
 
A2.3 Imaging analysis 
 
The bioluminescence images were acquired by SI Image SGL B software 
(Spectral Instrument). 
After removing the outliers and adjusting the contrast by NIH ImageJ Software, 
the bioluminescence images were processed by a Matlab program. 
This program processed all images acquired by frame by frame, dividing them in 
ROIs, whose pixel number can be modulated, depending on detail degree of 
interest (Figure A3.1-A3.2). 
Using large ROI allows to investigate a population behavior than the small those 
that enable to see single-cell details. 
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For each ROI was calculated the average intensity of luminescence integrated in 
the time, by implementation of Matlab function mean. 
These signals thus obtained were processed with LumiCycle Sofware for the 
baseline subtraction and the calculation of circadian parameters (period, amplitude 
and phase). 
 
 
Figure A3.1: Image processing. The initial image [256x256] pixel was divided in 256 ROIs 
[16x16] pixel. For each ROI was calculated the average intensity of luminescence. 
 
 
Figure A3.2: : Image processing. The initial image [256x256] pixel was divided in 1024 ROIs 
[16x16] pixel. For each ROI was calculated the average intensity of luminescence. 
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High temporal resolution detection of 
patient-specific glucose uptake from 
human ex-vivo adipose tissue on chip 
Zambon Alessandro, Zoso Alice, Gagliano Onelia, Magrofuoco Enrico, Gian 
Paolo Fadini, Angelo Avogaro, Mirto Foletto, Quake Stephen, Elvassore Nicola 
My contribution is concerning the design and development of the automation and 
of the user-friendly interface of multilayer microfluidic platform; I also 
participated to the fabrication of all components and external devices for the chip 
management and the relative calibration and validation. 
 
 
A4.5 ABSTRACT 
Human tissue in vitro models on-chip are highly desirable to dissect the 
complexity of physio-pathological in vivo response because of their advantages 
compared to traditional static culture systems in terms of high control of 
microenvironmental conditions, including accurate perturbations and high 
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temporal resolution analyses of medium outflow. Human adipose tissue (hAT) is a 
key player in metabolic disorders, such as Type 2 Diabetes Mellitus (T2DM). It is 
involved in the overall energy homeostasis not only as passive energy storage, but 
also as an important metabolic regulator. 
Here, we aim at developing a large scale microfluidic platform for generating high 
temporal resolution of glucose uptake profiles, and consequently insulin 
sensitivity, under physio-pathological stimulations in ex vivo adipose tissues from 
non-diabetic and T2DM individuals.  
A multi-scale mathematical model that integrates fluid dynamics and intra-cellular 
insulin signaling pathway description was used for assisting microfluidic design in 
order to maximize measurement accuracy of tissue metabolic activity in response 
to perturbations. An automated microfluidic injection system was included on 
chip for performing precise dynamic biochemical stimulations. The temporal 
evolution of culture conditions could be monitored for days, before and after 
perturbation, measuring glucose concentration in the outflow with high temporal 
resolution. As a proof of concept for detection of insulin resistance, we measured 
insulin-dependent glucose uptake by hAT from non-diabetic and T2DM subjects, 
mimicking the post-prandial response. The system presented thus represents an 
important tool in dissecting the role of single tissues, such as hAT, in the complex 
interwoven picture of metabolic diseases. 
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A4.2 INTRODUCTION 
In vitro biological and physio-pathological studies, drug testing and therapy 
development demand robust systems that not only reproduce human tissue 
response with high fidelity, but also mimic the in vivo stimulating dynamic 
environment and monitor the resulting biological response1. 
On-chip in vitro models have several advantages respect to conventional cultures 
in well. The microfluidic culture microenvironment can be accurately controlled 
at the micro-scale due to the laminar flow therein2. Furthermore, microfluidic 
large-scale integration systems couple the advantages of miniaturization with 
those of automatic and temporally controlled fluid handling3, making possible 
precise biochemical stimulations with high temporal resolution. Finally, being 
perfused systems, the culture outflow can be analyzed for on-line biological 
response monitoring without perturbing culture conditions4. 
A biopsy-derived human tissue culture is currently the most faithful in vitro model 
of human physiology1, because it preserves cell-cell and cell-matrix interactions 
within the native three-dimensional architecture. Traditionally, tissue cultures are 
maintained in static wells with poor spatial and temporal control of the cellular 
microenvironment5. Metabolic measurements are performed therein with limited 
temporal resolution, given the high perturbation induced at every medium 
collection6. Recently, Iori et al developed a large-scale perfused system for hAT 
co-culture with hepatocytes and endothelial cells7. However, cultures were 
stopped after 48 h, with only three time points for measurements of metabolic 
activity. 
Ex vivo culture of a freshly-isolated tissue within a microfluidic device adds to the 
traditional in vitro model the above-mentioned advantages of tight culture control, 
tissue accurate temporal stimulation, and on-line readout. In addition, being a 
perfused system, on-chip culture enhances mass transport throughout the whole 
tissue volume, avoiding internal necrosis. Lastly, miniaturization increases 
experimental throughput and decreases the amount of biological material required. 
A limited number of tissue cultures have been performed within microfluidic 
systems, mainly using animal cells1, because of human tissue scarce availability. 
However, few human microfluidic ex vivo models were reported for islets8, liver9, 
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brain10, and heart slices11. Considering the high rate of failure in the drug 
discovery pipeline, especially occurring at the last stages of clinical trials, human 
disease modeling in vitro is becoming the new frontier12, encouraged by the recent 
breakthrough discovery of induced pluripotent stem (hiPS) cells13. However, 
using hiPS to model diseases that develop over decades, such as T2DM, is 
currently prevented, although attempts to recapitulate in short-term at least the 
effects of ageing are under investigation14. Thus, using primary tissues from 
patients affected by late-onset diseases is currently the most reliable choice. 
Human adipose tissue (hAT) plays an important role in T2DM and, more 
generally, in metabolic disorders15–17. Rather than being a mere energy storage, it 
is actively involved in organ cross-talk18,19. With respect to other tissues, hAT is 
also more easily available from both non-diabetic and T2DM patients. To the best 
of our knowledge, no adipose tissue ex vivo cultures have been performed in 
microfluidics. On the other hand, hAT investigations under static conditions have 
been focused on different aspects, such as metabolic activity, adipokine and 
hormone release20–22. Static cultures of hAT showed good preservation of gene 
expression and adipocyte function for up to 1 week23. 
In this work, we present the development of a microfluidic chip for ex vivo hAT 
long-term culture that includes an automated system for precise dose-time 
stimulation and quasi-on-line glucose monitoring. A multi-scale mathematical 
model allowed a signaling-pathway-based design of the culture micro-chamber 
and operating conditions to maximize measurement accuracy. The fluidic 
configuration was designed in order to decouple normal culture conditions and 
perturbation analyses. The system proved suitable for long-term ex vivo culture of 
hAT. Technical variability of measurements was minimized allowing a robust 
high-throughput study of single-patient biopsy-derived samples. Due to the 
perfused culture conditions, measurements could be performed continuously at 
high temporal resolution without disruption of the tissue culture. Glucose 
concentration could be tracked for several days, without using radio-tracers24 or 
fluorescent probes25, to closely mimic physiological in vivo conditions. As a proof 
of concept, the differential response of hATs derived from healthy and T2DM 
patients was investigated applying a step stimulation of insulin under normal or 
high-glucose conditions. 
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A4.3 EXPERIMENTAL SECTION 
Mathematical  model.   A   two-dimensional   (2D)  multi-scale   mathematical   model  
has  been  developed  to  describe  medium  fluid  dynamics,  mass  transport  of  glucose  
and   insulin,   and   intracellular   insulin   signaling   pathway.   The   model   adapts   a  
previously  published  model  of  a  three-dimensional  cell  culture  on  a  scaffold26,  to  
a   2D   culture   system   with   a   different   geometry.   Figure   1A   describes   the  
configuration  of  the  setup,  and  the  physical  and  biological  processes  modeled.  The  
culture   chamber   is   a   cylinder   with   diameter   D,   which   hosts   a   hAT   sample   of  
height  Hb.  The  chamber  has  an  inlet  and  an  outlet  given  by  a  3.5-cm  long  channel,  
with   rectangular   section   of   100-μm   height   and   40-μm   width.   For   modeling  
purposes  the  system  was  sub-divided  into  two  regions:  the  medium  and  the  tissue  
domains  (Figure  1A).  Within  the   first  one,  mass  transport  of   insulin  and  glucose  
occurs  by  both  convection  and  diffusion,  while  in  the  tissue  domain  only  diffusion  
takes  place  along  with  processes  of  insulin  and  glucose  consumption  by  cells.  This  
cellular   uptake   was   included   in   the   model   by   describing   the   insulin   signaling  
pathway,   which   involves   insulin   internalization   and,   after   a   phosphorylation  
cascade,   glucose   entrance   into   the   cells   by   active   transport.   Specifically,   fluid  
dynamics   was   described   by   Navier-Stokes   equation   for   incompressible   fluids,  
molecular   diffusion   by   Fick’s   law,   and   glucose   and   insulin   consumption   by  
combining   a   model   of   the   insulin   signaling   pathway27,   reduced   as   previously  
described26,28,   with   a  Michaelis-Menten   kinetic   model29.   Results   are   reported   in  
terms  of  outlet  glucose  concentration  normalized  by  the  concentration  at  the  inlet.  
The   model   was   numerically   solved   by   finite   element   method   (FEM)   using  
COMSOL   Multiphysics   4.3   (Comsol   Inc.).   More   details   are   reported   in  
Supporting  information  (Extended  methods,  Table  S-1). 
Microfluidic   platform.   An   automated   microfluidic   chip   was   produced   by  
standard  photo-  and  soft-lithography  techniques30   (Figure  2A).  It   is  composed  of  
three   polydimethylsiloxane   (PDMS,   Sylgard   184,   Dow   Corning)   layers:   a   flow  
layer,  a  biopsy  sample  insertion  layer,  and  a  control  one.  The  flow  layer  includes  8  
independent   culture   chambers,   each   equipped   with   an   injection   system,   which  
allows  a  biochemical   stimulus  to  be   inserted  very  closely  to  the  culture  chamber  
inlet,   and   independent   inlet   and   outlet   channels   of   50-μm   height   and   170-μm  
width  for  medium  distribution.  Each  culture  chamber  is  a  3-mm  diameter  cylinder  
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that   can   contain   a   1-2   mm   high   tissue   sample   (Figure   2B).   An   array   of  
hexagonally  spaced  PDMS  micro-posts  of  50-μm  diameter  and  115-μm  center-to-
center   spacing,   are   located   at   the   top   surface   of   each   chamber.   The   injection  
system  is  composed  of  a  20-cm  long  serpentine,  with  rectangular  section  of  100-
μm  width   and   50-µm   height,   for   a   total   volume   of   approximately   1   µL   (Figure  
2C).   The   serpentine   has   dedicated   inlet   and   outlet   for   easy   off-line   refill.   The  
sample  insertion  layer  is  a  6-8  mm  high  PDMS  layer  that  contains  4-mm  diameter  
holes  at  culture  chamber  positions  (Figure  2B).  After  hAT  sample   insertion,  each  
hole   is   sealed   by   conical   polypropylene   caps,   having   a   flat   base   aiding   sample  
positioning  against  the  micro-post  array.  The  caps  are  made  using  a  1/8-in  fitting  
luer   (Cole  Parmer)   filled  with  PDMS.  The  control   layer,   fabricated  according   to  
Zambon   et   al.4,   includes   a   network  of   control   channels   that   actuate   a   peristaltic  
micro-pump31   near   medium   inlet   and   a   system   of   pneumatic   micro-valves   for  
controlling   medium   or   stimulus   delivery   to   each   culture   chamber   with   high  
temporal   resolution   (Figure   2A).   More   details   are   included   in   Supporting  
information  (Extended  methods,  Figure  S-1,  Table  S-2). 
Automation.  Control  channels  were  connected  via  Tygon®  tubes  (ID  0.02”,  Cole  
Parmer)  and  filled  with  distilled  water.  During  operation,  each  tube  was  internally  
pressurized  (P=250  kPa)  to  close  a  specific  set  of  normally-open  micro-valves  by  
miniature   pneumatic   solenoid   valves   (M3MAO,   CKD   Corporation),   which   are  
controlled   by   an   I/O   device   (USB   6008,   National   Instruments)   connected   to   a  
USB  port  of  a  computer.  The  electronic  unit  was  plugged  to  a  24-V  transformer.  
The   system   was   equipped   with   a   rechargeable   battery   to   guarantee   long-term  
functioning   also   during   repositioning   or   emergency   outage.  A   custom   software  
was   developed   in   LabVIEW®   (National   Instruments)   to   automatically   manage  
chip  operations.  Specific  subroutines  were  implemented  to  assist  all  the  phases  for  
the   organ   culture   in   microfluidics   (preliminary   valve   test,   chip   de-bubbling,  
feeding,   and   insulin   stimulation).   Cell   culture   medium   was   placed   inside   vials  
(Cryovial,  Greiner   Bio-one)   that  were   pressurized   at   70   kPa   by   compressed   air.  
When  on-chip  valves  were  open,  medium  could  flow  due  to  this  positive  pressure,  
useful   for   fast  fluid  changes  and  channel  rinsing  steps.  When  a  precise   flow  rate  
was   required,  medium  movement  was  controlled  by  using   the  on-chip  peristaltic  
micro-pumps.  An  image  of  the  complete  experimental  setup  is  shown  in  Figure  S-
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2.   Pump   calibration   was   performed   before   the   experiments   (Figure   S-3),   as  
previously  reported31. 
hAT  sample  collection  and  preparation.  Samples  of  visceral  adipose  tissue  were  
collected   from   individuals   undergoing   surgery   (sleeve   gastrectomy   or   routine  
abdominal  surgery)  at  the  University  Hospital  of  Padova  (Italy).  Subjects  provided  
informed  consent  to  the  procedure  and  for  collection  of  the  sample  to  be  used  for  
research  purposes.  Collection  and  storage  of  biological  samples  was  approved  by  
the   local   Ethical   Committee.   Patients’   age   varied   between   34-80   year   and   body  
mass  index  (BMI)  between  24-54  kg/m2.  Of  16  patients,  50%  were  female.  More  
details  are  reported  in  Table  S-3. 
hAT   in  vitro   culture  protocol  was  adapted   from   literature32.  After   isolation,  each  
biopsy  was  maintained  in  5  mL  of  Dulbecco’s  Modified  Eagle  Medium  (DMEM)  
with  5-mM  glucose  (Life  Technologies)  for  up  to  3  h  at  room  temperature.  Then,  
each   biopsy  was  washed  with   phosphate   buffer   saline   (PBS,  Life  Technologies)  
and  cut   into  3-mm  diameter   slices  with   the  aid  of  a   sterile  punch   (Miltex)  and  a  
scalpel.  Each  slice  was  weighted  and  put  in  a  48-well  plate  with  300  μL  of  5-mM  
glucose  DMEM.  At  least  18  h  of  static  culture  were  required  for  culture  adaptation  
before   microfluidic   integration   or   control   experiments   in   static  wells.  After   this  
period,   hAT   glucose   consumption   rate   was   estimated   by   measuring   its  
concentration   in   1   μL   of   culture   medium   using   FreeStyle   Lites   glucometer   and  
strips  (Abbott  Diabetes  Care). 
hAT  microfluidic  integration.  DMEM  having  4  and  7-mM  glucose  concentration  
were   obtained   by   mixing   25-mM   glucose   and   glucose-free   DMEM   (Life  
Technologies)   in   different   ratios.   Before   use,   medium   was   conditioned   in   a  
biological  incubator  (37°C,  5%  CO2,  95%  relative  humidity)  in  a  Petri  dish  for  at  
least   2   h.   Prior to biopsy sample integration in microfluidics, PDMS culture  
chambers  and  flow  channels  were  conditioned  with  medium  at  1-µL/min  flow  rate  
for   at   least   1   h   by   means   of   a   syringe   pump   (Harvard   Apparatus).   Medium  
perfusion  was  then  stopped  for  sample  insertion.  Each  experiment  was  performed  
with  at   least  three  parallel  chambers  filled  with  hAT  slices  having  similar  weight  
and  glucose  consumption  under  static  conditions.  The  chambers  were  then  closed  
and  pressurized  at  40  kPa   for   few  hours   to  dissolve   bubbles  possibly   introduced  
during   sample   insertion.   Then,   medium   perfusion   was   started   keeping   the  
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microfluidic   platform   in   a   biological   incubator   during   culture.   For   exploratory  
experiments  at  different  flow  rates  (V =0.025-0.6 µL/min), medium delivery was 
performed via a   syringe   pump   (Harvard   Apparatus)   equipped   with   250-μL  
Hamilton  Glass   syringes.  Once  selected  an  optimal   flow  rate  of  0.1  µL/min,   the  
integrated  micro-pumps   within   the   chip   were   used.   For   stimulations,   a   100-nM  
human   recombinant   insulin   (Sigma  Aldrich)   solution   was   used   in   4-   or   7-mM  
glucose   DMEM,   pre-loaded   in   the   injection   system.   hAT   slices   were   removed  
from   the   microfluidic   system   at   the   end   of   culture   for   further   characterization.  
During   control   static   culture   experiments,   the   sample  was  maintained   in   a  well,  
medium  replaced  every  3  days,  and  glucose  concentration  measured  daily. 
Glucose   measurement.   Glucose   concentration   at   the   outlet   of   the   culture  
chamber,  GOUT,  was  measured   to   derive   hAT  glucose   uptake   performing   a  mass  
balance   on   the  whole   culture   system4.   For   sampling,   outlet   tubes  were   removed  
from  the  microfluidic  chip  and  replaced  by  a  22G  dispensing  needle   for  medium  
collection4.   Medium   samples   of   0.6-μL   volume   were   analyzed   off-line   using  
FreeStyle  Lites  glucometer  and  strips  (Abbott  Diabetes  Care)  to  measure  glucose  
concentration   GOUT.   The   effect   of   medium   evaporation   during   culture   in   the  
microfluidic  chip  was  corrected  by  keeping,  as  a  control,  a  microfluidic  chamber  
without   any   hAT   sample   inside   and   measuring   glucose   outlet   concentration4.  
Glucometer  measurements  were  initially  validated  by  Gas  Chromatography  Mass  
Spectrometer   (Agilent   5973)   with   a   DB5ms   Column   (122-5532   J&W)   using  
standard  procedures.   
Biological   analyses.   hAT   characterization   at   the   end   of   culture   was   performed  
after   tissue   extraction   from   the   microfluidic   chip.   To   evaluate   tissue   viability,  
standard  MTT  test  was  performed  on  samples   immediately   after   isolation  and  at  
the  end  of   the  culture  period.  20  to  40-μm  thick  hAT  cryosections  were  obtained  
after   embedment   in   OCT®.   Subsequently,   hematoxylin   and   eosin   (H&E,   Bio-
Optica)   and   Masson   trichrome   (Bio-Optica)   staining   were   performed   on   the  
obtained  slices.  After  staining,  slices  were  mounted  in  HI-MO  (Lab-Optica). 
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A4.4 RESULTS AND DISCUSSION  
The development of a physiologically relevant in vitro model mandates important 
prerequisites for the precise readout of information. Two of the most critical are 
the long-term stability of the tissue culture, and the availability of a correlated and 
significant benchmark. Furthermore, even starting from a patient’s   biopsy   of  
human tissue, collecting data instructive for physio-pathological applications 
demands the simultaneous spatio-temporal control of biochemical stimulations 
and time-resolved detection of the induced metabolic target physiological 
perturbation. These essential requirements can be satisfied by a properly designed 
micro-perfused system. Design criteria of the microfluidic tissue-chamber 
geometry should take into account the role played by experimental and operative 
variables, such as biopsy-derived sample size and flow rate. For instance, a high 
residence time (given by the ratio of microfluidic chamber volume to medium 
flow rate) will result in stronger medium perturbation in the chamber as a 
consequence of cellular activity, but at the expenses of a limited time resolution of 
the measured response in the outflow. Whereas a low residence time leads to 
inevitably undetectable inlet/outlet variations. 
Multi-scale model-based culture chamber design. To proper design the 
microfluidic chamber, we took advantage of multi-scale mathematical modeling, 
as a means to theoretically investigate the effect of the most important 
experimental and operative variables (Figure 1A). We simulated a 100-nM 
insulin-pulse perturbation lasting 15 minutes, as an exacerbation of what occurs in 
vivo during post-prandial conditions, and evaluated the effect on glucose 
concentration at the outlet of the culture chamber (Figure 1B and C). Outlet 
glucose concentration is directly correlated to glucose uptake in the chamber, and 
its experimental measurement would allow the study of tissue response following 
a stimulation. 
By the model, we first studied the influence of chamber geometry (Figure 1B). 
Specifically, we varied sample and chamber heights within experimentally 
meaningful ranges. Results show that a thinner sample (Hb=1 mm) gives a faster 
response, i.e. it reaches the minimum of outlet concentration in a shorter time; 
whereas a thicker sample (Hb=2 mm) produces a larger overall concentration 
variation after stimulation respect to the initial basal level. Insulin transport within 
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the tissue domain is governed only by interstitial diffusion, which is slow 
compared to cell glucose uptake rate, and it is the limiting step in the overall 
process. Thus, insulin penetration into the thinner sample occurs more rapidly 
because a shorter distance needs to be covered. However, the double uptake-
volume of the thicker sample consumes a quantity of glucose that is higher, 
although less than the double because of the transport limitations mentioned. 
Therefore, in the experiments, sample height (Hb) was chosen as a trade-off 
between rapidity and amplitude of response. 
A positive height of the chamber inter-layer (Hc) has a negative effect on tissue 
response, in terms of rate of glucose uptake and overall consumption (Figure 1B). 
When sample surface is not in direct contact with medium flow channel (Hc>0), a 
gradient of glucose concentration establishes in in the chamber inter-layer, 
because insulin (fast) transport by convection is less efficient in this region 
(Figure S-4). This result highlights the importance of experimentally positioning 
the tissue sample as close as possible to the flow channel, with the consequent 
difficulty of avoiding channel clogging or sample partial wash-out. 
Then, we investigated the effect of flow rate in the system (Figure 1C), a 
parameter directly related to medium residence time in the culture chamber. The 
higher the flow rate, the lower is the outlet glucose concentration drop following 
an insulin pulse, down to the point of becoming practically undetectable. 
However, at very low flow rates ( 0.025V   µL/min) the amount of glucose 
provided by the flow becomes the limiting factor for glucose uptake, irrespective 
of insulin presence (Figure S-5). 
Experimental microfluidic platform. The microfluidic culture chamber 
represents the core of the platform. The mathematical model results instructed the 
choice of important parameters, but other practical considerations were also taken 
into account, such as access for sample insertion, device robustness, uniform 
distribution of medium. For easy hAT sample insertion into the chamber, a 
vertical opening was provided, and sealed by a flat cap during perfused culture 
(Figure 2B). In the medium channel, in correspondence to the chambers, an array 
of circular micro-posts was included (Figure 2B). This technical expedient 
ameliorates the homogeneous distribution of medium on the surface of the sample 
reducing the formation of dead volumes, gives support to the sample avoiding its 
High temporal resolution detection of patient-specific glucose uptake from 
human ex vivo adipose tissue on-chip 
Appendix A4 
 
 151 
partial wash-out or its clogging of the flow channel, and also prevented sample 
floating, allowing turning the device upside-down for ease of optical observation. 
The overall microfluidic platform includes eight culture chambers to increase 
experimental throughput and parallel culture control (Figure 2A). 
A patient-specific in vitro model should include not only the tissue itself, through 
the ability of performing long-term culture, but also a means of giving precise and 
modulated physiological stimuli. Thus, the experimental setup also includes an 
injection system near the entrance of each chamber, where a biochemical 
stimulus, such as insulin-containing medium, can be loaded and automatically 
delivered to the chamber with precise timing and concentration profile, 
minimizing delay and axial dispersion (Figure 2C). The shape of the stimulus can 
be customized by changing stimulus duration, flow rate, repeating the stimulation 
several times, or performing a step stimulation. The injection system is connected 
to a reservoir that allows fresh loading of perishable chemicals, inserted few 
minutes before injection, avoiding thermo-sensitive degradation. The injection 
system was validated with food dyes and fluorescent tracers in order to simulate a 
drug pulse delivery (Figure 2C and D). The system demonstrated suitability to 
perform precise stimulation into the chamber with high spatio-temporal resolution 
(Figure 2C). Specific validation experiments were performed integrating ex vivo 
hAT. Medium homogeneous distribution in the chamber was verified by means of 
a fluorescein solution, first in a simplified version of the microfluidic chip (Figure 
S-6), then within the final setup both in absence and presence of a hAT sample 
inside (Figure 2D). We observed a uniform distribution of the fluorescent tracer 
inside the chamber, aided by the presence of the micro-post array. hAT sample 
was tracer-soaked, with the most porous regions showing a higher fluorescence 
intensity. 
Microfluidic platform validation. Within our setup, hAT maintained high 
viability after one-week culture. No significant differences were observed 
between static and microfluidic cultures, and compared to the corresponding 
freshly isolated biopsy (Figure 3A). Thus, we confirmed that long-term hAT 
cultures can be successfully performed, as was previously found under static 
conditions33, and for the first time we extended this result to a microfluidic 
system. Moreover, tissue morphology from H&E stain (Figure 3B) and Masson 
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trichrome (Figure S-7) did not show significant differences between static or 
microfluidic conditions after 8 days of culture, even compared to the tissue 
morphology immediately after surgery. 
The maintenance of metabolic activity during culture was measured using 3 
samples from the same hAT biopsy and detecting glucose concentration at the 
outlet of the culture chamber (Figure 3C). A low GOUT means a high glucose 
uptake, at fixed flow rate (0.025 µL/min). After one day of sample adaptation to 
culture conditions, glucose concentration at the outlet was constant for the next 4 
days, confirming high metabolic tissue activity in microfluidics. We verified that 
a 24-h adaptation period was needed also under static culture conditions (data not 
shown). 
After confirming hAT viability, normal morphology, and accurate response in 
terms of glucose consumption, we investigated the effect of flow rate on glucose 
outlet concentration, starting from low (0.025 µL/min) to high values (0.6 
µL/min). Figure 3D shows outlet glucose profile at increasing flow rates, 
monitored at maximum time resolution, i.e. medium was continuously collected 
and analyzed every 0.6 µL eluted. This measurement was repeated for 4 samples 
derived from the same hAT biopsy. Consistently, glucose concentration profile 
was maintained for different samples with low variability. At low flow rates, 
glucose concentration drop between inlet and outlet was large, with high signal-
to-noise ratio. On the other hand, a high flow rate increased measurement time 
resolution, up to one measurement per minute for the highest flow rate 
investigated (0.6 µL/min). Thus, we chose a flow rate of 0.1 µL/min for further 
analyses with insulin stimuli, which guaranteed both high temporal resolution and 
a glucose concentration drop sufficiently detectable to capture differences in 
glucose uptake under stimulation.  
We also obtained consistent data analyzing the steady-state GOUT value at 
different flow rates (Figures 3E and F). Figure 3E shows the results of these 
measurements with a special focus on the temporal robustness of the 
methodology. Three samples derived from the same hAT biopsy were repeatedly 
analyzed during 3 successive days and showed remarkable reproducibility both in 
time and between samples. These important data had a positive impact in 
demonstrating robustness and high-throughput experimental feasibility, key 
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parameters for a robust in vitro physiological analysis. We also compared the 
experimental data with model results, which were in good agreement, and 
demonstrating the suitability of our mathematical model for experimental design 
(Figure 3F). From data in Figure 3F and knowing sample weight, we calculated 
glucose uptake as a function of flow rate, by a mass balance approach4 (Figure 
3G). Uptake depends on flow rate because of different glucose availability. It 
follows a Michaelis-Menten-like kinetics, approximately reaching a plateau at 
high flow rates ( 0.4V !  μL/min). 
Figure 3D-G were obtained using different samples derived from the same 
patient’s  hAT  biopsy.  Overall,  data  show  high  reproducibility  and  make  possible  
using the same biopsy for parallel studies with different conditions and 
biochemical stimulatory cues. We also observed a fair reproducibility of data 
using samples from different patients (Figure 3C and S-8). These results are 
particularly promising for the use of our system to discriminate between a healthy 
and pathological phenotype. 
hAT in vitro model for insulin resistance measurement. Once we had 
demonstrated the capability to ensure long-term culture, reliable readout and 
biological analysis, we focused our investigation on an advantageous application 
of our system for the physiological hAT field. hAT is a complex organ and its role 
in metabolic activity and disorders such as T2DM is an important field of 
investigation17. We applied our system for the obtainment of proof-of-concept 
data related to insulin effect on glucose uptake after a long stimulation. We 
evaluated the effect of an insulin step on outlet glucose concentration during hAT 
cultures exposed to normal or post-prandial physiologic glucose concentrations. 
We focused on discriminating between a healthy and a T2DM phenotype, by 
using hAT biopsies taken from patients in either state. Our goal was to determine 
differences in glucose uptake from insulin-stimulated and non-stimulated 
biopsies, thus to relate the profile to diabetic or healthy patients. Since we had 
previously observed some inter-patient variability, we expected differences in 
readout of outlet glucose concentration even within the same category of patients, 
and we performed each experiment with an internal control using samples from 
the same hAT biopsy. 
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We performed two sets of experiments. In the first one, we stimulated both 
healthy and diabetic samples with a 100-nM insulin step (Figure 4A and B), 
maintaining the same basal glucose concentration (GIN=4 mM) during the whole 
duration of the experiment. In this condition, as expected7, we did not observe 
differences in outlet glucose concentration in healthy and diabetic patients, 
compared with their respective unstimulated controls. In the second set of 
experiments, we stimulated hAT samples with a 100-nM insulin step overlapped 
to a step of glucose concentration, from basal to high (GIN=7 mM), mimicking the 
trend of a post-prandial phase (Figure 4C and D). hAT biopsy from a healthy 
patient showed a significant decrease in outlet glucose concentration from the 
insulin-stimulated chamber respect to the non-stimulated one (Figure 4C and S-9). 
Thus, as expected, insulin triggers glucose uptake at high-glucose concentration. 
On the other hand, for the diabetic patient-derived biopsy, no evidence of 
differences in glucose uptake between stimulated sample and control was apparent 
(Figure 4D). A progressive reduction of glucose uptake was also observed during 
the persistent post-prandial-like state. These data, even if derived from a limited 
number of patients, are promising for in vitro studies of insulin sensitivity and 
they represent a proof of concept for its applicability. 
 
A4.5 CONCLUSIONS  
Taking advantage of microfluidic large-scale integration systems, we developed 
an on-chip tissue culture platform that could be advantageously used to maintain 
ex vivo hAT for several days, without loss of viability and typical morphology. 
Although hAT has the advantage of being more accessible in comparison to other 
tissues, this miniaturized culture system can be readily applied also to other tissue 
types of interest. 
This microfluidic system requires only approximately 10-mm3 tissue, but allows 
the robust measurement of glucose uptake with high temporal resolution, due to 
the high surface-to-volume ratio and the properly defined geometrical and 
operative conditions. In particular, the design of the culture chamber took 
advantage of a multi-scale mathematical model, not only describing the fluid 
dynamics in the system, but also the intra-cellular signaling processes leading to 
insulin-stimulated glucose uptake. Thus, high-accuracy and repeatable 
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measurements  were  achieved  with  samples  taken  from  the  same  patient’s  biopsy,  
and sensitivity was sufficient to discriminate the biological patient-to-patient 
variability. 
The injection system was designed to maximize precision and controllability of 
the biochemical stimulations. In this work, as a proof of concept, a single step of 
insulin stimulation was performed, but more elaborated dynamics are also 
possible to fully explore the complexity of the biological response. Actually, the 
intracellular network architecture and its dynamic behavior are better investigated 
through system perturbations34. 
The availability of hAT from normal patients and those affected by T2DM made 
possible to show the feasibility of studying hAT insulin resistance in vitro with 
high accuracy. We measured glucose as the main target molecule of interest, but 
other compounds sampled from the outflow can be equally analyzed, for example 
by Gas  Chromatography  Mass  Spectrometry  or  other  enzymatic  assays.  Thus,  the  
micro-culture  system  we  developed  represents  a  springboard  for  future  studies  of  
insulin   resistance   in  vitro,   effectively  dissecting   the   role  of  a   single   tissue   in   the  
large  scenario  of  metabolic  diseases. 
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Figures and captions 
 
 
Figure 1. Multi-scale model-based design of the microfluidic culture chamber and 
definition of the operating conditions. (A) Schematic representation of the three 
scales simulated, from larger to smaller: the culture chamber geometry, including 
a tissue domain, where hAT biopsy sample is positioned, and a medium domain, 
where medium flows by convection; the tissue architecture, formed by a cluster of 
cells separated by interstitial spaces occupied by medium; and the single-
adipocyte intracellular insulin signaling pathway resulting in glucose uptake. (B) 
Simulated effect of sample and culture chamber heights on the mean normalized 
glucose concentration profile at the outlet of the chamber, following a 100-nM 
insulin pulse stimulation of 15 min at the inlet (red line). Flow rate, 0.1 μL/min. 
(C) Simulated effect of medium flow rate on the mean normalized glucose 
concentration profile at the outlet of the culture chamber after an insulin pulse at 
the inlet as in (B). Hb, 1 mm; Hc, 0; V , 0.005, 0.01, 0.025, 0.05, 0.1, 0.5 µL/min 
increasing in the direction indicated by the black arrow. 
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Figure 2. Experimental microfluidic setup validation and optimization. (A) Image 
of the multi-layer microfluidic platform including 8 independent culture chambers 
(blue), each with its dedicated injection system (orange). Medium channels used 
during non-stimulatory conditions are shown in blue, and control channels in 
yellow. (B) Optimized configuration of the culture chamber (top view and 
section) where an array of micro-posts provide stable and precise placement of 
hAT sample. A representative hAT sample is also shown. (C) Design of the 
injection system used for biochemical stimulation delivery at the entrance of the 
culture chamber. Validation of this system functionality by filling the chamber 
with different food dyes: image sequence and quantitative comparison between 
theoretical and actual concentration profile in the indicated ROI after a pulse. I/I0, 
red intensity in the indicated ROI, normalized by its maximum value during a 
pulse. (D) Insulin pulse stimulation into the culture chamber by the automated 
injection system, using a fluorescent tracer in the insulin-containing medium. The 
homogeneous distribution of the tracer in the chamber, without and with a hAT 
sample, is shown. 
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Figure 3. Validation and characterization of the microfluidic system during 
culture of hAT biopsy-derived samples from healthy patients. (A) MTT viability 
test (normalized by sample weight) of hAT samples from the same patient biopsy 
either freshly isolated, or after 7-day culture in a static well or a microfluidic 
chamber, as indicated.  Error  bar,  standard  deviation  (n≥4).  Patient  no.  10  (Table  
S-3). (B) Hematoxylin and eosin staining of hAT samples from the same patient 
biopsy, analyzed immediately after isolation (top), cultured for 7 day in a 
microfluidic chamber (center), or in a static well (bottom). Patient no. 5 (Table S-
3). (C) Glucose concentration at the outlet of the chamber where hAT samples 
were   cultured   for   6   days   (flow   rate,   0.025   μL/min).   Control   refers   to  
measurements at the outlet of a culture chamber without biological sample inside. 
Error bar, standard deviation (n=3). Patient no. 1 (Table S-3). (D) Glucose 
concentration at the chamber outlet measured at increasing flow rates (0.025-0.6 
µL/min). Sampling was performed continuously (medium was analyzed every 
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0.6-µL volume eluted). Data were obtained from 4 hAT samples (red) and a 
control (gray). (E) Steady-state measurements of outlet glucose concentration at 
different flow rates. Measurements were repeated using the same hAT cultures 
during 3 consecutive days. Error bar, standard deviation (n=3). (F) Steady-state 
measurements of outlet glucose concentration at different flow rates using 
different hAT samples and control chambers. Error bar, standard deviation (n=4). 
Corresponding results obtained by the mathematical model are also shown. (G) 
Calculated glucose uptake, Guptake, from data in (F) as a function of medium flow 
rate, normalized by hAT sample weight. The data point at 0.6 µL/min was 
excluded from Michaelis-Menten fitting because of its high standard deviation. 
(C-G) GIN, 4 mM. (D-G) Patient no. 2 (Table S-3). 
 
 
 
 
Figure 4. Response to insulin and glucose concentration of hAT samples from 
healthy and T2DM patients. (A-B) Effect of an insulin-step stimulus on glucose 
concentration at the outlet of the culture chamber. (C-D) Same as (A-B) with the 
simultaneous increase of glucose inlet concentration. Measurements taken at day 
3 after microfluidic integration. V =0.1 µL/min. (A, C) Patient no. 6; (B) Patient 
no. 4; (D) Patient no. 9 (Table S-3). 
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High-throughput reprogramming and 
differentiation on chip 
This Appendix is extract from the work entitled “high-throughput reprogramming 
and   differentiation   on   chip”  with   the following authors: C. Luni, S. Giulitti, E. 
Serena, L. Ferrari, A. Zambon, O. Gagliano, G. G. Giobbe, S. Knöbel, A. Bosio, 
F. Michielin, N. Elvassore.  
My contribution is concerning the design and development of the multilayer 
microfluidic platform, the fabrication of all components and external devices for 
the chip management and the relative calibration and validation. This microfluidic 
technology is was specifically designed and developed for long-term biological 
cell culture that also required high frequency (mostly, on daily bases) biochemical 
perturbations. These features it makes the technology suitable for circadian 
application as well for cellular reprograming.  
First of all, we decide to test the feasibility of the automatized microfluidic 
platform developed in this thesis for cellular reprograming because this biological 
process does not require bioluminescence-imaging acquisitions.  
A5.1 Abstract 
Human induced pluripotent stem cells (hiPSC) represent a limitless source of 
patient-specific and disorder-specific functional differentiated cells. Massive 
parallel production of hiPSCs fosters the establishment of large-scale population 
studies while considering human genetic diversity and polymorphisms. Here, we 
  164 
downscaled to microliter volume a feeder-free reprogramming process through 
transient expression of non-integrating modified mRNAs. Taking advantage of 
intrinsic properties of microfluidics, we improved the exogenous factors delivery 
and we shaped the endogenous extracellular microenvironment activating pro-
pluripotency pathways. We achieved highly efficient reprogramming (up to 
~40%) from human somatic cells within an automated microfluidic chip. Notably, 
the non-integrating reprogramming strategy enabled unbiased differentiation on 
chip into functional cardiomyocytes and hepatocytes, immediately after hiPSC 
derivation. This five-week microliter reprogramming-differentiation opens the 
perspective for large-scale population studies. 
 
A5.2 Introduction and Motivation 
The discovery of human induced pluripotent stem cells (hiPSC) opened a new 
frontier for the in vitro derivation of human functional cells and tissues1. Since 
hiPSCs can be derived from easily accessible somatic cells, they represent a very 
interesting source for patient-specific and disorder-specific studies and 
applications. Human medical conditions are characterized by marked genetic 
heterogeneity, far greater than previously appreciated2, raising implications for 
development of molecular treatments and their appropriate use in individual 
patients. To recapitulate the complexity and variety of human genetics and 
polymorphisms, the massive production of hiPSCs could represent a unique tool 
to obtain differentiated functional tissues for large-scale population studies and 
multiplex assay (Fig. 1a)3,4. 
Delivery of reprogramming factors, either by viral vectors or biomolecules, is 
critical to induce highly efficient conversion of somatic cells. Footprint-free 
strategies, like modified mRNAs (mmRNAs), allow the efficient production of 
hiPSCs preserving genomic integrity, but require daily transfections due to high 
mmRNA turnover.  
Microfluidic devices are particularly suitable for controlling cell culture 
microenvironment because, in their laminar flow regime, molecules are 
transported in a relatively predictable manner through microchannels5. They also 
have other advantages such as ease of automation and unmatched minimum 
requirements of reagents due to their microliter-scale volume (Fig. 1b). 
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Soluble microfluidic culture microenvironment differs from that in conventional 
culture systems because of the high ratio of culture surface to medium volume6. 
Thus, it offers new opportunities to shape the cellular niche7, taking into account 
that self-organized spatial gradients finely regulate the balance between 
differentiation and maintenance of pluripotency8,9.  
Here, we down-scaled reprogramming and subsequent differentiation of human 
cells within a microfluidic platform, also reducing the time requirements of the 
overall process (Fig. 1c), towards the final aim of increasing the production 
throughput of patient-specific functionally differentiated cells (Fig. 2a). We 
finally provide a proof of concept of one-step reprogramming and differentiation 
for highly parallel production of patient-specific functional cells. 
 
A5.3 Results 
Main requirements for the micro-scale culture technology are the ability to sustain 
long-term cell culture, efficiently and accurately deliver the reprogramming 
transcription factors, and provide a permissive microenvironment for highly 
efficient reprogramming. According to a mmRNA reprogramming protocol 
reported in literature having efficiency of up to 2.6%10, we designed the culture 
chambers as microchannels of approximately 27 mm2 (Fig. 2b), a surface 
sufficient to obtain up to about 10 hiPSC colonies from less than 300 cells using 
250   μL   of   medium   totally.   This   microfluidic   experimental   setup   will   provide  
enough biological material to perform biomolecular analyses using previously 
optimized protocols6,11 and it has already been tested in multiple other human cell 
culture experiments by our group6,11,12. 
To verify whether the microfluidic environment could sustain long-term cell 
culture, we optimized the biofunctionalization of the silicon chip surface enabling 
human fibroblast culture for up to 40 days. Optimal performances were obtained 
with a covalently bonded gelatin coating that we selected for all subsequent 
experiments (Extended Data Fig. S1). 
We then tested if we could efficiently perform mmRNA transfections within the 
microfluidic channels by delivering a mmRNA encoding for a nuclear-targeted 
green fluorescent protein (nGFP). mmRNA delivery resulted to be not only 
feasible, but also particularly efficient in microfluidics compared to a control in a 
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standard well, with up to 80% of nGFP+ cells after a low-dose single transfection 
(Fig. 2c and Extended Data Fig. S2). These data were confirmed with different 
transfection reagents and after multiple transfections (Extended Data Fig. S2). We 
optimized mmRNA delivery as for transfection duration and mmRNA 
concentration: two variables that we found, both experimentally and by 
mathematical modeling (Extended Data Fig. S3), to strongly affect transfection 
efficiency (Fig. 2d) and mmRNA distribution within the cell population (Fig. 2e). 
The efficient mmRNA-mediated induction of protein expression in microfluidics 
was also confirmed in early reprogramming phase quantifying KLF4 and OCT4, 
two major players in driving cell mesenchymal-epithelial transition and 
pluripotency establishment13,14, respectively (Fig. 2f and Extended Data Fig. S3). 
Thus, our microfluidic system proofed to be technically suitable to host the 
reprogramming process. 
Encouraged by the effective protocol for long-term culture and the high-efficiency 
transfection, we developed a new microfluidic platform that, in contrast to our 
previous prototype6,11,12, now provides increased automation options and a 
completely computer-assisted closed system. The main unit of this new 
configuration is a multilayered chip, built on top of a microscopy glass slide 
where cells grow in adhesion on a functionalized PDMS surface for long-term cell 
cultures (Fig. 2b and Extended Data Fig. S4). An external multi-port pump (with 
nano-liter accuracy) and an on-chip valve system are remotely controlled to 
distribute cells, medium and other reagents throughout the platform 
(Supplementary Video 1), with each cell culture chamber working independently.  
 
We previously showed that hiPSC colonies can be seeded and cultured in 
microfluidics with maintenance and stabilization of pluripotency6. To determine 
whether the microfluidic environment is permissive during all stages of 
reprogramming, we downscaled a reprogramming protocol (using mmRNAs 
encoding for OCT4, SOX2, KLF4, c-MYC, NANOG, and LIN28) we had used in 
a six-well plate with efficiency up to 2.6% on human fibroblasts. The micro-scale 
process development was instructed by our previous results on nGFP mmRNA 
transfections, balancing transfection efficiency and cell mortality (Fig. 2c). By 
adding nGFP mmRNA during reprogramming, we verified the sustained delivery 
efficiency of daily transfections (Extended Data Fig. S3) and the emergence of 
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nGFP+ epithelial-like cells (Fig. 2g). In 5 days cells were extensively E-CAD+ 
(Extended Data Fig. S5), and in less than 2 weeks stable hiPSC colonies with 
typical morphology could be identified in the channels (Fig. 2h and 2i). 
From our experimental observations, seeding density plays an important role in 
obtaining a balance between death and proliferation during reprogramming. We 
found an optimal cell seeding density of 10 cell/mm2 (Fig. 2j) for maximizing the 
number of TRA-1-60+/NANOG+ colonies (Fig. 2k and Extended Data Fig. S5), 
and we further optimized the biofunctionalization strategy by reducing gelatin-
coating amount, subsequent aspecific adsorption and unwanted cell migration 
throughout silicone surface. Under these conditions, we obtained up to 44 
colonies per channel (16 as average), with a hiPSC onset as early as 7 days after 
beginning of reprogramming; all channels showed multiple colonies (Fig. 2k, 
Extended Data Fig. S5, and Supplementary Video 2). Thus, in microfluidics, the 
maximum reprogramming efficiency with a feeder layer was 16% (5.9±4.2%), 
which is much higher than we and others obtained in a conventional multi-well 
plate (up to ~3% under normoxia conditions)10. Protocol optimization towards a 
feeder layer-free system is an important step forward in controlling the 
reprogramming process and closer to clinical-grade hiPSCs. However, in these 
conditions the balance between cytotoxicity induced by reprogramming factor 
delivery and target cell proliferation becomes even more critical. Accurate control 
of microenvironmental conditions within the microfluidic platform allowed 
consistent reprogramming of fibroblasts in feeder-free conditions (Fig. 2j and 
Extended Data Fig. S6) with efficiencies up to 38%. Finally, we demonstrated that 
the microfluidic system is also suitable for reprogramming non-fibroblast cell 
types, such as urine-derived renal epithelial cells (Extended Data Fig. S7). 
We verified the pluripotency of the hiPSC colonies obtained in microfluidics, first 
by in situ characterization (Fig. 3h, Extended Data Fig. S5, and S8), then after 
single-colony extraction from the microfluidic chip (Extended Data Fig. S9) and 
subsequent expansion (Fig. 3a-d, Extended Data Fig. S8, and Supplementary 
Video 3). Furthermore, microfluidic hiPSC colonies were able to give rise to cells 
from the three germ layers after differentiation either in monolayer or via 
embryoid bodies (Fig. 3e-g). Thus, microfluidic colonies demonstrated their 
pluripotency de facto. 
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We further asked whether microfluidics could substantially shape the culture 
environment to boost the reprogramming process, or if the higher reprogramming 
efficiency we obtained in microfluidics compared to the control multi-well plate 
were only attributed to the more effective exogenous transcription factor delivery. 
To this end, we performed a microarray analysis selecting four colonies both from 
the microfluidic system and from a parallel reprogramming experiment in well 
plates. Each colony was split into two halves: the one half (p0) was used for total 
RNA extraction, the other one was further expanded in feeder-free conditions for 
3 passages (p3) in well plates before total RNA extraction (Extended Data Fig. 
S9). Bioinformatics analyses highlighted differences between gene expression 
profiles of p0 colonies derived in microfluidics and in well plates (Fig. 3i and 
Supplementary Spreadsheet 1), which were abolished after the 3-passage 
expansion.  
Functional annotation analysis highlighted enrichment in multiple gene ontology 
(GO) categories of genes differentially expressed between p0 µF and p3 µF, and 
between p0 µF and p0 well (Supplementary Spreadsheet 2). The most significant 
are related to the extracellular space and receptor-mediated signaling pathways 
(Fig. 3j). In particular, the TGF-β pathway, which is strongly involved in hiPSC 
stabilization15,16, resulted as one of the most significant pathways affected by the 
microfluidic environment (Supplementary Spreadsheet 2). Microarray data 
showed a much higher expression of multiple TGF-β-related pathway components 
in freshly isolated microfluidic colonies with respect to both microfluidic colonies 
expanded in well plates and colonies initially obtained in a conventional well, 
suggesting this pathway superfamily is highly activated in the microfluidic system 
(Fig. 2j). Nonetheless both well and microfluidic colonies cluster together with 
other human pluripotent cell samples obtained from public repositories (Extended 
Data Fig. S9), suggesting that the microfluidic colonies obtained are still within 
the range of variability between different pluripotent clones.  
To validate a possible perturbation of soluble microfluidic microenvironment by 
cell-released factors, we investigated the conditioned medium during 
reprogramming. In particular, since TGF-β pathway superfamily acts through 
multiple extra-cellular activating and inhibitory ligands, we analyzed the 
activation of TGF-β pathway transcription factors SMAD2/316. A SMAD2/3 
luciferase-reporter cell line evidenced that TGF-β-free reprogramming media 
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collected from the microfluidic system during reprogramming more strongly 
activated luciferase expression (Fig. 3k), supporting the hypothesis of strong 
accumulation of cell-secreted TGF-β pathway ligands that activate pro-
pluripotency SMAD2/3. 
Thus, besides higher mmRNA delivery efficiency, a different soluble 
microenvironment could contribute to the enhanced reprogramming efficiency. 
However, a short expansion in a conventional system highlights that microfluidic-
derived hiPSC modify their gene expression profile resembling hiPSCs derived 
under standard conditions. 
 
To fully exploit the potential of the microfluidic platform in providing high-
throughput patient-specific in vitro models of human tissues, we asked if we could 
differentiate the freshly obtained hiPSCs into functional cells, without prior 
expansion. We have recently developed a method for successful differentiation of 
human pluripotent stem cells within a microfluidic chip into the three germ layers 
through accurate regulation of extrinsic environments and balance between 
exogenous and endogenous, cell-secreted, factors 6. We started all differentiation 
protocols 48 h after the last mmRNA reprogramming transfection to ensure using 
transgene-free colonies. 
First we found that, by sole introduction of an aspecific differentiation medium, 
freshly formed hiPSCs changed morphology resembling different cell types (Fig. 
4a). RT-PCR confirmed the presence of cells expressing markers of the three 
germ layers within each channel (Fig. 4b), although this analysis could not 
exclude that the expression of the three-germ layer markers were derived from 
different colonies within the same channel.  
To improve the selectivity of differentiation towards a specific cell type, we 
performed three sets of parallel experiments, each directing the obtained 
microfluidic colonies towards a single early germ layer. Consistently in 10 
parallel experiments, we obtained a robust and remarkable selectivity towards the 
specifically induced germ layer, in all three cases (Fig. 4c). 
Although a single hiPSC colony can be extracted from the microfluidic system for 
conventional differentiation, the full potential of the microfluidic technology is 
achieved with an integrated process of reprogramming and differentiation that 
increases the throughput of subsequent studies. As cardiac and hepatic tissues are 
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involved as main targets or side effects of a number of tested drugs, we focused 
on directed differentiation towards these two phenotypes. 
As a proof-of-concept that freshly obtained hiPSC colonies could be successfully 
differentiated, without any intermediate process of expansion, we applied our 
previously developed protocols for efficient differentiation into cardiomyocyte- 
and hepatic-like cells in microfluidics6. We pooled the colonies reprogrammed in 
microfluidics and seeded them at a higher density in new microfluidic channels 
before starting the cardiac and hepatic protocols. With this one-passage protocol, 
we confirmed our previous data obtaining cardiomyocytes showing remarkable 
troponin-T expression and sarcomeric organization. In parallel, we obtained 
polygonal-shaped hepatocyte-like cells expressing CK18, and occasionally poly-
nucleated cells. These cellular phenotypes were obtained as early as 35 and 36 
days from the day of fibroblast seeding for reprogramming, respectively (Fig. 4d). 
Finally, we asked whether we could differentiate primary hiPSCs in microfluidics 
into a specific cell fate without prior passaging to achieve the maximum 
throughput of this technology. Within the same channels where cells were 
reprogrammed, we performed either the hepatic or cardiac differentiation 
protocols. In the former case, after 15 days, extensive morphologically 
differentiated areas were present and we characterized the cells obtained for their 
functional maturation (Fig. 4e). Cells were CK18+ and albumin-positive and 
showed remarkable glycogen storage ability. Cardiac differentiation was tested by 
PCR and revealed cell positivity to markers of advanced cardiac maturation: FLK-
1, NKX-2.5, and cTNT (Extended Data Fig. S10). 
Thus, a one-step process of reprogramming and differentiation within a 
microfluidic chip was obtained, allowing the automated production of functional 
hepatocyte- and cardiomyocyte-like cells starting from fibroblasts in 36 and 35 
days, respectively, within the same device (Fig. 4f). 
 
A5.4 Conclusion 
In this study, we reprogrammed human fibroblasts and derived functional tissue-
specific cells within a high-throughput microfluidic platform through a robust 
one-step process. This technology opens a new perspective in generating tissue-
on-chips from hiPSC for extensive screening studies, overcoming the issues 
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related to the limited availability of human primary cell sources and process costs. 
Although recent advances in genome-editing technologies make possible the 
artificial introduction of genetic variability in vitro, they still cannot handle the 
wide variety of genetic backgrounds, including possibly multi-factorial idiopathic 
diseases, present in the human population, as only few loci can be modified at 
once17. 
The specific characteristics of the microfluidic culture environment not only 
turned out to enhance process efficiency, but also ensured a robust performance 
due to automation and tight control of the soluble microenvironment under 
reproducible laminar flow conditions. The use of this technology is not restricted 
to the specific application presented, but rather allows population studies in a 
broader sense18,19. For example, in cases where a primary cell source of a specific 
tissue is available, a screening study can be accomplished within the microfluidic 
platform taking advantage of the possibility to perform precise dynamic 
stimulations. Tight control over extrinsic and intrinsic cell microenviroment 
establishes microfluidics as a tool to trigger cellular self-specification, promote 
hiPSC stabilization and impose targeted differentiation. 
This study made an important step forward to ultimately exploit the translational 
potential of hiPSCs18,19. Further mimicking of organogenesis in vitro and 
developing in-line functional assays will provide scientific and technological cues 
to establish pluripotent stem cells in biomedicine. 
  
 
A5.5 Methods 
Cell culture. Human foreskin BJ fibroblasts (Miltenyi Biotec) were cultured in 
Dulbecco’s   modified   Eagle  Medium   (DMEM,   Life   technologies)   supplemented  
with 10% fetal bovine serum (FBS, Life Technologies). HFF-1 fibroblasts 
(ATCC) were cultured in DMEM with 15% FBS. Renal epithelial cells (RE) were 
isolated and expanded from a healthy 28-year old donor in RE medium (Lonza) as 
previously described20. Inactivated human newborn foreskin fibroblasts NuFF-
RQs (AMS Biotechnology) were seeded on 0.2% type-A gelatin (Sigma-Aldrich) 
at 260 cells/mm2 in DMEM with 10% FBS, in case of use as a feeder layer for 
reprogramming and for Pluriton medium (Stemgent) conditioning. 
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hiPSC were mechanically passaged on mytomicin-treated mouse embryonic 
fibroblasts (MEF, Millipore) with daily changes of hiPSC medium (DMEM/F12, 
20%   knockout   serum   replacement,   1%   NEAA,   1%   glutamine,   1%   β-
mercaptoethanol (all Life Technologies), 20 ng/ml b-FGF (Peprotech). 
Alternatively, freshly derived hiPSC were directly cultured in feeder-free medium 
StemMACSTM iPS-Brew XF (Miltenyi Biotec) or transferred from MEF without 
any adaptation. hiPSC were passaged every 3-4 days on vitronectin XF treated 
plates using gentle cell dissociation reagent (both Stemcell Technologies). All cell 
lines were cultured at 37 °C and 5% CO2 atmosphere. 
Microfluidic platform. Microfluidic platforms were fabricated according to 
standard soft-lithographic techniques and molded in poly-dimethylsiloxane 
(PDMS), as previously described11,12. Briefly, Sylgard 184 (Dow Corning) was 
cured on a 200-µm-thick patterned SU-2100 photoresist (MicroChem) in order to 
obtain a single PDMS mold with multiple independent channels. The PDMS mold 
was punched and sealed on a 75 x 25 mm microscope glass slide (Menzel-Glaser) 
by plasma treatment. Channels were rinsed with isopropanol and distilled water to 
check proper flow, before autoclaving. A syringe step-motor pump (Cavro, 
Tecan) was used to periodically control medium flow rate into the microfluidic 
channels at 120 µL/min for 5 s. 0.5 ID Tygon tubings (Cole-Parmer) and 21G 
stainless-steel needles were used to connect the microfluidic channels to the pump 
head. 
Microfluidic platform with integrated medium distribution system. 
Multilayer soft lithography was used to fabricate this type of microfluidic 
platform, composed of a 3-layer PDMS chip21,22. Transparent photomasks were 
printed at 8000 dpi. A 4-inch silicon wafer (Siegert) was used for molding. 
Control   mold   was   made   by   SU8   2050   (Microchem),   obtaining   45   μm   square  
channels.   Flow   mold   had   45   μm   round   channels   made   by   SPR   220-7 (Dow 
Corning); to avoid unintentional cross-section  valves,  90  μm  square  channels have 
been made over the previous by a second SU8 2100 layer. Culture channel mold 
has  220  μm  square  section  made  by  SU8  2100.  Every  mold  was  previously  coated  
for 1 hour at room temperature with chlorotrimethylsilane vapors (Sigma-
Aldrich). Sylgard 184 (Dow Corning) was mixed at 5:1 ratio (base:cure agent) for 
the flow layer (FL), 20:1 ratio for the control layer (CL) and 10:1 ratio for the cell 
culture layer (CCL). All layers were partially cured at 333 K before peeling, 
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cutting and punching: 45 minutes for FL, 60 minutes for CL and 70 minutes for 
CCL. After alignment, another 2 hours at 353 K completed the curing. The PDMS 
chip was finally bonded by plasma activation on a large glass slip (75 x 50 mm, 
Ted Pella) covered with a thin (<0.5 mm) 20:1 PDMS layer. 
The microfluidic platform was fully assisted by an automated medium delivery 
and distribution system into the culture channels. A periodic 120 µL/min 
perfusion for 5 s was controlled twice a day by Cavro pumps (Tecan) and a lab-
made software interface written in Labview (National Instruments). The 
experimental setup is shown in Fig. 2B and Extended Data Fig. S4. 
Surface coating in microfluidic setup. After autoclaving and before cell seeding, 
microfluidic culture channels were treated for surface functionalization. 
Extracellular matrix proteins were either adsorbed or chemically bound to the 
silanized glass bottom of each channel to provide a durable coating for cell culture 
(Extended Data Fig. S1). For the adsorbed substrates either fibronectin (Fn, 10 
μg/mL,   Sigma-Aldrich) or type-A pork gelatin (Gel, 0.1% and 0.6%, Sigma-
Aldrich) were incubated within the microfluidic channels for 1 h at 37 °C before 
rinsing with DPBS. For glass silanization, surface was treated either with a 5% 
water solution of (3-aminopropyl)-triethoxysilane (APTES, Sigma-Aldrich) for 20 
minutes, or a 0.3% ethanol solution of 3-(trimethoxysilyl)-propyl methacrylate 
(TMSPMA, Acros Organics) for 5 minutes. Covalent bonding of adsorbed Gel on 
APTES was obtained treating with 0.5% v/v glutaraldehyde for 10 minutes. 
Covalent bonding of Gel on TMSPMA was obtained treating Gel with 
methacrylic anhydride (Sigma-Aldrich) in PBS buffer for 1 h at 60 °C to produce 
an acrylate-reactive variant (GelMA). A TMSPMA-GelMA bonding was 
performed for 15  minutes  by  adding  0.1%  ammonium  persulphate  and  N,N,N’,N’-
tetramethylenethylenediamine (Sigma-Aldrich) prior to GelMA (0.1% or 0.6%) 
injection within each channel. After surface biofunctionalization, channels were 
extensively rinsed with DPBS prior to cell seeding. In multilayered platforms 
(Extended Data Fig. S4), the distribution layer was functionalized by directly 
incorporating 0.3% TMSPMA in the PDMS before curing. 
Reprogramming. For technological validation, an mmRNA encoding for nuclear 
GFP (StemMACS Nuclear eGFP, Miltenyi Biotec) was used alone, carried into 
the cells by different transfection reagents: RNAiMAX (RiM, Life Technology), 
Stemfect (SF, Stemgent), and StemMACS Transfection Reagent (SM, Miltenyi 
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Biotec), according to the transfection protocols below. Comparisons of 
transfection efficiencies, between microfluidics and wells, and between different 
transfection reagents, were carried out with the same cell density. SF was used if 
not specified. SM was used for feeder-free protocols. 
hiPSCs were generated via mmRNA-mediated reprogramming, adapting the 
protocols reported in literature for feeder23 and feeder-free24 hiPSC derivation, 
from multiple cell sources: human foreskin BJ and HFF-1 fibroblasts, and urine-
derived renal epithelial cells (RE). 
For reprogramming with a feeder layer, NuFF-RQs were seeded at day -2. At day 
-1, the reprogramming target fibroblasts (either BJ or HFF) were seeded at 
different densities (5, 10, and 26 cell/mm2) in DMEM with 10% FBS. At day 0, 2 
h prior to the first mmRNA transfection, medium was switched to Pluriton 
reprogramming medium (Stemgent) supplemented with B18R interferon inhibitor 
(eBioscience) at a final concentration of 200 ng/mL. 
The transfection mix was prepared according to the manual of the StemMACS 
mRNA Reprogramming Kit (Miltenyi Biotec) pooling two solutions: the first 
obtained   diluting   5X   100   ng/μL   mmRNA   of   OCT4,   SOX2,   KLF4,   c-MYC, 
NANOG, LIN28, and nGFP, with stoichiometry 3:1:1:1:1:1:1, in transfection 
buffer solution, and the second diluting 10X transfection reagent in transfection 
buffer solution. The two solutions were mixed in 2:1 volume ratio (RiM and SF) 
or 3:1 (SM), and the final solution was incubated for 15 min (RiM and SF) or 20 
min (SM). Where not specified, SF transfection reagent was used. 
Transfections using the final mmRNA solution were started at day 0 and daily 
repeated for at least 12 days. In well, the final mmRNA solution was added drop-
wise gently rocking the plate, 4 hours prior to daily medium changes with B18R-
supplemented Pluriton medium. In microfluidics, the final mmRNA solution was 
added to different percentages of B18R-supplemented Pluriton medium, pipetted 
inside a reservoir and automatically perfused inside each channel. Fresh B18R-
supplemented Pluriton was added to the reservoir and automatically perfused after 
the transfection period and 12 h thereafter. 
To compensate for progressive NuFF death during reprogramming, NuFF-
conditioned B18R-supplemented Pluriton medium was used from day 6. Pluriton 
medium was conditioned daily with 4 ng/mL b-FGF on a separate NuFF culture.  
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At the end of the transfection series, hiPSC were cultured for two days in Pluriton 
medium without B18R. Few experiments were stopped at this point for 
performing immunofluorescence analysis and determining reprogramming 
efficiency, defined as the ratio of the number of TRA-1-60+ colonies to the 
number of target cells seeded. Otherwise hiPSC colonies were picked and 
passaged as previously described. Microfluidic hiPSC colonies were collected 
either by coring the rubber of the microfluidic chip with a biopsy punch or by a 
preferential detachment using a high flow rate corresponding to a shear-stress of 
25 Pa 25, as shown in Extended Data Fig. S9. 
Feeder-free reprogramming was performed solely seeding BJ, HFF or RE cells at 
day -1 and using B18R-supplemented Pluriton medium for the whole duration of 
reprogramming. RE cells were also kept in RE medium during the first 5 days of 
reprogramming transfections, and were additionally transfected with 45 nM hsa-
miR-372 on day -1 and 4 of the mmRNA reprogramming protocol. 
TRA-1-60+ colonies obtained in microfluidics were catalogued as hiPSC with 
progressive numbering and labeled thereafter.  
Immunofluorescence and colorimetric assays. Immunofluorescence analysis 
was performed either in conventional wells or microfluidic channels with the 
same protocols. Cells were fixed in 4% (w/v) paraformaldehyde (Sigma-Aldrich) 
for 10 min and stained with primary antibodies in 5% goat serum with 0.1% (v/v) 
Triton-X-100 (Sigma-Aldrich). Membrane markers were stained without cell 
permeabilization. Primary antibodies: OCT4 and SSEA-4 (Santa Cruz), NANOG 
(Reprocell), TRA-1-60 and TRA-1-81 (Millipore), SOX2 (Novus Biologicals); 
AFP and BRACHYURY-T (Sigma-Aldrich),   β-III-TUBULIN (Abcam), CK18 
(GeneTex), ALBUMIN (R&D). Alexa488 or Alexa594 conjugated rabbit or 
mouse secondary antibodies were used (Life technologies). Nuclei were stained 
with Hoechst 33342 (Life Technologies). Images were acquired with a 
DMI6000B fluorescence microscope with motorized stage (Leica Microsystems). 
The alkaline phosphatase (AP) assay was performed either by a live AP-kit in 
KnockOut DMEM (both Life Technologies) with a 45-minute incubation, or after 
cell fixation by AP-staining kit II (Stemgent) with a 10-minute incubation of the 
staining solution. Glycogen storage analysis was performed by periodic acid-
Schiff (PAS) staining (Sigma-Aldrich)  following  manufacturer’s  specifications. 
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Image analysis. Image analysis was performed as previously described12. Briefly, 
pairs of images of Hoechst 33342 stained nuclei and nGFP+ cells were analyzed 
using the software MATLAB R2012b (The MathWorks). HOECHST images 
were binary transformed for nuclei localization, after contrast adjustment and 
morphological filtering. In the detected nuclei positions, mean nGFP fluorescence 
intensity was evaluated. A background correction was performed to account for 
differences in cell substrates and in image acquisition conditions. A threshold of 
fluorescence intensity was chosen to discriminate between nGFP positive and 
negative cells. Images were taken at 10X magnification for quantification of 
nGFP+ cells, and 20X for quantification of single nucleus fluorescence intensity. 
Stochastic model. A mathematical model was developed to describe the 
transfection process of nGFP-encoding mmRNA at different concentrations (from 
0.48 to 20 pg/100 cell in microfluidics) and transfection durations (1, 2, and 4 h). 
The model is in the form of a stochastic simulation algorithm to capture the 
discrete nature of mmRNA-containing vesicles and cells (Extended Data Fig. S3). 
Cells are described as a two-dimensional partially adsorbing boundary layer at the 
bottom of the culture volume. In each simulation, they are randomly positioned 
within a regular square grid of 1 mm2, on the cartesian plane . The grid 
spacing,  and ,  was  fixed  at  57.7  μm,  corresponding  to  the side of a square 
having the same area as the average cell, determined experimentally. In the 
experiments we observed that BJ cells, seeded at a density of 250 cell/mm2, 
reached a density of 300 cell/mm2 after 24 h, when transfection occurred, and of 
600 cell/mm2 after another 24 h, when nGFP images were taken. Thus, we 
simulated the transfection process at 300 cell/mm2 and assumed that proliferation 
rate was not affected by cell transfection. 
The stochastic model is discrete both in time and space. A vesicle in position 
, in a time interval  will jump to the neighbor position on the 
lattice with probability 26, where ,  equal  to  10  μm,  is  the  lattice  
spacing and the capture boundary layer27. , the time interval simulated, is 
arbitrary as long as the inequality  holds, where  is the diffusion 
coefficient of vesicles in medium.  was estimated to be 10-12 m2/s by Stokes-
Einstein equation: 
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  (1) 
where  is Boltzmann constant,  absolute temperature (310.15 K),  medium 
viscosity (691.6 10-6 Pa·s28, approximated by water property), and  the vesicle 
radius assuming a spherical shape (approximately 300 nm29).  
Named  the direction perpendicular to the plane of cell culture, the boundary 
condition at  (the cell plane) was defined as partially adsorbing: a vesicle is 
adsorbed with probability  and reflected otherwise, where  
represents the vesicle concentration in the bulk, and  is a positive constant that 
describes the reactivity of the boundary and is the only parameter fitted (1.4·103 
μm2/pg), using experimental data collected in microfluidics at an nGFP mmRNA 
concentration of 16 pg/100 cell. Thus, the overall probability a vesicle enters a 
cell at the boundary is given by two contributions, the probability of reaching the 
boundary and the probability of adsorption: 
  (2) 
provided a vesicle is at distance  from the boundary at the previous time point 
simulated. 
As the characteristic time of adsorption at the surface is much longer than the 
diffusion characteristic time in the medium bulk, we simulated the process within 
the capture boundary layer, assuming the medium bulk plays as an infinite source 
of vesicles. The model was solved using Matlab software (version R2012b). 
RT-PCR and qPCR analyses. Microfluidic channels were first perfused with D-
PBS, then with iScript (Bio-Rad) for total RNA extraction. The solution was left 
in the channels for 2 min before collection. Total RNA was isolated with the 
RNeasymini kit (Qiagen), treated with DNase (Life Technologies), and quantified 
using  NanoDrop   spectrophotometer.  RNA   (0.1  μg)  was   reverse   transcribed   into  
cDNA (Life Technologies). The list of primers used is available in Supplementary 
Table 1. PCR was performed with Platinum Taq polymerase (Life Technologies). 
Electrophoresis was perfomed in a 2% (w/v) agarose gel with SYBR Green (Life 
Technologies). qRT-PCR was performed with TaqMan gene expression assay 
probes (Life Technologies) according to manufacturer's instructions. Reactions 
were performed on ABI Prism 7000 machine and results were analyzed with ABI 
6
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Prism 7000 SDS software. GAPDH expression was used to normalize Ct values 
of gene expression, and data were shown as relative fold change to control cells, 
using the delta-delta Ct method. 
Western blotting analysis. Whole cell lysate was obtained by solubilization of 
cells in 10 µL of 5% deoxycholic acid (DOC, Sigma-Aldrich) and Complete 
protease inhibitor (Roche). PAGE was performed with 4-12% NuPAGE 
polyacrylamide gels and MOPS buffer (Life Technologies). Proteins were blotted 
on PVDF membranes (Life Technologies) and detected with Carestream films 
(Kodak).  A 1:1000 dilution of primary antibodies and HRP-conjugated secondary 
antibodies (mouse, Bio-Rad; rabbit, Life Technologies) were used. Whole cell 
lysate from HES2 embryonic stem cells was used as OCT4 reference. 
TGF-β   assay. Cell-conditioned media were collected every 24 h during the 
reprogramming process. In the microfluidic system this corresponds to mixing the 
medium collected 3 times/day. To activate latent TGF-β,  conditioned  media  were  
heat-treated for 5 min at 368 K prior to use. CAGA12 SMAD2/3 reporter HaCaT 
cell   line   was   obtained   from   Stefano   Piccolo’s   Lab   (Department   of   Molecular  
Medicine, University of Padova), cultured in DMEM supplemented with 10% 
FBS. For luciferase assay, cells were plated in 24-well plates at 90% confluence 
and incubated overnight in DMEM without serum. Cells were then treated with 
conditioned media for 10 h, and supplemented with 1 µM TGF-β   receptor  
inhibitor SB431542 (SB, Peprotech) where indicated. Luciferase expression was 
detected as previously described30. Data were normalized on total protein content, 
determined through Bradford assay. 
Karyotype. Q-banded karyotype was performed by the Cytogenetic and 
Molecular Genetics Laboratory at the University of Brescia (Italy). 
Microarray and bioinformatics. 48 hours after last reprogramming mmRNA 
transfection, four freshly derived colonies of comparable size (~8000 cells) were 
selected both from the microfluidic system and from a parallel reprogramming 
experiment in well plates. After a 24-h conditioning in StemMACS iPS-Brew XF 
medium, each colony was split in two halves: the one half (passage p0) was used 
for total RNA extraction, the other one was further expanded in feeder-free 
conditions for 3 passages (p3) in well plates before total RNA extraction from 
another sectioned colony of comparable size (Extended Data Fig. S9). Each 
colony was lysed using SuperAmp Lysis Buffer (Miltenyi Biotec) and stored 
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appropriately according to the instructions of the SuperAmp Preparation Kit. The 
samples were sent on dry ice to Miltenyi Biotec, where amplification, cDNA 
quantification using ND-1000 Spectrophotometer (NanoDrop Technologies), 
evaluation of cDNA integrity using a 2100 Bioanalyzer (Agilent Technologies), 
and microarray analysis were performed. 250 ng of each of the cDNAs were 
labeled with Cyanine 3 and hybridized (17 hours, 318.15 K) to an Agilent Whole 
Human Genome Oligo Microarrays 8x60K v2. Fluorescence signals of the 
hybridized  Agilent  Microarrays  were  detected  using  Agilent’s  Microarray  Scanner  
System (Agilent Technologies). Agilent Feature Extraction Software (FES) was 
used to read out the microarray image files. Extracted signals were analyzed using 
GeneSpring v12.6 software (Agilent Technologies). Gene expression values were 
normalized by the 75th percentile shifts, and baseline-corrected to the median of 
all samples. Differentially expressed genes between pairs of conditions were 
found using ANOVA with Tukey post-test (significance set at P<0.05), combined 
with a two-fold change expression threshold. Differentially expressed genes were 
checked for functional enrichment using DAVID bioinformatics database 
(http://david.abcc.ncifcrf.gov/). Principal Component Analysis (PCA) was 
performed with variance-based weights, and hierarchical clustering with 
Euclidean distance and nearest-neighbor linkage clustering method, using 
MATLAB (version R2012b). Microarray data are available at the National Center 
for Biotechnology Information Gene Expression Omnibus database under the 
series accession number GSE59534. 
Comparison with microarray datasets deposited in public databases (GEO and 
Synapse Commons Repository) was performed after selection of relevant samples 
obtained with similar Whole Human Genome Agilent arrays (GSE50206, 
GSE42445, syn1447097, syn1449098). Single-batch data normalization was 
performed as above. Only probes common to all the datasets were taken into 
consideration, and genes whose detection was compromised in at least one sample 
were excluded from the analysis. After this filtering procedure, 18479 genes were 
further processed. Datasets merging was performed after batch-effect removal 
using an empirical Bayes method implemented in ComBat R-code31. PCA was 
then performed in MATLAB as above. 
Aspecific differentiation. Embryoid bodies (EB). hiPSC colonies were treated 
with CTK (0.1 mg/mL collagenase IV, 0.25% trypsin, 0.01 M CaCl2, and 0.2% 
  180 
KSR in dH2O) for 30 s, mechanically scratched with a serological pipette and 
resuspended in EB medium (DMEM/F12, 20% knockout serum replacement, 1% 
L-glutamine,   1%   NEAA,   β-mercaptoethanol, all Life Technologies). EB were 
cultured in ultra-low adhesive plates (Corning) for 20 days and then transferred on 
custom-made PDMS micro-wells with a Matrigel (BD) coated glass bottom. 
Characterization was performed after 6 days. 
Aspecific differentiation in monolayer. EB  medium  (without  β-mercaptoethanol) 
was used to aspecifically differentiate hiPSC colonies for 6 days. In microfluidics 
differentiation was performed perfusing the medium every 12 h. In wells medium 
was changed every 48 h. 
Early-germ layer differentiation. hiPSC were differentiated in the following 
germ-layer-specifing media. Ectoderm. DMEM/F12, 1% NEAA, 1 mM L-
glutamine, 0.1 mM beta-mercaptoethanol, 20% KnockOUT serum replacement 
(all Life technologies), 1 uM dorsomorphin. 
Mesoderm. Supplemented StemPro-34 (Life Technologies), 5 ng/mL b-FGF, 2 
mM L-glutamine,   50   μg/mL   ascorbic   acid,   150   μg/mL   transferrin,   0.3   ng/mL  
activin-A, 10 ng/mL BMP-4, 46  μg/mL  methyl-thio-glycerol. Endoderm. Days 1-
2, RPMI, 2% B27 supplement, 100 ng/mL activin-A, 50 ng/mL Wnt3a. Days 3-5, 
RPMI, 2% B27 supplement, 100 ng/mL activin-A. 
Cardiac differentiation. Small molecules were used to promote cardiac 
differentiation of hiPSC colonies. RPMI with B27 without insulin (cardiac basal 
medium, CBM, Life Technologies) with 10 mM CHIR99021 and was perfused in 
microfluidics every 12 h for the first 24 h. Thereafter the medium was changed 
every 24 h. CBM was used in the following 36 h and CBM with 4 mM IWP-4 in 
the next 24 h. CBM was then used until cardiac maturation at day 14 from the 
beginning of differentiation protocol. Medium change in wells was performed 
only at changes of medium composition as above. 
Hepatic differentiation. hiPSC colonies obtained in microfluidics were 
maintained in StemMACS iPS-Brew XF medium to grow over the channel 
surface. RPMI-B27 was supplemented with 100 ng/ml activin-A and 0.5 mM 
sodium butyrate for 3 days. Medium was changed to KO-DMEM, 20% Serum 
Replacement (both from Invitrogen), 1 mM L-glutamine, 1% NEAA, 0.1 mM b-
mercaptoethanol, 1% DMSO (Sigma-Aldrich) for 6 days. Hepatic-like cells were 
maturated with L15 medium (Sigma-Aldrich) supplemented with 8.3% FBS, 
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8.3%   tryptose   phosphate   broth,   10   μM   hydrocortisone   21-hemisuccinate,   1   μM  
insulin (all from Sigma-Aldrich) and 2 mM L-glutamine containing 10 ng/ml 
hepatocyte growth factor and 20 ng/ml oncostatin M (both from R&D) for 6 days. 
Medium was changed every 12 h in the microfluidic system, and every 24 h in 
wells. 
Statistical analysis. For statistical analyses, single pairwise comparisons were 
analyzed using Student's t-test with P < 0.05 (*), P < 0.01 (**) or P < 0.001 (***), 
indicating significance. Multiple comparisons were performed by one-way 
ANOVA with Tukey post-test, with P < 0.05 (*), P < 0.01 (**) or P < 0.001 
(***), indicating significance. Values are expressed by mean and standard 
deviations (s.d.).  
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Fig. 1 | Miniaturization of human tissue development in vitro. (a) Perspective high-throughput 
derivation of human tissues for biological assays on a population scale. (b) Quantitative 
comparison of resources requirements between reprogramming in a microfluidic channel and in a 
well of a 6-well plate. (c) Progressive down-scaling strategy:  from miniaturization of 
reprogramming, to miniaturization of differentiation, to a fully integrated one-step 
reprogramming-and-differentiation process. 
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Fig. 2 | Design and validation of microfluidic technology for cell reprogramming. (a) 
Microfluidics reprogramming and differentiation of somatic cells are integrated in a joint 
workflow. (b) Automated microfluidic platform setup, comprising a microfluidic chip, which 
accommodates 32 parallel microchannels, and a liquid handling (2 ports) and pneumatic control of 
fluids (15 ports) managed remotely by a computer. (c) Efficiency of transfection of nGFP in BJ 
fibroblasts as a function of mmRNA amount, derived from images taken 24 h after a single 
transfection by RNAiMAX (RiM). Error bars, mean±s.d. (n>4). (d) Experimental (large dots) and 
mathematical model-derived (small dots) transfection efficiency for different incubation periods 
(RiM). Error bars, mean±s.d. (n>4). (e) In silico simulation of mmRNA content distribution in the 
cell population, as a function of mmRNA amount and transfection duration. (f) Western blot 
analysis of the indicated proteins expressed from exogenous mmRNAs of single microfluidic 
channels and wells, and appropriate controls, performed 24 h after two daily mmRNA 
transfections in BJ fibroblasts. Error bar, mean±s.d. (n=4). (g) Transfection progression in 
microfluidics during reprogramming, verified by nGFP expression. Scale bar, 500 and 150 µm 
(macro). (h) Representative hiPSC colony generated inside an automated microfluidic chip. (i) 
Expansion of primary hiPSC in a microfluidic channel. Scale bar, 750 µm. (j) Reprogramming 
efficiencies of different cell types under optimal (opt) or non-optimal (non-opt) conditions. Error 
bar, mean±s.d., (n>8). (k) Microfluidic chip with superimposed TRA-1-60+ colonies at the end of 
reprogramming protocol with feeders cells. 
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Fig. 3 | Characterization of microfluidic-generated hiPSC. hiPSC were expanded in wells for at 
least 12 passages and characterized by means of  (a) immunofluorescence,  (b) alkaline 
phosphatase, (c) RT-PCR, and (d) karyotype. (e) Expanded microfluidic hiPSCs are able to 
generate cells expressing markers from the three germ layers after directed differentiatio. (f) 
Embryoid bodies from microfluidic hiPSC, and (g) their characterization by RT-PCR of germ-
layers markers. (h) In situ immunofluorescence characterization of microfluidic hiPSC before and 
after fixation. (i) Principal component analysis of freshly-derived and expanded hiPSC from 
microfluidics and wells, grouped according to results from hierarchical clustering. (j) Microarray-
derived expression profiles of genes differentially expressed between the 4 conditions in Fig. 2I, 
belonging to GO category extracellular space and to TGF-β  KEGG  pathway.  (k) TGF-β  pathway  
activation during reprogramming measured as SMAD2/3 activity of a reporter line. Error bar, 
mean±s.d. (n=3). Scale bars, 25 µm (a,e), 500 µm (f),  200 µm (h). 
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Fig. 4 | Differentiation of freshly obtained hiPSC in microfluidics. (a) hiPSC differentiated in 
aspecific medium comprising cells with different morphological phenotypes (scale bar, 250 µm) 
and (a) expressing markers of the three germ layers, as evidenced by RT-PCR. (c) qPCR analysis 
to detect specific early germ-layer commitment of hiPSC colonies purified and directly seeded in 
new microfluidic channels for differentiation. Error bars, mean±s.d. (n=10). (d) Cardiomyocytes 
(cTNT) and hepatic-like (CK18 and actin) cells from late-stage specification of hiPSC, extracted 
and pooled into new channels for differentiation. Scale bars, 50 µm. (e) One-step maturation of 
primary microfluidic hiPSC into hepatic lineage. Each colony differentiated in large areas of 
mature cells, also presenting functional markers (albumin, PAS, CK18). Scale bars, 250 µm, 50 
µm (albumin). (f) Schematic summary describing the one-step process of reprogramming and 
differentiation in microfluidics without intermediate passaging. 
 
